A studyof the association of cold weather and all-cause and cause-specific mortality on the island of Ireland between 1984 and 2007. by Browne, Stephen
 
 
 
A STUDY OF THE ASSOCIATION OF COLD WEATHER 
AND ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY 
ON THE ISLAND OF IRELAND BETWEEN 1984 AND 
2007 
 
 
 
 
 
A thesis submitted for the degree of  
Master of Philosophy 
 
 
 
by Stephen David Browne 
 
 
 
College of Health and Life Sciences 
 
 
 
Brunel University 
 
 
 
May 2015 
 
 i 
 
Abstract 
Background: 
This study explored the differences between the seasonal mortality rates (by age and 
gender) between the two jurisdictions (the Republic of Ireland (RoI) and Northern 
Ireland (NI)). The study assessed the relationship between cold temperatures and daily 
mortality, and assessed for effect modification of the cold weather-mortality 
relationship by age and gender.  
Methods: 
Mortality rates were calculated for each cause-specific mortality group during various 
seasons in both jurisdictions. A time-stratified case-crossover approach was applied to 
examine the cold weather-mortality relationship, 1984-2007. The daily mortality risk 
was explored in association with exposure to daily maximum temperatures on the same 
day and up to 6 weeks preceding death, during the winter months and extended cold 
period (October-March), using distributed lag models. Model stratification by age and 
gender assessed for modification of the cold weather-mortality relationship.  
Results: 
The winter mortality rates were significantly greater than the summer rates. NI 
experienced higher mortality from cardiovascular disease, respiratory disease and 
stroke. The impact of cold weather in the winter months persisted up to 35 days in the 
RoI, with a cumulative mortality increase for all-cause of 6.4% (95%CI: 4.8%-7.9%) 
with regards to every 1
o
C drop in the daily maximum temperature with similar 
associations for cardiovascular disease and stroke with twice as much for respiratory 
diseases. The associations were less pronounced and less persistent in NI.  
Conclusions: 
The study observed excess winter mortality. The cold weather-mortality associations 
increased with age with some suggestion of gender differences. There were strong cold 
weather-mortality associations in both jurisdictions, with suggestive differences in 
associations by age and gender. The findings suggest the potential contribution of 
societal differences, and require further exploration. These findings will hopefully 
contribute to the current efforts to modify fuel policy and reduce winter mortality in 
both jurisdictions. 
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1.0 INTRODUCTION 
1.1 Background 
The impact of weather on human health is increasingly being evidenced by 
epidemiological studies in the light of the effects of climate change (Michelozzi et al. 
2007). Under the influences of global climate change, both mean temperature and 
temperature variability are expected to increase globally, likely affecting the increasing 
frequency of weather extremes, such as cold spells and heatwaves (Field et al. 2014; 
McMichael et al. 2006; Michelozzi et al. 2007). The Intergovernmental Panel on 
Climate Change (IPCC) has projected that in the coming decades, extreme weather 
events will become more frequent and more intense in some parts of the world and such 
events will impact upon health (Stocker et al. 2013). Recent record low temperatures in 
Northern Europe and the United States highlight the potential health and societal 
impacts of extreme winter weather, despite the rise in global average temperatures 
(Barnett et al. 2012; Staddon et al. 2014).  
 
The nature and magnitude of the association between temperature and human health has 
been increasingly recognised (Basu and Samet 2002; Braga et al. 2001; Kunst et al. 
1993; Martens 1998; Medina-Ramon et al. 2006; Patz et al. 2000; Samet et al. 1998). 
Mortality is known to be associated with meteorological conditions and to display a 
seasonal pattern, with excess mortality during the winter as well as during hot days in 
the summer (Kalkstein and Greene 1997).  Generally, the health effects of extreme heat 
events are acute and some harvesting is observed, but the effects of extreme cold 
temperatures are generally more prolonged than heat without mortality displacement 
(Analitis et al. 2008; Kysely et al. 2009; Xie et al. 2013). Heatwaves in Europe in the 
summer of 2003 produced a rise in general mortality and concern in both the public and 
public health authorities (Kovats et al. 2004; Martinez-Navarro et al. 2004). However, 
the impact of cold weather on health has received much less attention despite its 
relationship with higher mortality and morbidity (Gomez-Acebo et al. 2010). 
 
Exposure to cold temperatures contributes to a wide range of impacts on public health, 
such as increased mortality from cardiovascular, cerebrovascular and respiratory disease 
(Alberdi et al. 1998; Analitis et al. 2008; Anderson and Bell 2009; Armstrong 2006; 
Barnett et al. 2012; Braga et al. 2002; Carder et al. 2005; Donaldson and Keatinge 
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1997; Goodman et al. 2004; Gouveia et al. 2003; Hajat et al. 2005; Kunst et al. 1993; 
Pattenden et al. 2003; Yu et al. 2011). Although the association between cold weather 
and ill-health has been known for some time, populations across Europe still experience 
significantly more deaths in winter and non-winter months (Analitis et al. 2008; Fowler 
et al. 2014; Healy 2003; McKee 1989). Relative excess winter mortality was found to 
be highest in Southern Europe, the Republic of Ireland and the United Kingdom, where 
seasonality in mortality of 18-28% was calculated (Healy 2003). This is apparent at all 
ages but is greatest in relative and absolute terms in elderly people (Laake and Sverre 
1996; Wilkinson et al. 2001). Much of the excess seems to be related to cold 
(Armstrong et al. 2000; Pattenden et al. 2003) yet Britain has a larger seasonal 
fluctuation in mortality than many other countries in continental Europe and 
Scandinavia despite having milder winters (McKee 1989). Relative seasonal variation in 
mortality appears lowest in countries with cold winters, such as Russia, Norway and 
Canada and is higher in Britain, Israel and Portugal where winters are milder (Curwen 
1991; Douglas and Rawles 1999; Laake and Sverre 1996; McKee 1989). Although 
many countries currently experienced an increase in mortality during the winter, the 
magnitude of this increase varies considerably, suggesting that some winter excess may 
be avoidable (Davie et al. 2007). 
 
In several temperate countries, associations between daily outdoor temperature 
mortality appear to have weakened in recent decades (Barnett 2007; Carson et al. 2006; 
euroMOMO 2013; Hajat et al. 2007; Lerchl 1998; Medina-Ramon and Schwartz 2007). 
However, it is still reported that in temperate countries, mortality rates are typically 10 
to 30% higher during the winter compared to the warmer months (Aylin et al. 2001; 
Carson et al. 2006; Davie et al. 2007; Gemmell et al. 2000; Hajat et al. 2007; Healy 
2003; McMichael et al. 2008; Wilkinson et al. 2001). The large death toll and the 
disruption associated with the cold weather in Central and Eastern Europe in the winter 
of 2005-2006 was a timely reminder of how poorly prepared many people were to the 
dangers of extreme cold temperatures (Hajat et al. 2007). 
 
The immediate cause of most excess winter death is cardiovascular or respiratory 
disease, including seasonal respiratory infections, particularly in older people and those 
with chronic health conditions (Davie et al. 2007; Donaldson and Keatinge 1997; Rudge 
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and Gilchrist 2005; The Marmot Review Team 2011; Wilkinson et al. 2001). Mortality 
rates for cardiovascular and respiratory disease typically exhibit seasonal variation with 
the highest rates occurring in the winter months (Bowie and Jackson 2002). In 
temperate zones, all-cause mortality exhibits a marked seasonality with the highest 
number of deaths in the winter, and a lower number in the summer period (Nielsen et al. 
2011).  Excess winter mortality which is largely attributed to cardiovascular and 
respiratory diseases, might be related to seasonal changes in ambient exposures 
(temperature, humidity, ultraviolet light, air-pollution), diet behaviour, infectious 
disease transmission and other unidentified exposures (Barnard et al. 2008). Studies 
from European (Douglas et al. 1995; Haberman et al. 1981) and Asian (Enquselassie et 
al. 1993; Marshall et al. 1988; Pan et al. 1995) countries have observed an increase in 
death rates from acute myocardial infarction (AMI) and stroke in winter.  
 
The gradient of the low-temperature mortality relationship has declined progressively 
over the century, with the steepest temperature-related gradients observed for 
cardiovascular and respiratory deaths (Carson et al. 2006); the gradient of the decline in 
mortality was more moderate for respiratory disease (Carson et al. 2006). The 
vulnerability to cold has decreased over the course of the 20th century, despite the 
ageing of the population and a progressive increase in the prevalence of 
cardiorespiratory disease (Carson et al. 2006). Temperature-related mortality is of 
current scientific and public health interest in the United Kingdom (UK) (Carson et al. 
2006) because of the persistently high number of excess winter deaths (Wilkinson et al. 
2001) which is paradoxically higher in Britain than in many other colder-winter 
countries of continental Europe (Healy 2003). 
 
1.2 Physiological effects of exposure to cold temperatures 
Extreme temperatures are associated with daily mortality in numerous regions of the 
world; generally, non-linear relations (U, Y, or V shaped) have been observed with 
increased mortality at high or low temperatures (Braga et al. 2001; Kunst et al. 1993).  
There is an association between cardiovascular admissions and low temperatures 
(Schwartz et al. 2004). Cold weather alone causes striking short term increases in 
mortality, mainly from thrombotic and respiratory disease (Donaldson and Keatinge 
1997).  Some of the physiological consequences of the reduction in temperature, 
 4 
 
thought to be involved in increased coronary risk, might be hazardous in heart failure 
(Stewart et al. 2002) and similar patterns were found with deaths from stroke (Sheth et 
al. 1999). The definition of ‘cold environment’ includes environmental conditions that 
activate the human thermoregulatory system (Raatikka et al. 2007). This system may be 
activated even at 15°C, although cold-induced sensations and physiologic responses 
usually develop at lower temperatures (Makinen 2006). The physiological and 
psychological aspects of cold are reflected in occupational health standards, which 
define cold as temperatures below 10 to 15°C (BS7915 1998). The combination of cold 
air, wind and wetness can quickly overwhelm human thermoregulation, the 
consequences ranging from impaired performance to death (Raatikka et al. 2007). 
 
People expose themselves to cold ambient temperatures while commuting to work, 
while working and during recreation (Raatikka et al. 2007). Cold exposure may be due 
to environmental conditions, such as cold air, wind, rain, snow and ice or cold water 
immersion or contact with cold materials (Keim et al. 2002). Housing conditions and 
the ability to keep warm plays a key role in whether old people can survive the winter; 
and this is taken in conjunction with their general health to begin with (Goodman et al. 
2011). The evidence indicates that cold may be a more important risk factor for 
morbidity and mortality than has been seen so far (Mercer 2003). For both clinical and 
public health reasons, it is important to estimate the prevalence of cold related 
complaints, symptoms and diseases in the general population (Raatikka et al. 2007). 
Patients with certain chronic medical conditions, such as cardiovascular and 
cerebrovascular diseases, diabetes mellitus and respiratory diseases, are most 
susceptible to cold (Makinen 2006). 
 
Furthermore, it seems that long periods of cold weather appears to weaken those who 
are susceptible; and that if the cold weather continues, they may get progressively 
weaker and eventually die while if the temperature rises they may recover (Goodman et 
al. 2011). Excess winter mortality is not normally recorded as being from hypothermia, 
but it appears that cold weather interacts to trigger deaths from existing cardiovascular 
disease and/or respiratory conditions (Goodman et al. 2011). 
 
Air temperature changes are associated with increased cardiovascular and respiratory  
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risk (Hampel et al. 2010). Temperature decrease is associated with change in several 
blood parameters; the complex interplay of blood markers at low temperatures may 
contribute to the observed associations between cold and cardiovascular mortality and 
morbidity (Hampel et al. 2010). Extreme cold temperatures are related to the increase in 
the heart rate, peripheral vasoconstriction, blood pressure, blood cholesterol levels, 
plasma fibrinogen concentrations and platelet viscosity (Ballester et al. 1997; Barnett et 
al. 2007; Carder et al. 2005). Exposure to winter conditions may induce physiologic 
stress including sympathetic activation, hypercoagulability and infection which can 
increase the incidence or case fatality of acute myocardial infarction and stroke 
(Douglas et al. 1995).   
 
Environmental temperature has been implicated in seasonal variations in the evidence of 
acute myocardial infarction (AMI) and sudden death as these events peak in winter 
(Stewart et al. 2002). AMI deaths showed significant seasonal changes overall with 
deaths being higher in winter and lower in the summer with seasonal variation in 
mortality of nearly 10% (Sheth et al. 1999). Deaths such as myocardial ischaemia from 
increased work demands on the heart muscle or from increased formation of thrombus 
can occur in hours or days (Mercer 2003; Neild et al. 1994). A raised blood pressure in 
a cold environment has several adverse effects: it alters the ratio of myocardial oxygen 
supply to demand, and increases the ventricular wall stress, cardiac work, and oxygen 
requirements, but it also reduces mechanical efficiency and may impair coronary blood 
flow, particularly in people with fixed stenosis (Wilmshurst 1994). Consequently cold 
can precipitate myocardial ischaemia (Wilmshurst 1994). It is hypothesised that a wide 
range of blood markers are involved in the development of atherosclerosis leading to 
chronic as well as acute cardiovascular disease (Hampel et al. 2010). The excess 
number of coronary events in cold climates may also be related to blood clotting 
(Wilmshurst 1994). The plasma concentration of fibrinogen is inversely related to 
environmental temperature, but part of the rise in fibrinogen concentrations in the 
winter may be the result of seasonal respiratory infections (Elwood et al. 1993; 
Woodhouse et al. 1994).  
 
For respiratory deaths, on the other hand, the timescale for manifestation of an adverse 
health effect may be longer – running into days or weeks with the progression to a full 
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blown exacerbation of chronic pulmonary disease taking longer (Carder et al. 2005; Yu 
et al. 2011a). Cold related increases in respiratory mortality are generally attributed to 
cross infection from increased indoor crowding during colder months and to the 
detrimental effect of exposure to cold temperatures, on the immune system’s resistance 
to respiratory infections (The Eurowinter Group 1997). 
 
Seasonal variations in fibrinogen concentrations due to temperature changes may be 
half that resulting from smoking (Elwood et al. 1993). In cold conditions the plasma 
concentrations of some clotting factors are increased, as a platelet count and in vitro 
platelet aggregation (Elwood et al. 1993; Keatinge et al. 1984; Neild et al. 1994; 
Woodhouse et al. 1994). Plasma volume and increased blood viscosity during the cold 
exposure also tend to promote thrombosis (Keatinge et al. 1984; Neild et al. 1994). 
Whether these factors have a role in atherogenesis is uncertain (Wilmshurst 1994). The 
cold can adversely alter plasma lipid concentrations, making abnormal thrombosis more 
likely and having a potential chronic atherogenic effect (Woodhead et al. 1994). 
 
1.2.1 Aging 
There is evidence that the effects of cold temperatures on mortality are pronounced in  
vulnerable groups such as the elderly and persons affected by chronic respiratory or  
cardiovascular diseases (Alberdi et al. 1998; Anderson and Bell 2009; Ballester et al. 
1997; Curriero et al. 2002; Keatinge and Donaldson 2004; Kunst et al. 1993; Lin et al. 
2011; O'Neill et al. 2003; Revich and Shaposhnikov 2008; Rocklov et al. 2011; The 
Eurowinter Group 1997). The effects of temperature on mortality are generally 
heterogeneous across socio-demographic strata such as age and gender (Basu and Samet 
2002).  Excess winter mortality, particularly in the older age groups is a well-known 
phenomenon, and most countries suffer from 5 to 30% excess winter mortality (Eng and 
Mercer 1998; Keatinge and Donaldson 1995; Kunst et al. 1993), mainly due to 
cardiovascular and respiratory diseases (Keatinge 2002; The Eurowinter Group 1997) . 
 
The ability of older adults to maintain core temperature is usually compromised (Yu et 
al. 2011a).  The reduced sweat gland output, reduced skin blood flow, smaller increase 
in cardiac output and less redistribution of blood flow from renal and splanchnic 
circulations can consequently aggravate the injury to thermoregulation 
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(Basu 2009; Bouchama and Knochel 2002; McGeehin and Mirabelli 2001).   
 
Aging is associated with an augmented systolic and mean blood pressure (BP) response 
to non-internal body temperature-reducing cold stress in humans and that these 
responses are strongly associated with increased levels of central arterial stiffness (Hess 
et al. 2009).  Age-associated increases in arterial stiffness may be a critical factor 
underlying this augmented BP response in older individuals, as suggested by the strong 
correlation between these measures (Hess et al. 2009).  Increased levels of central 
arterial stiffness may lead to greater increases in myocardial oxygen demand during 
cold exposure in older adults (Hess et al. 2009).   
 
A pronounced age effect in seasonal variations of death rates was observed with winter 
increases as mortality from AMI and stroke being greater in the elderly compared with 
younger individuals (Sheth et al. 1999).  The elderly, with their reduced physiologic 
reserve, may be more vulnerable to these influences than young people (Sheth et al. 
1999).  Aging is associated with augmented presser responses (systolic and mean BP) to 
non-internal body temperature-reducing cold stress in humans (Sheth et al. 1999).  
 
1.3 Cold weather-mortality relationship  
It is well-established that in many countries, there is significantly more mortality in 
winter than in summer (Goodman et al. 2011). Mortality presents seasonal dynamics 
with a maximum number of deaths in the winter and a minimum in the summer, which 
has been related to meteorological variables, mainly temperature (Alderson 1985; 
Mackenbach et al. 1992). Heatwaves in Europe in the summer of 2003 produced a rise 
in general mortality and concern in both the public and public health authorities (Kovats 
et al. 2004; Martinez-Navarro et al. 2004). However, the impact of cold weather on 
health has received much less attention despite its relationship with higher mortality and 
morbidity (Gomez-Acebo et al. 2010). 
 
Although some of the excess winter mortality can be explained in some instances in 
terms of epidemics such as influenza; there are many studies which have taken account 
of influenza and still demonstrate a strong relationship between increased mortality and 
cold temperatures (Goodman et al. 2011). In several temperate countries, associations 
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between daily outdoor temperature and mortality appear to have weakened in recent 
decades (Barnett 2007; Carson et al. 2006; Hajat et al. 2007; Lerchl 1998; Medina-
Ramon and Schwartz 2007).  
 
The mortality of current day is often derived from exposure to today’s temperatures and 
temperatures on several previous days or weeks (Anderson and Bell 2009; Bi et al. 
2008). The effects for cold weather have been estimated to increase after several days, 
persisting for approximately several weeks and can exhibit a direct and indirect impact 
on mortality from days to weeks showing that temperature variability is an important 
determinant of human health effects (Alberdi et al. 1998; Analitis et al. 2008; Anderson 
and Bell 2009; Barnett et al. 2012; Braga et al. 2002; Carder et al. 2005; Donaldson and 
Keatinge 1997; Goodman et al. 2004; Gouveia et al. 2003; Guo et al. 2011; Pattenden 
et al. 2003; Saez et al. 1995; The Eurowinter Group 1997; Yu et al. 2011). The 
distributed lag model has been applied to explore the delayed effects of temperature on 
mortality (Analitis et al. 2008; Baccini et al. 2008; Hajat et al. 2005). Previous studies 
have explored the lag effects of temperature on mortality (Alberdi et al. 1998; Analitis 
et al. 2008; Anderson and Bell 2009; Braga et al. 2002; Carder et al. 2005; Goldberg et 
al. 2011; Goodman et al. 2004; Huynen et al. 2001; Lin et al. 2011) . 
 
In both the United States and Europe, an increase in the number of deaths has been 
recorded after winter cold spells and summer heatwaves (Larsen 1990). The immediate 
associations of cold on mortality rates have been reported in several studies (Alberdi et 
al. 1998; Ballester et al. 1997; Kunst et al. 1993; Larsen 1990; The Eurowinter Group 
1997). In the Netherlands, annual cold-related mortality was higher than heat-related 
mortality (Keatinge 2002). Most of the excess mortality in winter was reportedly due to 
respiratory, cardiac and cerebrovascular disease (Hajat and Haines 2002). The 
associations on respiratory, cardiovascular and cerebrovascular diseases of cold 
temperatures has been reported to occur over prolonged periods, in some cases up to a 
few weeks duration (Alberdi et al. 1998; Donaldson and Keatinge 1997). Lower mean 
temperatures in south-east England (including London) were associated with excess 
deaths from all causes, observing the maximum associations three days after the cold 
peak and lasting up to 40 days (Donaldson and Keatinge 1997). Although cold 
temperatures show greater effects than hot temperatures, other factors such as 
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respiratory epidemics, usually present during the winter time, make unclear the precise 
role of temperature on increased morbidity and mortality (Braga et al. 2002). 
 
A large US study described the decrease in mortality risk as a temperature increase from 
the coldest days to certain threshold temperature, above which mortality risk increased 
with temperature (Curriero et al. 2002). A similar pattern has been seen in Europe 
(Baccini et al. 2008; Hajat and Haines 2002; Keatinge et al. 2000; Kunst et al. 1993), 
and in a number of lower and middle income countries (McMichael et al. 2008). 
Periods of extreme cold or heat have also been associated with mortality peaks (Huynen 
et al. 2001). A Chinese study showed that significant associations between cold 
temperatures and mortality (cold associations) appeared after three days and last for up 
to 10 days (Guo et al. 2011). A study in Thailand observed that cold temperature was 
significantly associated with the risk of all mortality types and age groups, except for 
respiratory mortality (Guo et al. 2012).  
 
A study of temperature-related mortality for Dublin showed that cold temperatures were 
associated with increased all-cause mortality; and that the effects extended for 2 to 3 
weeks, and were not just an immediate acute effect: these increases in mortality were 
observed in all age groups, with the biggest effects in the elderly (Goodman et al. 
2004). These effects of temperature on mortality in Dublin were similar to reports from 
other European studies (Analitis et al. 2008; Goodman et al. 2004). A study in Scotland 
reported that each 1°C reduction in weekly average temperature in Scotland was 
associated with an approximately 1% increase in total mortality, which persisted for 
several weeks (Gemmell et al. 2000). Lower mean temperatures in the East of England 
have been associated with excess deaths from all causes (Donaldson and Keatinge 
1997). A study in London reported that a 1°C decrease in temperature was associated 
with 3% increase in total deaths over the next 24 days in greater London (Keatinge and 
Donaldson 2001). Others have also reported strong associations between increased 
mortality and prolonged periods of cold weather in London (The Eurowinter Group 
1997; Wilkinson et al. 2001).  
 
A study in the United States (US) found that both high and low temperatures were 
associated with increased cardiovascular mortality in analysis of cardiovascular 
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mortality in eight US cities (Braga et al. 2002). It was reported that winter respiratory 
deaths peaked about 12 days after the cold spell (Keatinge 2002). The short-term 
associations of cold on mortality persisted for up to 23 days with no evidence of 
mortality displacement (Analitis et al. 2008). A large US study reported that cold-
related mortality was most associated with the longer lag period (average of current day 
to 25 days preceding death) (Anderson and Bell 2009). A study in the US found no clear 
evidence for an extra association of cold waves of the general associations of cold 
temperatures, although they stress that cold temperatures still posed a significant health 
problem (Barnett et al. 2012). A study in Scotland observed that respiratory mortality 
persisted to 4 weeks preceding death (Gemmell et al. 2000). 
 
Cold-related mortality was most associated with longer lags (average the current day to 
25 days previous) (Anderson and Bell 2009). A study in Germany found that cold spells 
lead to excess mortality to a relatively small degree which lasted for weeks (Laschewski 
and Jendritzky 2002). A Japanese study reported that exposure to cold temperatures 
triggered cardiovascular deaths (Atsumi et al. 2013). However, a Spanish study did not 
detect a trend on the cold-related mortality trigger thresholds (Miron et al. 2012). They  
suggested that the trend towards a decline in the cold temperature-mortality associations 
has also been accompanied by the favourable trend in economic indicators during the 
study period including improvement of the Spanish health service (Miron et al. 2012). 
 
A Russian study observed that the cold weather-mortality associations persisted up to 6 
days preceding death (Revich and Shaposhnikov 2008). A Chinese study found that the 
cold associations persisted for 10 to 12 days (Yang et al. 2012). A Canadian study 
reported modest increased associations from 2 to 5 days in cold temperatures (Goldberg 
et al. 2011). However, although they applied a long distributed lag structure over a long 
study period, they suggested that the lack of pronounced cold associations may be the 
result of homes in the study population being well insulated (Goldberg et al. 2011). An 
Australian study observed that the cold associations persisted for 21 days preceding 
death (Yu et al. 2011). A US study finds similar prolonged associations (Braga et al. 
2001). A study in Thailand observed that cold temperature was significantly associated 
with the risk of all mortality types and age groups, except for respiratory mortality (Guo 
et al. 2012). A study of 12 cities in the United States found that the cold associations 
persisted for several weeks (Braga et al. 2002). A Chinese study showed that significant 
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associations between cold temperatures and mortality (cold associations) appeared after 
three days last for up to 10 days (Guo et al. 2011). 
 
1.4  Modelling approaches 
There have been a number of studies, which have assessed the cold weather-mortality 
associations, and have been conducted across the world from temperate to tropical 
climates, varying in population type, study design, length of study, population sample 
size and length of lag structure (see Table 1). Studies have indicated that prolonged 
associations of exposure to cold temperatures may increase mortality and show that 
temperature variability is an important determinant of human health (Analitis et al. 
2008; Barnett et al. 2012; Braga et al. 2002; Carder et al. 2005; Donaldson and 
Keatinge 1997; Guo et al. 2011; Saez et al. 1995; The Eurowinter Group 1997). Studies 
have also examined the effect modification of age and gender on the cold weather and 
mortality relationship (Barnett et al. 2012; Kysely et al. 2009; Medina-Ramon et al. 
2006; Nielsen et al. 2011; O'Neill et al. 2003; Sheth et al. 1999; Yang et al. 2012).  
 
The distributed lag model has been applied to explore the delayed effects of temperature 
on mortality (Analitis et al. 2008; Anderson and Bell 2009; Hajat et al. 2007). 
Epidemiologic studies have explored the delayed effects of temperature on mortality 
over medium lag structures (up to 2 weeks) (Atsumi et al. 2013; Barnett et al. 2005; 
Hajat et al. 2007; McMichael et al. 2008; Rocklov et al. 2011); while long lag 
structures of up to 5 weeks have also been explored (Analitis et al. 2008; Anderson and 
Bell 2009; Barnett et al. 2012; Goldberg et al. 2011; Lin et al. 2011; Miron et al. 2012; 
Tian et al. 2012).  
 
Fewer studies have considered a longer lag structure (longer than 5 weeks) (Donaldson 
and Keatinge 1997; Gemmell et al. 2000; Goodman et al. 2004). Studies have explored 
the lagged association of temperature on mortality, including longer lag structures and 
these studies have applied the Poisson generalised additive models and regression 
models to explore the temperature impact on mortality (Analitis et al. 2008; Anderson 
and Bell 2009; Armstrong 2006; Carder et al. 2005; Dominici et al. 2004; Goldberg et 
al. 2011; Goodman et al. 2004).  
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In addition to the distributed lag structures, the length of the study periods and the 
population sample size add to the strength of the studies. Many of the above studies 
have applied Poisson regression with short-medium or long lag structures to varying 
lengths of study periods and population sample sizes. However, few studies have 
applied a combination of long lag structures, a long study period and a large sample size 
(Anderson and Bell 2009) while others have used a longer lag structure and long study 
period but have not specified their population sample size (Carder et al. 2005; Carder et 
al. 2008; Goldberg et al. 2011; Huynen et al. 2001; Keatinge and Donaldson 2001; Lin 
et al. 2011). None of these studies applied the case-crossover approach. 
 
Some studies have applied a combination of both Poisson regression and case-crossover 
approach to their studies (Guo et al. 2011; Guo et al. 2013; Tian et al. 2012). However, 
two of these studies applied short-medium distributed lag structures (Guo et al. 2013; 
Tian et al. 2012) while the other study used a long distributed lag structure (Guo et al. 
2011). However, all of those studies applied a short study period while two studies did 
not specify their population sample size (Guo et al. 2011; Guo et al. 2013) while the 
other study used a small sample population (Tian et al. 2012). 
 
The Poisson generalised additive model was widely used to explore the lagged 
association of temperature on mortality (Analitis et al. 2008; Anderson and Bell 2009; 
Armstrong 2006; Ballester et al. 1997; Dominici 2004; Goodman et al. 2004; Hajat et 
al. 2007; Rocklov et al. 2011).  Poisson regression has the advantage of controlling for 
many potential confounders by design since same population is examined repeatedly 
under varying exposure conditions but with constant, or slowly varying, covariate 
patterns such as gender and racial make-up (Bateson and Schwartz 1999). Time trend 
and seasonal effects of exposure levels and counts of outcomes are potential 
confounders, and are typically controlled for by modelling (Bateson and Schwartz 
1999).  
 
Another approach to estimating the effects of cold temperature on mortality involves the 
use of the case-crossover by design and this has been used in recent studies assessing 
temperature and mortality (Guo et al. 2011; Wichmann et al. 2011; Yu et al. 2012). The 
case-crossover design controls for seasonal variation, time trends, and slowly time 
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varying confounders by design (Bateson and Schwartz 1999, 2001; Levy et al. 2001a). 
The case-crossover approach makes examination of effect modification more 
straightforward because it focuses on individual events rather than daily counts 
(Schwartz, 2004). 
 
The studies, which have used the case-crossover design, have applied a short-medium 
lag structure and a short-medium study period (Atsumi et al. 2013; Gomez-Acebo et al. 
2010; Hong et al. 2003; Medina-Ramon and Schwartz 2007; Wichmann et al. 2011; 
Wichmann et al. 2012) at the time of writing.  There have been no studies which have 
applied the case-crossover design to explore the association of temperature on all-cause 
mortality:  cardiovascular disease (CVD), ischaemic heart disease (IHD), myocardial 
infarction (MI), all respiratory disease (RD), chronic obstructive pulmonary disease 
(COPD), pneumonia and stroke mortality over a longer lag structure (5 weeks or more) 
and longer study period (24 years) in a temperate zone with a large population sample, 
including urban and rural communities across the whole of the island of Ireland, which 
included two different governmental jurisdictions.   
 
A previous Irish study had examined the relationship between cold weather and 
mortality in one city over a period of 17 years using Poisson regression models 
(Goodman et al. 2004).  However, this MPhil study expanded upon an earlier Irish 
study by Goodman et al (2004) by applying a different modelling approach (case-
crossover) over a longer and more recent study period to the whole of the island of 
Ireland with a large population sample, incorporating both urban and rural communities 
rather than one city.  There have been no studies to date which have determined the 
effect modification of age and gender on the relationship between cold weather and 
mortality by case-crossover design over a longer lag structure and longer study period in 
a temperate zone under the influence of the Gulf Stream and the control of two different 
governmental jurisdictions and assessing the pneumonia, COPD and stroke mortality 
relationship.  The present study sought to address this gap in the literature. 
 
1.5 Aims of the study 
Although there has been a general trend of rising average temperatures in Ireland over 
the past 30 years, the island has witnessed extreme cold weather events over the same 
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period (Met Eireann 2014a, 2014b; The United Kingdom Met Office 2014a, 2014b). 
Taking into consideration the differences in underlying population health, public 
policies targeted at preventing winter mortality, health care provision, and 
socioeconomic and demographic construct of the two Irish jurisdictions (Goodman et 
al. 2011; Healy and Clinch 2004; McAvoy 2007), the health impacts of cold weather 
could potentially differ. It is therefore important to understand the magnitude and 
geographic differences of the cold weather-health relationship on the island of Ireland in 
order to inform public policies aimed at improvement of population health, and 
targeting of vulnerable groups during periods of cold weather.  
 
It is against this background that this thesis explores winter mortality on the island of 
Ireland, comparing the Republic of Ireland with Northern Ireland, and comparing the 
winter and summer periods and winter and cold periods. A clear message from the 
literature is that cold weather effects can act over quite a prolonged time period, and that 
it is not just one or two cold days that effect people.  It seems that long periods of cold 
weather appear to weaken those who are susceptible; and that if the cold weather 
continues they may get progressively weaker and eventually die while if temperatures 
rise they may recover.   
 
This study carried out a comparative, two jurisdictional, cross-border project which 
worked in collaboration with the Centre for Ageing Research and Development in 
Ireland, Dublin Institute of Technology and the Public Health Institute in Ireland.   
There were two aims of this Master of Philosophy (MPhil) project (within the overall 
study).   
 
The first aim of the study was to explore the comparison of the differences between the 
summer and winter mortality rates and the differences within the winter and cold period 
mortality rates by age and gender between the Republic of Ireland and Northern Ireland.  
 
The second aim of the study was to assess the distributed lag structure of cold 
temperature association on mortality during the cold period and winter months in the 
Republic of Ireland and Northern Ireland over a study period of 24 years, applying a 
case-crossover approach with longer distributed lag structure and study period than  
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most previous studies; and to assess for effect modification of the cold weather 
mortality relationships by age and gender. 
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2.0 METHODS AND MATERIALS 
There were two aims to this study: the first aim involved a comparison of excess winter 
mortality rates between the two jurisdictions of the Republic of Ireland and Northern 
Ireland, and the mortality rates amongst the younger and older population groups in the 
winter months and cold period; the second aim involved an assessment of the cold 
weather-mortality associations in both jurisdictions and the effect modification of that 
relationship by age and gender. The methods, analysis and findings of this study were 
included in a chapter within an international report published by the Public Health 
Institute in Ireland as part of a collaboration between Brunel University, Dublin Institute 
of Technology and the Centre for Ageing Research and Development in Ireland and in 
an academic paper in the Environmental Health Journal, of which the author of this 
study was a co-author in both publications (see Appendices 1 and 2). 
 
2.1 Mortality counts 
Individual daily deaths for ages ≥18 years were obtained from the Irish Central 
Statistics Office for data in the Republic of Ireland and Northern Ireland Social 
Research Agency for data in NI for the period of January 1
st
 1984 and December 31
st
 
2007. The international Classification of Disease-9 (ICD-9) codes were used up to 
2006, and ICD-10 codes from 2007. Non-accidental deaths were used for this study 
(ICD-9 codes 001-799/ICD-10 codes A00-R99), further categorised to primary cause-
specific mortality for CVD (390-429; I01-I52), IHD (410-414, 429.2; I20-I52), MI 
(410; I21-I22), RD (460-519; J0-J99), pneumonia (480-486; J12-J18), COPD (490-492, 
494-496; J40-J44, J47), and stroke (430-438; I60-I69). The above coding was used in 
both stages of this study and in the two co-authored publications enclosed in 
Appendices 1 and 2. The mortality parameters also included county codes and 
social/occupational class as well as place of birth in the Republic of Ireland and 
comparable parameters were used in Northern Ireland. The mortality data was read into 
SAS 9.1/9.2 to create SAS datasets which were checked for accuracy before analysis. 
 
2.2 Weather data 
The weather data for the study period (1984-2007) were obtained from Met Eireann, the 
Irish Meteorological Service for the Republic of Ireland; and the United Kingdom 
Met Office for Northern Ireland and this weather data was also used in the analysis for 
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 the second stage of this research, the results of which were included in the publication 
attached in Appendix 2.   
 
Ten weather stations were selected for the Republic of Ireland and these included Birr, 
Clones, Casement Aerodrome, Cork, Dublin, Kilkenny, Malin Head, Rosslare, Shannon 
and Valentia; and the four weather stations, which were selected for Northern Ireland 
included Armagh, Aldergrove, Ballywatticock, and Banagher.  The parameters of the 
weather data included maximum, minimum, and mean daily temperatures, relative 
humidity, wind speed and direction, and air pressure for the Republic of Ireland and 
maximum, minimum, and mean daily temperatures and relative humidity for Northern 
Ireland. There was inconsistent data available for air pressure and wind speed and 
direction for all the weather stations in Northern Ireland. The weather data was checked 
for accuracy and descriptive analysis was performed (see Table 15).  
 
The county codes obtained from the mortality data were assigned to the nearest weather 
station based on their geographical proximity to them. The weather and mortality data 
for each jurisdiction were merged by their county codes and this was used to generate 
hazard datasets for running models in the application of the time-stratified case-
crossover approach used in this study and highlighted in the co-authored paper in 
Appendix 2. 
  
2.3 Mortality rates 
The census population data for the years 1986, 1991, 1996, 2002, 2006 was accessed 
from the Central Statistics Office in Ireland with regards to the Republic of Ireland, and 
from the Northern Ireland Research and Statistics Agency for Northern Ireland. The 
census was undertaken every 5 years in the Republic of Ireland and every 10 years in 
Northern Ireland, in line with the rest of the United Kingdom. In order to compare the 
mortality rates in both jurisdictions, an assumption was made that there was an uniform 
increase in population during the intervening census years in Northern Ireland and the 
non-census year population estimated by subtracting the population of the lower census 
year from the following census year (for example, population in 1981 subtracted from 
the population in 1991, etc.) and dividing by the number of intervening years to 
estimate the population increase. This was multiplied by the number of years from the 
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lower census year (for example, 1981 and the year required (for example, 1986) for 
comparison and added to the lower census year.  This was repeated for the remaining 
comparative years of 1996, 2002, and 2006. The mortality rates were calculated as 
follows: (mortality/population) x 100,000 to give the mortality rates per 100,000. This 
study analysed the mortality data by age stratification (18-64 years old, 65-74 years old, 
75-84 years old, and 85 years and older).  Initially, all-cause mortality, CVD, RD and 
stroke were selected as these particular causes of death had been shown in other studies 
as demonstrating strong seasonal trends, such as excess winter mortality (Goodman et 
al. 2011).  This study also analysed the mortality data for IHD, MI, COPD and 
pneumonia for age and gender and compared mortality rates of all year (annual), 
summer/winter mortality rates, winter mortality rates, mortality rates during the cold 
period (October – March) and by age and gender between each jurisdiction.  
 
2.4 The concept of the case-crossover approach 
The second stage of this study involved the assessment of the cold weather-mortality 
association between the two jurisdictions and by effect modification of that relationship 
with the application of the case-crossover approach. The most common technique for 
modelling the co-variation of environmental exposures and counts of health events over 
time has been Poisson regression analysis (Schwartz 1993; Schwartz et al. 1996). An 
approach that examines associations over time rather than over space is attractive 
because many potential covariates are controlled by design, rather than by regression 
modelling (Neas et al. 1999).Time invariant characteristics such as sex and race are not 
potential confounders because the same population is examined repeatedly under 
varying exposure conditions (Neas et al. 1999). Covariates that have secular trends or 
vary seasonally may be weakly correlated with environmental exposures, but the 
potential for these covariates to confound the short-term health effects of temperature 
may be controlled by modelling time trends and season. More sophisticated analytical 
techniques have been introduced for trend and seasonal adjustment, culminating in the 
introduction of generalised additive models (Schwartz 1993).  An issue in the Poisson 
regression analyses has been the lack of a full enumeration and characterisation of the 
population at risk (Neas et al. 1999). To omit the offset term from the Poisson 
regression model, the investigator must assume that the population at risk is very large 
relative to the daily number of events and that the composition and size of the 
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population at risk does not co-vary with the exposure of interest (Neas et al. 1999). The 
case-crossover design avoids both problems by restructuring the analysis (Maclure 
1991). 
 
The case-crossover study design has been applied in a large number of epidemiologic 
studies, and its use is common in studies of the health effects of environmental exposure 
(Wang et al. 2011).  It has also been reported (Wang et al. 2011) that case-crossover 
methods have been applied to studies in a number of different substantive areas, 
including cardiovascular disease (Baylin et al. 2007; Levy et al. 2001b; Mittleman 
2005; Muller et al. 1996), and environmental epidemiology (Ng et al. 2008; O'Neill et 
al. 2003; Tsai et al. 2003). The case-crossover design is a form of the matched case-
control design, making it influentially appealing for epidemiologic studies (Maclure and 
Mittleman 2000; Neas et al. 1999).  
 
The case-crossover design is used to evaluate associations between short-term exposure 
to risk factor and the onset of adverse health effects (Janes et al. 2005; Maclure 1991).  
In one common implementation of this design, each subject’s exposure before a case-
defining event (case period) is compared with his or her own exposure experience 
during one or more control periods in which the subject did not become a case (Wang et 
al. 2011).  The study population consists solely of cases who serve as their own controls 
in the analysis (Lu et al. 2008).  Hence, the control periods are chosen from each case’s 
history as a substitute for the selection of an external comparison group (Lu et al. 2008).  
The use of matched, within-subject comparison provides effective control of 
confounding by measured or unmeasured subject characteristics that are stable over 
time; although confounding by time-varying characteristics or exposures is still possible 
(Janes et al. 2005; Maclure 1991).  The implementation of the case-crossover design is 
analogous to a matched case-control study, and the odds ratio estimated with 
conditional logistic regression – or equivalently the stratified Cox proportional hazards 
model- is typically used as the measure of association (Wang et al. 2011). 
 
The application of the case-crossover method involves assigning the same exposure 
history to all persons experiencing the event of interest on a given day (Wang et al. 
2011).  In theory, case-crossover analyses should treat each event as a separate stratum 
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in the analysis; however, in settings where exposure is shared, it is often convenient to 
condition the analyses on calendar day rather than the individual (Wang et al. 2011).  
An advantage of conditioning on day allows data to be aggregated into fewer strata and 
so analytic data sets are small and computation time is reduced substantially (Wang et 
al. 2011). It has been shown that when an appropriate control selection strategy is used, 
conditional logistic regression stratified on the individual subjects yields unbiased 
estimates of the relative risk (Levy et al. 2001a; Lumley and Levy 2000).  
 
The set of event and referent periods established for each case’s exposure history is the 
reference window (Lu et al. 2008).  The self-matching approach allows for control of 
potential confounding by time-sized factors – an often-cited benefit of the design (Lu et 
al. 2008). Various sampling strategies are used to select reference periods to estimate 
the associations of air pollution and/or temperature exposures on a health outcome of 
interest (Lu et al. 2008).  Various referent sampling strategies have been employed to 
control for confounding by time-varying factors (Bateson and Schwartz 1999; 
Checkoway et al. 2000; Navidi 1998; Navidi and Weinhandl 2002).  The goal is to limit 
the referent selection interval to short-term periods that restrict time-varying factors 
(such as seasonal characteristics of health and exposure, day-of-the-week effects, of  
other long term trends in air pollution or weather patterns) to be essentially constant 
within the reference window (Bateson and Schwartz 2001; Janes et al. 2005a; Lumley 
and Levy 2000). 
 
Referent sampling schemes specific to environmental epidemiology use reference 
periods both before and after the time of the event (bidirectional referent sampling) as a 
method to reduce bias due to temporal trends in exposure and outcome variables 
(Greenland 1996; Navidi 1998).  Due to concerns about potential overlap bias in the 
symmetric bidirectional design, the time-stratified design is considered the most 
generally valid approach for case-crossover studies of acute air pollution and 
temperature effects (Mittleman 2005).  In the time-stratified design, the follow-up 
period is partitioned a priori into disjoint reference windows (Lumley and Levy 2000).   
 
The most common analytic approach employs conditional logistic regression to 
compare the exposure at the time of the event to the exposure for the remaining control 
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periods within this pre-specified window (Lu et al. 2008). The time-stratified design 
method maintains desirable multivariable modelling properties by restricting reference 
windows that minimise confounding by seasonal and short-term patterns in exposure 
measures (Lu et al. 2008). A typical strategy is to constrain the reference-period 
selection to exposures matched by day of the week during the same calendar month as 
the case event (Levy et al. 2001a; Lumley and Levy 2000). This allows for asymmetric 
reference windows in which the case event is not centrally located by design (Lu et al. 
2008). It has been shown that the case-crossover method using conditional logistic 
regression is a special case of a time-series log-linear model when there are common 
exposures across subjects in each time period (Lu and Zeger 2007). This is the case in 
temperature and mortality studies.   
 
It has been advocated that time-stratified referent selection be used, because this design, 
avoids overlap bias and time trend bias (Janes et al. 2005).  The stratification can be 
tailored to match on the most important time-dependent confounders; stratifying on year 
and month (as well as one or more of the following variables – day of week, 
temperature, measurement time, and weather metrics such as relative humidity and air 
pressure) is adequate for most studies (Janes et al. 2005).  Although the semi-symmetric  
bidirectional design can also achieve these goals, this design requires modification of 
the traditional conditional logistic regression analysis and will be less efficient than a 
time-stratified design because fewer referents are used (Janes et al. 2005). 
 
The case-crossover design has been viewed as an attractive alternative to time-series 
model for studying the acute effects of transient exposures (Lu et al. 2008). The current 
understanding is that the case-crossover approach controls for potential confounding by 
design, while time-series methods control for this source of bias by modelling (Bateson 
and Schwartz 2001; Janes et al. 2005; Mittleman 2005). Important modelling 
assumptions must be recognised and addressed during data collection and analysis using 
the case-crossover approach (Lu et al. 2008).  
 
Both Poisson regression and case-crossover methods control for potential confounding  
in their respective regression models; however, different assumptions are made about 
the nuisance function (St) that represents potential temporal confounding influences (Lu 
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et al. 2008). It was reported that the equivalence of case-crossover and time-series 
methods allows one to use standard log-linear model diagnostic tools  to check models 
inherent in case-crossover analysis (Lu et al. 2008; McCullagh and Nelder 1989). 
 
The equivalence of time-series and case-crossover estimating equations means that the 
two methods produce the same estimator of the relative risk (Lu et al. 2008).  Most 
case-crossover analysis relies on conditional logistic regression and assume that all 
subjects are independent (Lu et al. 2008).  For common exposures shared by subjects, 
such as in ambient air pollution studies and temperature studies, this is equivalent to 
assuming that the number of events on day t, follows a Poisson distribution (Lu and 
Zeger 2007).  Hence, the case-crossover approach is equivalent to log-linear time-series 
model without over dispersion, and it uses the Poisson variance to calculate the standard 
error (SE) of the log relatives risk estimates (Agresti 2002). The time-stratified case-
crossover design is equivalent to Poisson regression with indicator variables for strata 
(Levy et al. 2001a). The smooth function of time (St) is assumed to be a step function 
with different levels of total population baseline risk for each stratum (Lu and Zeger 
2007). The symmetric bidirectional case-crossover design is equivalent to Poisson 
regression using a locally weighted running-mean smoother to estimate St. 
 
2.4.1 Advantages of the case-crossover design approach 
The case-crossover design is attractive because it only involves cases and each case is 
compared to himself/herself, thereby controlling for time-invariant personal factors (Lu 
and Zeger 2007).  The current understanding is that case-crossover methods control for 
potential confounding “by design” while time-series methods control by modelling 
(Bateson and Schwartz 2001; Janes et al. 2005; Zanobetti and Schwartz 2005). An 
often-claimed rationale for the use of the case-crossover design is that it provides self-
matched data both case and control periods and removes confounding by time-sized 
characteristics (Lu et al. 2008; Mittleman 2005; Redelmeier and Tibshirani 1997).  
Another claimed advantage is that is controls time-varying confounders such as 
seasonal and day of the week (dow) factors by design through short-interval reference-
window specification; hence the conditional logistic regression model includes fewer 
terms than time-series models (Fung et al. 2003). The case-crossover conditional 
logistic regression model is equivalent to a particular time-series log-linear model  
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without over-dispersion (Lu and Zeger 2007). 
 
Other strengths of the case-crossover design are that it does not require a control sample 
(and hence avoids bias associated with improper control selection); it makes effect 
modification assessment relatively simple; it controls for fixed confounders (Janes et al. 
2005a).  Another cited advantage of the case-crossover design is that more extensive 
personal information may be used in the analysis; for example, subject-specific 
characteristics and time-activity patterns that influence individual exposures or the time 
of case periods (Sheppard et al. 2001; Symons et al. 2006).  The use of individual-level 
measures in a case-crossover analysis permits the researcher to estimate directly the 
effect of personal exposures, and to assess effect modification of exposure by individual 
attributes (Lu et al. 2008).  
 
The time-stratified design is not subject to bias resulting from time trend because there 
is no pattern in the placement of referents relative to the index time: the design can 
control for season and day of the week (dow) by restricting referents to the same day of 
the week, month, and year as the index day (Janes et al. 2005a).  Referents should be 
matched on the most dominant time-varying confounders and should be sampled bi-
directionally (Janes et al. 2005a).  Sampling referents too close to the index day will  
result in a loss of power as a result of auto-correlation in the exposure series (Janes et 
al. 2005a).   
 
If there still remains a choice as to the number of referents at this point, larger number 
of referents will increase efficiency: the analysis should condition on the fixed exposure 
series (Janes et al. 2005a). The main difference between time-series regression method 
and analysis of a case-crossover design using conditional regression is that the former 
requires modelling for confounders (Janes et al. 2005).  Within conditional logistic 
regression analysis in the case-crossover design, the confounding effects of all matching 
variables are controlled by design (Janes et al. 2005). 
 
2.4.2 Limitation of the case-crossover design approach 
Methods for addressing time-varying risk factors in case-crossover analyses have relied  
on the assumption that St, is constant within the reference window (Lu et al. 2008).   
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When this assumption is not satisfied, estimates from case-crossover models can also be 
biased, just as in any model when the predictors are incorrectly specified (Lu et al. 
2008). 
 
2.5 Method design and statistical analyses 
This study applied a time-stratified case-crossover approach to assess the associations 
between cold weather and mortality in each of the two governmental jurisdictions on the 
island of Ireland (Republic of Ireland and Northern Ireland) and to assess for effect 
modification of the cold weather-mortality relationship by age stratification and gender 
and this approach was used in the co-authored paper (see Appendix 2).   
 
As discussed earlier, the case-crossover design has been originally developed and used 
in air pollution’s studies, and had been extensively described elsewhere (Bateson and 
Schwartz 2001; Levy et al. 2001a; Maclure 1991).  The case-crossover design was 
developed as a variant of the case control design to study the effects of transient 
exposures on emergency events, comparing each person’s exposure at the time of the 
case defining event or death (case time) with that person’s exposure in other times 
(control times) (Maclure 1991).   
 
A time-stratified approach was applied in this design to select the control days with the 
day of death chosen as the case day, and controls chosen as all other days, the same day  
of the week, in the same month and year as the case day, leaving two days between each 
control to eliminate any serial correlation (Bateson and Schwartz 1999, 2001; Lee et al. 
2000; Levy et al. 2001a). Schwartz et al (2003) showed that monthly strata had been 
used to produce unbiased estimates of effect sizes and coverage probabilities even in the 
presence of strong seasonal confounding (Schwartz et al. 2003).  Conditional logistic 
regression was applied to matched pairs to compare different characteristics (Maclure 
1991). An added advantage of this design is that, if control days are chosen close in 
time to the day of death, there is no confounding by slowly varying personal 
characteristics, and even very strong confounding by season and time trend can be 
removed (Bateson and Schwartz 1999; Lee et al. 2000; Lumley and Levy 2000). 
 
The time-stratified case-crossover approach used in this study adjusted for the function  
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of time (St).  This function approximately controls for time-varying confounders and 
time trends if there was no over-dispersion present in the data (Janes et al. 2005; Lu et 
al. 2008).  The weather-mortality data was tested prior to choosing the modelling 
approach and no important over-dispersion was found in the data in both jurisdictions; 
therefore, the case-crossover approach was considered to be the most appropriate for 
estimating the cold weather-mortality relationship in this study (Zeka et al. 2014). The 
case-crossover using conditional logistic regression is a special case of time-series 
analysis (Lu and Zeger 2007). This equivalence provides computational convenience 
and permits model checking for the case-crossover design using log-linear model 
diagnostics (Lu et al. 2008) 
 
2.5.1 Definition of seasons 
The data were analysed for the winter season (December-February) and an extended 
cold period (October-March), with separate analyses conducted for the other months in 
the extended cold period; that is, Oct, Nov and March, commonly referred to as the cold 
months in order to investigate whether the observed cold weather-mortality associations 
were just confined to the winter months.  This study observed cold-weather related 
mortality increases during the extended cold period, including the cold months.  The 
associations in the cold months were weaker and less persistent than the cold period and 
winter months and so only the results for the cold period and winter months are 
presented in the next chapter. The definition of seasons, which was used in this study, 
was included in the published paper (see Appendix 2). 
 
2.5.2 Temperature metrics 
Different temperature definitions have been used in literature with no uniform criteria  
used to identify the best cold weather exposure metric (Barnett et al. 2012; Yu et al. 
2011a).  Some uncertainty remained as to which temperature indicator was the most 
suitable for analysing the impact of temperature on the various age groups and mortality 
categories (Yu et al. 2011a).  This study tested daily maximum, daily mean and daily 
minimum temperatures as the exposure metrics in the models.  There was an 
assumption that there would be little relief from the cold during the day (maximum 
temperature) whereas at night people’s housing would provide protection from the 
effects of exposure to the cold (minimum temperature).  In order to assess the influence 
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of temperature variability, such as sudden drops in temperature, the associations with 
the temperature differences between the daily maximum and daily minimum 
temperatures, the daily maximum and daily mean temperature, and weekly mean 
maximum and weekly mean minimum temperature were tested and examined as 
independent variables in the models (see Tables 6-9) (Zeka et al. 2014).  The strongest 
mortality associations were observed with the daily mean and daily maximum 
temperatures in both jurisdictions, with only slight differences between them; these 
were slightly greater than those observed for minimum temperature, and so the daily 
maximum temperature was selected as an exposure metric. A previous study found that 
all temperature measured (mean, minimum, maximum, apparent) have a similar ability 
to predict mortality (Barnett and Astrom 2012). This study found that there were no 
important associations with regards to these definitions of temperature (Zeka et al. 
2014). 
 
2.5.3 Time periods 
So, although the case-crossover approach controls for time-varying confounders and 
time periods by design, in preliminary analyses, this study tested the cold weather-
mortality relationships for different time periods defined by the presence of fuel policy 
for each jurisdictions (1989-1990; 1995/1996)  (Zeka et al. 2014). The cold period was 
chosen to include the enactments of the policies.  In these analyses, there were some 
differences observed over time, with the associations slightly diminishing in more 
recent years for both jurisdictions (see Tables 10-13) (Zeka et al. 2014). However it was 
acknowledged that the temporal separation in these preliminary analyses was quite 
crude, and did not take into account other immediate and gradual changes in public  
policies and health care in the two jurisdictions (Zeka et al. 2014). It was possible that 
the response of the populations in the two jurisdictions to the cold temperatures has 
changed over time (Zeka et al. 2014). 
 
2.5.4 Definition of exposure variables 
This study aimed to examine the risk of mortality in association with exposure to daily 
maximum temperatures on the same day of the event (lag0) initially up to 6 weeks prior 
to death (lag 1-42 days).  Weekly means of daily temperatures were calculated for each 
of the 6 weeks, for lag 1-7, lag 8-14, lag 15-21, lag 22-28, lag 29-35 and lag 36-42 days.  
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The distributed lag models included all weekly lags, with lag0 included as an 
independent variable.  This modelling approach was a way to estimate unbiased time 
trends of the exposure-response relationship by controlling for any confounding in the 
temperature-mortality associations in one lag structure by temperature-mortality 
associations in other lags (Lee et al. 2000).  The models were tested with a finer 
definition of lag structures such as the means of lag 1-2, 3-5, 6-9, 10-14, 15-21, 22-28 
and 29-35 days to examine acute, medium and longer term effects of temperatures.  
However, the application of weekly mean temperature lag structures in the models 
revealed more efficient and stable results with the overall results being similar, whether 
using finer or average lag structures.  All models included ‘day of the week’ as an 
indicator variable, with Monday as the reference.  Additional variables in the model 
included relative humidity and atmospheric pressure, both of which were averaged over 
3 days:  the day of death and two days prior.  There were no important contributions of 
relative humidity and atmospheric pressure found in any other lag structures.  The 
models were tested with six, five and four distributed mean weekly lag structures.  
There were no important associations that were observed between any mortality cause 
and temperature in week 6 prior to death (lag 36-42 days) in both jurisdictions.  This 
study found that there were important associations observed with temperatures up to 35 
days (lag 29-35 days) before death for the Republic of Ireland, and up to 28 days (lag 
22-28 days) for Northern Ireland during the cold period and winter months and these lag 
structures were chosen for the models.  The models with the lowest Akaike Information 
Criterion (AIC) produced the strongest associations between the exposure to cold 
temperature and increased mortality outcomes, thus indicating a better fitting model. 
Although the models tested the cold weather-mortality relationship throughout the 
whole year, during the cold period, during the cold months and during the winter 
months, only the results for the cold period and the winter months are presented (see 
chapter 3). The cold weather-mortality relationship was analysed by applying 
conditional logistic regression analysis through the use of the PROC PHREG function 
in SAS 9.1/9.2, SAS Institute Cary, NC. The above method was applied in the co-
authored published paper (see Appendix 2). 
 
2.5.5 Cumulative mortality increase estimate calculation 
The estimate for important associations between daily mortality and lags of weekly  
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average of maximum temperature prior to death was used to calculate cumulative 
estimates of mortality increases by summing the coefficients and the cumulative 
estimates did not include the association of mortality with temperature on the same day 
(lag 0) (Zeka et al. 2014). This association was consistent with previous studies 
assessing the cold weather-mortality relationship (Analitis et al. 2008; Goodman et al. 
2004), where lag 0 was positive and potentially suggestive of warm temperature 
associations (Zeka et al. 2014). The overall variance was computed using previously 
described algorithms (Schwartz 2000).   
 
During the cold period in the Republic of Ireland, the cumulative estimate (change) was 
calculated for the lag of week 1-5 for all-cause mortality, and RD mortality; for the lag 
of week 1-4 for, CVD mortality, IHD mortality, MI mortality, COPD mortality, and 
pneumonia mortality; and for lag 1-3 for stroke mortality.  In the winter months, the 
cumulative estimate calculation did not change from that used for the cold period except 
for COPD mortality and pneumonia mortality where their cumulative change was 
calculated for lag of week 1-5.  In Northern Ireland, during the cold period, the 
cumulative estimates were calculated for the lag of week 1-4 for all-cause mortality and 
stroke mortality; for the lag of week 1-3 for CVD mortality, IHD mortality, MI 
mortality, RD mortality and pneumonia mortality; and for the lag of week 1-2 for 
COPD mortality.  During the winter months in Northern Ireland, the cumulative 
estimates were calculated for the lags of week 1-4 for RD mortality, COPD mortality 
and pneumonia mortality; and the lag of week 1-3 for the remaining mortality groups. 
The above approach was applied in the co-authored published paper (see Appendix 2). 
 
2.5.6 Modifying variables 
As the case-crossover approach focuses on individual events rather than daily counts, it 
also makes examination of effect modification more straightforward (Schwartz 2004). 
The effect modification of the temperature mortality relationship was examined by 
stratifying the models by gender, and age in the following groups: 18-64 year olds, 65-
74 year olds, and 75+ years old (Zeka et al. 2014).  Statistically important differences 
between cumulative estimates of strata of a potential modifier were tested by calculating 
the 95% confidence interval (95% (CI) of this difference (Payton et al. 2003).   
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This study did not consider adjustment for air pollution; these data were inconsistent 
across the two jurisdictions for the study period.  The current practice in epidemiologic 
studies of weather and health association is to automatically adjust for air pollution, if 
the information on this is available.  However, in a recent article, Buckley et al, indicted 
that there is no known mechanism by which  air pollution confounds the cold 
temperature and mortality (health) relationship (Buckley et al 2014).  In support of this 
rationale, previous epidemiologic studies showed little or no influence of air pollution 
on the cold temperature-mortality relationship (Analitis et al. 2008; Anderson and Bell 
2009; Barnett et al. 2012; Braga et al. 2002; Goldberg et al. 2011; Goodman et al. 
2004; Guo et al. 2012). This evidence emphasizes the robustness of these study 
findings, which are very important from a public policy perspective. The above 
approach was applied in the co-authored published paper (see Appendix 2). 
Results are presented as percentage (%) change in mortality per 1
o
C decrease in weekly 
average of daily maximum temperature. 
 
2.5.7 Ethical approval 
This study received ethical approval from The Central Statistics Office in Ireland and 
Brunel University Ethics Committee.  This study involved working in collaboration 
with the Centre for Age Reduction in Ireland, the Dublin Institute of Technology, and 
the Public Health Institute in Ireland. 
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3.0 RESULTS 
3.1 Mortality counts 
This study reported that there were 709,110 non-accidental deaths in the Republic of 
Ireland and 347,936 in Northern Ireland over the 24 years of the study data.  Of these 
deaths during the year over the study period in the Republic of Ireland 33% of deaths 
were from cardiovascular disease (CVD), 25% from ischaemic heart disease (IHD), 
17% from myocardial infarction (MI), 15% from all respiratory diseases (RD), 6% from 
chronic obstructive pulmonary disease (COPD), 7% from pneumonia and 9% from 
stroke.  Northern Ireland showed a similar distribution with small variations; 31% of the 
deaths were from CVD, 23% were from IHD, 20% from MI, 17% from RD, 4% were 
from COPD, 10% from pneumonia and 11% from stroke.  When this study stratified the 
deaths into the cold period (October – March), it was found that there were 381,099 
non-accidental deaths in the cold period, which accounted for 54% of the deaths in the 
study data.  The distribution of deaths during the cold period was comparable to the 
distribution throughout the year in the Republic of Ireland.  In Northern Ireland, non-
accidental deaths in the cold period accounted for 186,083, which was 53% of the 
deaths in the study data.  The distribution of deaths in the cold period was comparable 
to the distribution for the whole year over the study period in Northern Ireland.  More 
males died from non-accidental deaths, CVD, IHD, MI, RD and COPD while more 
females died from pneumonia and stroke in the Republic of Ireland.  There was a 
similar trend reflected in Northern Ireland with the exception of RD where more 
females died than males in that cause-specific mortality group.  This study observed that 
more males died amongst the 18-74 year olds while female deaths were greater in the 
75+ year old age group with more than half of the deaths occurring in the 75+ year olds 
in both jurisdictions. Some of the above results have been presented in the co-authored 
publication in Appendix 2. 
 
3.2 Mortality Rates 
3.2.1 Annual mortality rates 
There was a downwards trend in the annual mortality rates (all ages) for all-cause 
mortality in both jurisdictions across the study period (1986-2006) with an approximate 
overall decline of 20-25% (see Figure 1a).  The annual mortality rates for all-cause 
mortality were higher in Northern Ireland than in the Republic of Ireland throughout the 
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study period and the Republic of Ireland experienced a sharper decline.  Mortality from 
CVD also showed a downwards trend in both jurisdictions (see Figure 1b).  The CVD 
mortality rate was higher in Northern Ireland than in the Republic of Ireland with a 
convergence of the rates in the middle of the study period.  The rate of decline in CVD 
mortality was more constant in Northern Ireland although the rates of decline were 
comparable between the two jurisdictions.  CVD mortality rates decreased by 
approximately 50% and 45% over the study period in the Republic of Ireland and 
Northern Ireland respectively.  The annual mortality rates for IHD showed an overall 
downwards trend in both jurisdictions (see Figure 1c). The annual IHD mortality rates 
were higher in Northern Ireland compared to the Republic of Ireland.  However, there 
was a reversal of this trend in the middle of the study period where the mortality rates 
were higher in the Republic of Ireland. The annual IHD mortality rates showed similar 
patterns to the CVD mortality rates, with similar overall rates of decline in both 
jurisdictions.  Figure 1d showed the annual mortality rates (all ages) for MI in the 
Republic of Ireland and Northern Ireland, 1986-2006.  The MI mortality rates showed 
an overall downwards trend in both jurisdictions, with an overall decline of 
approximately 67% and 60% in the Republic of Ireland and Northern Ireland 
respectively.  The mortality rates for MI were higher in Northern Ireland than in the 
Republic of Ireland. 
 
The annual mortality rates (all ages) for RD showed an overall downwards trend with a 
decline of approximately 30% at the end of the study period in both jurisdictions (see 
Figure 2a).  The RD mortality rates were higher in Northern Ireland than in the 
Republic of Ireland; although in the year 2002, this pattern was reversed with the rates 
higher in the Republic of Ireland.  In Northern Ireland, there was little change in the RD 
mortality rates until the year 1996 when there was a sharp drop.  The annual mortality 
rates (all ages) for COPD showed an overall downwards trend in the Republic of Ireland 
while there was an increase in the COPD mortality rates in Northern Ireland throughout 
the study period (see Figure 2b).  The COPD mortality rates were higher in the Republic 
of Ireland until the end of the study when the mortality rates were higher in Northern 
Ireland.  There was a decrease in the annual COPD mortality rates of approximately 
45% in the Republic of Ireland and an increase of 30% in Northern Ireland.  The annual 
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mortality rates for pneumonia (all ages) showed an overall decline over the study period 
in both jurisdictions with the sharpest decline observed in Northern Ireland (see Figure  
2c). Pneumonia mortality rates were higher in Northern Ireland than in the Republic of 
Ireland with a convergence of the rates towards the latter stages of the study.  The 
annual pneumonia mortality rates declined by approximately 55% for Northern Ireland 
and 25% for the Republic of Ireland.  Northern Ireland observed the sharpest decline in 
its pneumonia annual mortality rates between the years 1996 and 2002.  The annual 
mortality rates for stroke (all ages) showed an overall downwards trend in both 
jurisdictions, with a decline of approximately 40-55% over the study period (see Figure 
2d).  The stroke mortality rates were higher in Northern Ireland compared with the 
Republic of Ireland. 
 
3.2.2 Summer and winter mortality rates 
Figure 3a showed the summer and winter mortality rates for all-cause mortality amongst 
the male population.  Winter mortality was much greater than the summer mortality in 
both jurisdictions.  Northern Ireland presented higher summer and winter mortality rates 
with the exception of the years 1996/1997 when this trend was reversed with the 
Republic of Ireland presenting higher mortality rates.  Summer and winter mortality for 
the female population increased during the first half of the study period before declining 
during the remainder (see Figure 3b).  Winter mortality was higher than summer 
mortality with Northern Ireland presenting higher summer and winter mortality rates 
compared to the Republic of Ireland. 
 
The winter CVD mortality rates in the male population were higher than the summer 
mortality rates in both jurisdictions; with both the summer and winter mortality rates 
higher overall in Northern Ireland compared to the Republic of Ireland (see Figure 4a).  
There was some convergence of the CVD mortality rates by the end of the study.  There 
was an overall downwards trend in both the summer and winter CVD mortality rates in 
the female population in both jurisdictions with the winter mortality rates being higher 
than the summer rates (see Figure 4b).  The mortality rates were higher in Northern 
Ireland compared with the Republic of Ireland, with some convergence of rates by the 
end of the study. 
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The winter IHD mortality rates were higher than the summer rates in both jurisdictions.   
The summer and winter IHD mortality rates for the male population showed an overall 
downwards trend with the winter mortality rates being higher than the summer mortality 
rates in both jurisdictions (see Figure 5a), although there was some convergence of the 
summer and winter mortality rates in Northern Ireland.  In the female population, the 
summer and winter IHD mortality rates showed an overall downwards trend in both 
jurisdictions (see Figure 5b).  The winter IHD mortality rates were higher than the 
summer rates in both jurisdictions and there was some convergence of the rates in both 
jurisdictions by the end of the study.  Both the summer and winter IHD mortality rates 
were higher in the male population than the female population in both jurisdictions (see 
Figures 5a-b).  The difference between the summer and winter mortality rates decreased 
over the study period. 
 
In the male population, the summer and winter MI mortality rates showed an overall 
downwards trend across the study period in both jurisdictions (see Figure 6a).  The 
winter MI mortality rates were higher than the summer mortality rates in both 
jurisdictions while both the summer and winter mortality rates were higher in Northern 
Ireland than in the Republic of Ireland.  The differential between the summer and winter 
MI mortality rates decreased over the study period with a convergence of the rates in 
both jurisdictions by the end of study.  The summer and winter mortality rates for MI in 
the female population declined over the study period in both jurisdictions; the winter 
mortality rates were higher than the summer mortality rates in both jurisdictions (see 
Figure 6b).  Northern Ireland showed higher summer and winter mortality rates than 
Republic of Ireland.  The differential between the summer and winter mortality rates in 
the female population declined over the study period with a convergence of the rates by 
the end of the study.  Both the summer and winter MI mortality rates were higher in the 
male population than the female population (see Figures 6a-b).  
 
Although there was an overall downwards trend in the summer and winter RD mortality 
rates in the male population in both jurisdictions, this study observed that the winter RD 
mortality rates, in particular, had increased during the first half of the study before 
declining sharply in the second part of the study period (see Figure 7a).  The winter RD 
mortality rates were approximately 35-40% higher than the summer mortality rates in 
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Northern Ireland and the Republic of Ireland at the start of the study; this differential 
declined over the study period to approximately 20-25% by the end of it in Northern 
Ireland and the Republic of Ireland. The summer and winter RD mortality rates were 
higher in Northern Ireland than in the Republic of Ireland.  This study showed that there  
was a similar pattern in the female population; however the overall summer and winter 
mortality rates remained relatively unchanged by the end of the study in both 
jurisdictions (see Figure 7b).  Both the summer and winter RD mortality rates were 
higher in Northern Ireland than in the Republic of Ireland.  Although the winter RD 
mortality rates were higher in males than females for both jurisdictions at the start of the 
study; it was observed that the winter mortality rates were higher in females than males 
by the end of the study in Northern Ireland with comparable rates between both 
populations in Republic of Ireland (see Figures 7a-b).  The study observed that the 
summer RD mortality rates were higher in the male population at the start of the study 
in both jurisdictions with a convergence of the rates between both populations by the 
end of the study period (see Figures 7a-b). 
 
Comparable patterns and trends in the summer/winter pneumonia mortality rates were 
observed in both the male and female populations in both jurisdictions (see Figure 8a-
b).  Although the winter pneumonia mortality rates for the male population were 
approximately 30% higher than the summer rates in both jurisdictions at the start of the 
study, both rates converged by the end of the study period in both jurisdictions. A 
similar trend was observed for the female population although there was less 
convergence of the differential between the summer and winter mortality rates in 
Northern Ireland. The summer and winter pneumonia mortality rates were higher in 
Northern Ireland than Republic of Ireland (see Figs 8a-b). 
 
In the male population, the study observed that the summer and winter COPD mortality 
rates declined over the study period in the Republic of Ireland; whilst in Northern 
Ireland, the summer mortality rate increased and the winter COPD mortality rates 
remained relative static across the study period (see Figure 9a).  Although the summer 
and winter COPD mortality rates were higher in the Republic of Ireland at the start of 
the study, the winter mortality rates converged in both jurisdictions while the summer 
mortality rates were higher in Northern Ireland than the Republic of Ireland (see Figure 
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9a).  The summer and winter mortality COPD mortality rates in the female population 
showed a small overall downwards trend in the Republic of Ireland although the winter 
mortality rates increased sharply at the beginning of the study (see Figure 9b).  In 
Northern Ireland both the summer and winter COPD mortality rates increased over the 
study period.  The difference between the summer and winter COPD mortality rates 
increased over the study period in the female population in Northern Ireland while it  
decreased in the Republic of Ireland (see Figure 9b).  The summer and winter COPD 
mortality rates were higher in males than in females, a trend reflected in both 
jurisdictions (see Figures 9a-b). 
 
The summer stroke mortality rates decreased over the study period in both jurisdictions; 
the winter mortality rates showed an overall downwards trend in the male population in 
both jurisdictions (see Figure 10a).  The winter stroke mortality rates were higher than 
the summer mortality rates in both jurisdictions at the start of the study; however, by the 
end of the study, the summer and winter mortality rates were comparable in Northern 
Ireland, while the winter mortality rates remained higher than the summer rates in the 
Republic of Ireland (see Figure 10a).  Both stroke mortality rates were higher in 
Northern Ireland than in the Republic of Ireland for the female population and there was 
a convergence of the rates by the end of the study (see Figure 10b). The summer and 
winter mortality rates were higher in females than males in both jurisdictions (see 
Figures 10a-b). 
 
3.2.3 Winter mortality rates  
The winter mortality rates for all-cause mortality remained stable until 1996/97 after 
which they declined sharply in both jurisdictions with Northern Ireland presenting 
higher mortality rates than the Republic of Ireland (see Figure 11a). A similar pattern 
was observed for CVD mortality rates in the winter months in both jurisdictions with a 
convergence of the rates by the end of the study (see Figure 11b). The IHD mortality 
rates in winter showed an overall downwards trend with the rates very comparable 
between each jurisdiction (see Figure 11c). The winter MI mortality rates declined 
steadily in each jurisdiction with Northern Ireland presenting higher mortality rates than 
the Republic of Ireland (see Figure 11d). The winter RD mortality rates increased 
initially before declining sharply from the middle of the study in both jurisdictions (see 
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Figure 12a). Northern Ireland presented higher winter RD mortality rates at the start of 
the study while the mortality rates were comparable between each jurisdiction by the 
end of the study. The COPD mortality rates increased initially in the Republic of Ireland 
before declining midway through the study period while the COPD mortality rates 
increased throughout the study period in Northern Ireland (see Figure 12b). The COPD  
mortality rates were higher in the Republic of Ireland at the start of the study while this 
pattern was reversed by the end of the study. The winter mortality rates for pneumonia 
increased initially before declining midway through the study period in both 
jurisdictions; with Northern Ireland presenting higher mortality rates than the Republic 
of Ireland although there was some convergence between the two jurisdictions by the 
end of the study (see Figure 12c). The winter mortality rates for stroke showed an 
overall downwards trends in both jurisdictions with Northern Ireland presenting higher 
mortality rates than the Republic of Ireland (see Figure 12d). 
 
3.2.4 Winter mortality rates by age stratification  
The CVD mortality rates amongst the 18-64 year olds were very low and showed an 
overall downwards trend in both jurisdictions with Northern Ireland presenting higher 
mortality rates than the Republic of Ireland (see Figure 13a). The winter CVD mortality 
rates amongst the 65-74 year olds showed an overall downwards trend in both 
jurisdictions; with the mortality rates higher in Northern Ireland than in the Republic of 
Ireland although there was some convergence of the mortality rates between the two 
jurisdictions by the end of the study period (see Figure 13b).  There were decreases in 
the winter CVD mortality rates of approximately 63% and 68% in the Republic of 
Ireland and Northern Ireland respectively over the study period.  Amongst the 75-84 
year olds, the winter mortality rates showed an overall downwards trend, with a decline 
across the study period of approximately 54% and 49% in the Republic of Ireland and 
Northern Ireland respectively (see Figure 13c).  The winter mortality rates for CVD 
were higher in the Republic of Ireland than in Northern Ireland for the 75-84 year olds.  
The 85+ year olds’ winter mortality rates for CVD showed an overall downwards trend 
over the study period in both jurisdictions (see Figure 13d).  The decline in the mortality 
rates was approximately 27% and 37% in the Republic of Ireland and Northern Ireland 
respectively with Northern Ireland presenting higher mortality rates than the Republic 
of Ireland.  The winter mortality rates for CVD were highest in the 85+ year olds and 
 37 
 
lowest amongst the 65-74 year olds in both jurisdictions (see Figures 13b-d), when 
considering the older population. 
 
The IHD mortality rates amongst the 18-64 year olds were very low and showed an 
overall downwards trend in both jurisdictions with Northern Ireland presenting higher 
mortality rates than the Republic of Ireland (see Figure 14a). The winter mortality rates 
amongst the 65-74 year olds showed a sharp decline throughout the study period (see  
Figure 14b). There was a decrease in the winter mortality rates of approximately 66% in 
both jurisdictions and the mortality rates were higher in Northern Ireland than Republic 
of Ireland over the study period.  The winter IHD mortality rates amongst the 75-84 
year olds also showed an overall downwards trend over the study period in both 
jurisdictions (see Figure 14c).  There was a decrease of approximately 54% and 45% in 
the winter IHD mortality rates in the Republic of Ireland and Northern Ireland 
respectively, and the mortality rates were higher in the Republic of Ireland than 
Northern Ireland in this age group.  The winter IHD mortality rates amongst the 85+ 
year olds showed an overall downwards trend despite a spike around the middle of the 
study period in both jurisdictions; with Northern Ireland presenting higher mortality 
rates than the Republic of Ireland.  There was a decrease of approximately 12% and 
24% in the winter IHD mortality rates in the Republic of Ireland and Northern Ireland 
respectively (see Figure 14d).  The winter IHD mortality rates were higher amongst the 
85+ year olds and lower in the 65-74 year olds (see Figures 14b-d), when considering 
the older population. 
 
The winter mortality rates for MI amongst the 18-64 year olds were very low and 
showed an overall downwards trend in both jurisdictions with Northern Ireland 
presenting higher mortality rates than the Republic of Ireland (see Figure 15a). The 
winter MI mortality rates amongst the 65-74 year olds declined over the study period in 
both jurisdictions, with Northern Ireland presenting higher winter MI mortality rates 
than the Republic of Ireland (see Figure 15b).  The study found that the winter MI 
mortality rates decreased by approximately 81% and 74% in the Republic of Ireland and 
Northern Ireland respectively.  The winter MI mortality rates amongst 75-84 year olds 
showed an overall downwards trend over the study period in both jurisdictions; with the 
Republic of Ireland presenting higher mortality rates than Northern Ireland at the start 
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of the study whilst the mortality rates in Northern Ireland were higher throughout the 
remainder of the study period (see Figure 15c). The study found that the winter MI 
mortality rates decreased by approximately 67% and 60% in the Republic of Ireland and 
Northern Ireland respectively.  The winter MI mortality rates amongst the 85 + year 
olds showed an overall downwards trend despite a spike around the middle of the study 
period in both jurisdictions (see Figure 15d).  The mortality rates were higher in the 
Republic of Ireland at the start and end of the study, while Northern Ireland experienced 
higher rates around the middle of the study period.  This study found the winter MI 
mortality rates decreased by approximately 33% and 52% in the Republic of Ireland and 
Northern Ireland respectively.  The winter mortality rates were highest amongst the 85+ 
year olds and lowest amongst the 65-74 year olds (see Figures 15b-d), when considering 
the older population. 
 
The RD mortality rates amongst the 18-64 year olds were very low and, despite 
increasing at the start of the study, showed an overall downwards trend in both 
jurisdictions with Northern Ireland presenting higher mortality rates than the Republic 
of Ireland (see Figure 16a). The RD mortality rates amongst the 65-74 year olds showed 
an overall downwards trend over the study period despite an increase around the middle 
of the study period in both jurisdictions (see Figure 16b).   The winter RD mortality 
rates were higher in the Republic of Ireland at the start of the study and up to the middle 
of the study period while the rates were higher in Northern Ireland in the latter stages of 
the study.  This study found that there was a decrease in the winter RD mortality rates 
of approximately 62% and 45% in the Republic of Ireland and Northern Ireland 
respectively.  The winter RD mortality rates amongst the 75-84 year olds increased 
sharply during the first half of the study before decreasing even more sharply in the 
second half of the study period (see Figure 16c).  The Republic of Ireland experienced 
higher winter RD mortality rates than Northern Ireland across the study period except 
for the years 1991/1992 when this pattern was reversed.  This study observed that there 
was a decrease in the winter RD mortality rates amongst the 75-84 year olds of 
approximately 32% and 38% in the Republic of Ireland and Northern Ireland 
respectively.  The winter RD mortality rates amongst the 85+ year olds increased during 
the first half of the study before declining in the second half of the study period (see 
Figure 16d).  The winter RD mortality rates were higher in Northern Ireland than in the 
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Republic of Ireland.  This study noted that the winter RD mortality rates decreased by 
approximately 27% and 39% in the Republic of Ireland and Northern Ireland 
respectively.  The winter RD mortality rates were highest amongst the 85+ year olds 
and lowest in the 65-74 year olds in both jurisdictions (see Figures 16b-d) within the 
older population. 
 
The COPD mortality rates amongst the 18-64 year olds were very low and showed an 
overall downwards trend in both jurisdictions with the Republic of Ireland presenting 
higher mortality rates at the start of the study while this pattern was reversed at the end 
of the study (see Figure 17a). The COPD mortality rates amongst the 65-74 year olds 
showed an overall downwards trend in both jurisdictions with a sharp decline in the 
Republic of Ireland between the years 1996/1997 and 2002/2003 (see Figure 17b).  The  
winter COPD mortality rates were higher in the Republic of Ireland than Northern 
Ireland, until the latter stages of the study when this pattern was reversed with the rates 
higher in Northern Ireland than in Republic of Ireland.  This study found that the winter 
COPD mortality rates decreased by approximately 63% and 14% in the Republic of 
Ireland and Northern Ireland respectively.  The winter COPD mortality rates amongst 
the 75-84 year olds showed an overall downwards trend for the Republic of Ireland 
although there was an increase around the middle of the study, while there was an 
overall upwards trend for Northern Ireland (see Figure 17c).  The winter COPD 
mortality rates were higher in the Republic of Ireland than in Northern Ireland although 
there was a convergence of those mortality rates in each jurisdiction by the end of the 
study period.  There was a decrease in the winter COPD mortality rates of 
approximately 34% for the Republic of Ireland and an increase of 38% for Northern 
Ireland. There was an overall downward trend in the winter COPD mortality rates 
amongst the 85+ year olds in the Republic of Ireland and an overall upwards trend in 
the winter COPD mortality rates in Northern Ireland over the study period (see Figure 
17d).  The winter COPD mortality rates were higher in the Republic of Ireland than in 
Northern Ireland. There was some convergence of the mortality rates between the two 
jurisdictions over the study period.   This study observed that there was a decrease in 
those mortality rates of 25% in the Republic of Ireland and an increase of approximately 
22% in the COPD winter mortality rates in Northern Ireland.  The winter COPD 
mortality rates were highest amongst the 85+ year olds and lowest amongst the 65-74  
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year olds (see Figures 17b-d).  
 
The mortality rates for pneumonia were very low and showed an overall downwards  
trend in both jurisdictions, with Northern Ireland presenting higher rates than the  
Republic of Ireland (see Figure 18a). The winter mortality rates for pneumonia amongst 
the 65-74 year olds showed an overall downwards trend over the study period in both 
jurisdictions (see Figure 18b).  The mortality rates were higher in Northern Ireland than 
the Republic of Ireland apart from the years 2002/2003 when the rates were higher in 
the Republic of Ireland. There was a convergence of the mortality rates by the end of 
the study.  The study found that there was a decrease of approximately 74 and 72% in 
the Republic of Ireland and Northern Ireland respectively over the study period.  The 
winter mortality rates for pneumonia amongst the 75-84 year olds increased initially  
before declining in the latter stages of the study (see Figure 18c).  The mortality rates 
were higher overall in Northern Ireland than the Republic of Ireland with the exception 
of the reversal of trends in 2002/2003 when it was higher in the Republic of Ireland.  
There was a convergence of the mortality rates by the end of the study period.  The 
study showed that there was a decrease of approximately 43% and 60% in the Republic 
of Ireland and Northern Ireland respectively by the end of the study period.  The winter 
mortality rates for pneumonia amongst the 85+ year olds showed an overall downwards 
trend in both jurisdictions (see Figure 18d).  There was an initial increase in the 
mortality rates during the first half of the study followed by a larger decline in the 
second half of the study period; this was more pronounced in Northern Ireland.  The 
mortality rates were generally higher in Northern Ireland than the Republic of Ireland 
except for the years 2002/2003 which noticed a reversal of the trend with slightly higher 
rates in the Republic of Ireland.  This study observed decreases of 38% and 55% in the 
winter pneumonia mortality rates in the Republic of Ireland and Northern Ireland 
respectively.  The winter mortality rates for pneumonia were highest amongst the 85+ 
year olds and lowest amongst the 65-74 year olds (see Figures 18b-d) within the older 
population. 
 
Stroke mortality rates were very low and showed an overall downwards trend in both 
jurisdictions with Northern Ireland presenting slightly higher rates than the Republic of 
Ireland while there was a slight increase in the rates in Northern Ireland at the end of the 
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study (see Figure 19a). The winter mortality rates for stroke amongst the 65-74 year 
olds declined throughout the study period with Northern Ireland experiencing higher 
mortality rates than the Republic of Ireland (see Figure 19b).  This study found that 
there were decreases of approximately 76% and 71% in the Republic of Ireland and 
Northern Ireland respectively over the study period.  The winter mortality rates also 
showed an overall downwards trend amongst the 75-84 year olds with a convergence of 
the rates by the end of the study period (see Figure 19c).  The mortality rates were 
higher in Northern Ireland compared to the Republic of Ireland throughout the study.  
This study noted that there were decreases of approximately 56% and 60% in the 
Republic of Ireland and Northern Ireland in their respective winter stroke mortality rates 
over the study period.  The winter mortality rates for stroke amongst the 85+ year olds 
showed an overall downwards trend in both jurisdictions although there was an increase 
in the mortality rates in Northern Ireland around the middle of the study (see  
Figure 19d).  The mortality rates from stroke were generally higher throughout the 
study in Northern Ireland compared with the Republic of Ireland although this trend was 
temporarily reversed in the years 1991/1992 when the winter stroke mortality rates were 
higher in the Republic of Ireland.  This study found that the winter stroke mortality rates 
amongst the 85+ year olds decreased by approximately 50% and 46% over the study 
period in the Republic of Ireland and Northern Ireland respectively.  This study 
observed that the winter stroke mortality rates were highest amongst the 85+ year olds 
and lowest amongst the 65-74 year olds in both jurisdictions (see Figures 19b-d) within 
the older population.    
 
3.2.5 Cold period mortality rates by gender 
The male all-cause mortality rates during the cold period showed an overall downwards 
trend in both jurisdictions with Northern Ireland presenting higher mortality rates 
compared to the Republic of Ireland across the study period (see Figure 20a).  This 
study found that the cold period all-cause mortality rates in the male population 
decreased by approximately 29% and 17% in the Republic of Ireland and Northern 
Ireland respectively.  The CVD mortality rates for the male population showed an 
overall downwards trend in both jurisdictions; with Northern Ireland presenting overall 
higher mortality rates than the Republic of Ireland across the study period with the 
exception of the years 1996/97 when this trend was reversed with higher mortality rates 
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in the Republic of Ireland (see Figure 20b).  This study found that there were decreases 
approximately 47% in the male CVD mortality rates during the cold period in both 
jurisdictions.  The IHD mortality rates for the male population reflected a similar trend 
to the male CVD mortality rates in both jurisdictions (see Figures 20b-c).  Northern 
Ireland presented higher mortality rates in the early and latter stages of the study while 
the Republic of Ireland reported higher rates around the middle of the study. This study 
observed that the cold period IHD mortality rates for the male population declined over 
the study by approximately 52% and 46 % in the Republic of Ireland and Northern 
Ireland respectively.  The cold period MI mortality rates for the male population 
declined throughout the study; with Northern Ireland presenting higher mortality rates 
than the Republic of Ireland (see Figure 20d).  This study reported mortality rates for 
male MI mortality rates during the cold period decreased by approximately 69% and 
61% in the Republic of Ireland and Northern Ireland respectively. 
 
The male RD mortality rates for the cold period showed an overall downwards trend 
over the study period (see Figure 21a).  Northern Ireland presented higher mortality 
rates during the first half of the study and at the end of the study while this pattern was 
reversed around the middle of study. This study observed that the cold period RD 
mortality rates for the male population decreased overall by approximately 31% in both 
jurisdictions.  The COPD mortality rates for the male population reported an overall 
downwards trend in the Republic of Ireland while there was a small upwards trend in 
Northern Ireland (see Figure 21b).   The Republic of Ireland presented higher mortality 
rates across the study period until the end of the study when this trend was reversed 
with Northern Ireland presenting the higher mortality rates. The COPD mortality rates 
for the male population decreased by approximately 47% in the Republic of Ireland and 
increased by 5% in Northern Ireland.  The pneumonia mortality rates for the male 
population displayed comparable trends to COPD mortality rates (see Figures 21b-c).  
However, in the case of the pneumonia mortality rates, Northern Ireland presented 
higher rates over the study period with the exception of the years 2002/2003 when the 
trends were reversed with Republic of Ireland presenting higher mortality rates (see 
Figure 21c).  The pneumonia mortality rates for the male population decreased by 
approximately 23% and 56% in the Republic of Ireland and Northern Ireland 
respectively. The stroke mortality rates for the male population declined across the 
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study in both jurisdictions with Northern Ireland presenting higher mortality rates than 
the Republic of Ireland (see Figure 21d).  Stroke mortality rates decreased by 52% and 
39% in the Republic of Ireland and Northern Ireland respectively. 
 
The all-cause mortality rates for the female population showed an overall downwards 
trend during the cold period in both jurisdictions with Northern Ireland presenting 
higher mortality rates throughout the study period (see Figure 22a).  This study reported 
that the female all-cause mortality rates decreased by approximately 19% and 6% in the 
Republic of Ireland and Northern Ireland respectively.  The cold period CVD mortality 
rates for the female population showed an overall downwards trend in both jurisdictions 
(see Figure 22b).  Northern Ireland presented higher mortality rates over the study 
period although there was a convergence of the mortality rates in both jurisdictions by 
the end of the study.  This study observed that the female CVD mortality rates during 
the cold period decreased by approximately 38% and 46% in the Republic of Ireland 
and Northern Ireland respectively over the study period.  The female IHD mortality 
rates in the cold period followed a similar pattern to the female CVD mortality rates 
(see Figure 22b and 22c).  Northern Ireland presented higher mortality rates in the 
female population over the study period although the rates were comparable between 
the two jurisdictions in the middle of the study.  This study noticed that the female IHD 
mortality rates for IHD in the cold period had decreased by approximately 41% in both 
jurisdictions by the end of the study.  The female MI mortality rates during the cold 
period declined across the study period in both jurisdictions with Northern Ireland 
presenting higher mortality rates over the whole of the study period (see Figure 22d).  
There was some convergence of the mortality rates by the end of the study.  This study 
found that the female MI mortality rates during the cold period declined by 
approximately 60% and 61% in the Republic of Ireland and Northern Ireland over the 
study period. 
 
The female RD mortality rates during the cold period increased during the first half of 
the study period before declining in the second half of the study; with Northern Ireland 
presenting higher mortality rates than the Republic of Ireland over the whole of the 
study period (see Figure 23a).  There was a decrease of approximately 7% in the 
Republic of Ireland and an increase of 4% in Northern Ireland in the female RD 
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mortality rates during the cold period.  The female COPD mortality rates showed no 
overall change over the study period in the Republic of Ireland while they increased 
steadily in Northern Ireland over the same period (see Figure 23b).  The mortality rates 
for COPD mortality in females were higher in the Republic of Ireland until the middle 
of the study, after which the trend was reversed with Northern Ireland presenting higher 
mortality rates.  This study reported that the female COPD mortality rates during the 
cold period did not show any overall change in the Republic of Ireland while in 
Northern Ireland the mortality rates increased significantly (163%) over the study 
period.  The mortality rates for pneumonia in the female population reflected a similar 
trend displayed by the female RD mortality rates (see Figures 23a and 23c).  Northern 
Ireland presented higher mortality rates over the whole of the study period.  This study 
noted that the female pneumonia mortality rates decreased by approximately 20% and 
29% in the Republic of Ireland and Northern Ireland respectively. The female stroke 
mortality rates during the cold period declined over the whole of the study in both 
jurisdictions (see Figure 23d). This study observed that the female stroke mortality rates 
during the cold period decreased by approximately 46% and 38% in the Republic of 
Ireland and Northern Ireland respectively with the mortality rates higher in Northern 
Ireland. 
 
3.2.6 Cold period mortality rates by age stratification 
The mortality rates for CVD amongst the 18-64 year olds were very low and showed an 
overall downwards trend in both jurisdictions with Northern Ireland presenting higher 
mortality rates although the rates converged by the end of the study (see figure 24a). 
The CVD mortality rates amongst the 65-74 year olds declined throughout the study 
period in both jurisdictions (see Figure 24b).  Northern Ireland presented higher 
mortality rates until the middle of the study period while the Republic of Ireland 
presented higher mortality rates in the latter stages of the study.  This study reported 
that the cold period CVD mortality rates amongst the 65-74 year olds decreased by 
approximately 65% and 70% in the Republic of Ireland and Northern Ireland 
respectively.  The CVD mortality rates amongst the 75-84 year olds declined across the 
study period in both jurisdictions; with the Republic of Ireland presenting higher 
mortality rates than Northern Ireland in this age group (see Figure 24c).  This study 
found that there was a decrease in the cold period CVD mortality rates amongst the 75-
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84 year olds of approximately 52% and 54% in the Republic of Ireland and Northern 
Ireland respectively. The CVD mortality rates amongst the 85+ year olds showed an 
overall downwards trend in both jurisdictions; with the Republic of Ireland presenting 
higher mortality rates than Northern Ireland over the study period (see Figure 24d).  
This study observed that the CVD mortality rates amongst the 85+ years olds decreased 
by approximately 28% and 34% in the Republic of Ireland and Northern Ireland 
respectively.  The cold period CVD mortality rates were highest amongst the 85+ year 
olds and lowest amongst the 65-74 year olds in both jurisdictions (see Figures 24b-d) 
within the older population. 
 
The mortality rates for IHD amongst the 18-64 year olds were very low and showed an 
overall downwards trends in both jurisdictions with Northern Ireland presenting higher 
mortality rates than the Republic of Ireland (see Figure 25a). IHD mortality rates 
amongst the 65-74 year olds declined over the study period (see Figure 25b).  Although 
Northern Ireland presented higher mortality rates at the start and in the latter stages of 
the study period, the Republic of Ireland presented higher mortality rates during the 
middle stages of the study.  This study found that the cold period IHD mortality rates 
amongst the 65-74 year olds decreased by approximately 69% in both jurisdictions.  
The IHD mortality rates amongst the 75-84 year olds showed an overall downwards 
trend in both jurisdictions with the Republic of Ireland presenting higher mortality rates 
than Northern Ireland over the study period (see Figure 25c).  This study reported that 
the IHD mortality rates amongst 75-84 year olds decreased over the study period by 
approximately 55% and 49% in the Republic of Ireland and Northern Ireland 
respectively.  The IHD mortality rates amongst the 85+ year olds showed an overall 
downwards trend in both jurisdictions; again with the Republic of Ireland presenting 
higher mortality rates than Northern Ireland over the study period (see Figure 25d).  
This study observed that the cold period IHD mortality rates amongst the 85+ year olds 
decreased by approximately 16% and 23% in the Republic of Ireland and Northern 
Ireland respectively.  The cold period IHD mortality rates were highest amongst the 85+ 
year olds and lowest amongst the 65-74 year olds in both jurisdictions (see Figure 25b-
d) within the older population. 
 
Mortality rates for MI amongst the 18-64 year olds were very low and showed an  
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overall downwards trend in both jurisdictions with Northern Ireland presenting higher 
mortality rates although the rates converged by the end of the study (see Figure 26a). 
The MI mortality rates for the 65-74 year olds declined over the study period in both 
jurisdictions; with Northern Ireland presenting the higher mortality rates than the 
Republic of Ireland during this time (see Figure 26b).  This study found that the MI 
mortality rates amongst the 65-74 year olds decreased by approximately 81% and 77% 
in the Republic of Ireland and Northern Ireland respectively over the study period.  The 
cold period MI mortality rates amongst the 75-84 year olds declined over the study 
period in both jurisdictions (see Figure 26c).  Although the MI mortality rates were 
higher in Republic of Ireland at the start of the study, Northern Ireland presented higher 
mortality rates for the remainder of the study.  This study reported that the cold period 
MI mortality rates amongst the 75-84 year olds decreased by approximately 67% and 
62% in the Republic of Ireland and Northern Ireland respectively.  The MI mortality 
rates amongst the 85+ year olds showed an overall downwards trend in both 
jurisdictions (see Figure 26d).  The mortality rates varied between the two jurisdictions 
with both Northern Ireland and Republic of Ireland presenting higher mortality rates at 
some stage over the study period: Northern Ireland presented higher mortality rates at  
the start of the study and lower rates at the end of the study.  This study observed that 
the cold period MI mortality rates amongst the 85+ year olds decreased by 
approximately 36% and 49% in the Republic of Ireland and Northern Ireland 
respectively.  The MI mortality rates were highest amongst the 85+ year olds and lowest 
amongst the 65-74 year olds in both jurisdictions (see Figures 26b-d) within the older 
population. 
 
The RD mortality rates for respiratory disease amongst the 18-64 year olds were very 
low and showed an overall downwards trend in both jurisdictions with Northern Ireland 
presenting higher mortality rates (see Figure 27a). The RD mortality rates amongst the 
65-74 year olds showed an overall downwards trend in both jurisdictions (see Figure 
27b).  The Republic of Ireland presented higher mortality rates until the latter stages 
when the mortality rates were higher in Northern Ireland compared to the Republic of 
Ireland.  This study reported that the RD mortality rates amongst the 65-74 year olds 
decreased by approximately 53% and 44% in the Republic of Ireland and Northern 
Ireland respectively.  The RD mortality rates amongst the 75-84 year olds increased 
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during the early stages of the study before declining sharply in the latter stages of the 
study (see Figure 27c).  The Republic of Ireland presented higher mortality rates 
compared to Northern Ireland over the study period.  This study found that the RD 
mortality rates amongst the 75-84 year olds decreased by approximately 30% and 32% 
in the Republic of Ireland and Northern Ireland respectively.  Amongst the 85+ year 
olds, the cold period RD mortality rates showed an overall downwards trend over the 
study period in both jurisdictions (see Figure 27d).  Northern Ireland presented higher 
mortality rates over the study period with the exception of the years 2002/2003 when 
the trend was reversed.  This study observed that the cold period RD mortality rates 
amongst the 85+ year olds decreased by approximately 19% and 33% in the Republic of 
Ireland and Northern Ireland respectively.  The RD mortality rates were highest 
amongst the 85+ year olds and lowest amongst the 65-74 year olds (see Figures 27b-d) 
within the older population. 
 
The mortality rates for COPD amongst the 18-64 year olds was very low and showed an 
overall downwards trend in both jurisdictions with the Republic of Ireland presenting 
higher mortality rates at the start of the study while this pattern reversed by the end of 
the study (see Figure 28a). The COPD mortality rates amongst the 65-74 year olds 
showed an overall downwards trend in both jurisdictions (see Figure 28b).  The  
Republic of Ireland presented higher mortality rates until the latter stages of the study  
when this trend was reversed with Northern Ireland presenting the higher mortality 
rates.  This study reported that the cold period COPD mortality rates amongst the 65-74 
year olds decreased by approximately 61% and 6% in the Republic of Ireland and 
Northern Ireland respectively.  The COPD mortality rates amongst the 75-84 year olds 
showed an overall downwards trend in the Republic of Ireland while there was an 
overall upwards trend in Northern Ireland over the study period (see Figure 28c).   The 
COPD mortality rates were higher in the Republic of Ireland over the study period 
although there was some convergence of the mortality rates in both jurisdictions by the 
end of the study.  This study observed that the cold period COPD mortality rates 
amongst the 75-84 year olds decreased by approximately 34% in the Republic of Ireland 
and increased by approximately 61% in Northern Ireland.  The COPD mortality rates 
for amongst the 85+ year olds showed an overall downwards trend in the Republic of 
Ireland and an overall upwards trend in Northern Ireland over the study period (see 
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Figure 28d).  The Republic of Ireland presented higher mortality rates than Northern 
Ireland.  This study found that the cold period COPD mortality rates amongst the 85+ 
year olds decreased by approximately 9% in the Republic of Ireland and increased by 
approximately 55% in Northern Ireland.  The COPD mortality rates were highest 
amongst the 85+ year olds and lowest amongst the 65-74 year olds in both jurisdictions 
(see Figures 28b-d) within the older population. 
 
The mortality rates for pneumonia amongst the 18-64 year olds were very low and 
showed an overall downwards trend in both jurisdictions with Northern Ireland 
presenting slightly higher rates than the Republic of Ireland (see Figure 29). The 
pneumonia mortality rates amongst the 65-74 year olds showed an overall downwards 
trend in both jurisdictions (see Figure 29b). Northern Ireland presented higher mortality 
rates until the latter stages of the study when this trend was reversed with the Republic 
of Ireland presenting the higher mortality rates. This study reported that the mortality 
rates for pneumonia amongst the 65-74 year olds decreased by approximately 55% and 
74% in the Republic of Ireland and Northern Ireland respectively.  The pneumonia 
mortality rates amongst the 75-84 year olds showed an overall downwards trend over 
the study period in both jurisdictions (see Figure 29c).  Northern Ireland presented 
higher mortality rates until the latter stages of the study when this trend was reversed 
with the Republic of Ireland presenting the higher mortality rates although there was a 
convergence of the rates at the end of the study.  This study observed that the  
pneumonia mortality rates amongst the 75-84 year olds decreased by approximately 
40% and 66% in the Republic of Ireland and Northern Ireland respectively.  The cold 
period pneumonia mortality rates amongst the 85+ year olds showed an overall 
downwards trend in both jurisdictions (see Figure 29d).  Northern Ireland presented 
higher mortality rates during the early and final stages of the study while the Republic 
of Ireland presented higher mortality rates during the latter stages of the study.  This 
study found that the pneumonia mortality rates amongst the 85+ year olds decreased by 
approximately 35% and 51% in the Republic of Ireland and Northern Ireland 
respectively.  The pneumonia mortality rates were highest amongst the 85+ year olds 
and lowest amongst the 65-74 year olds in both jurisdictions (see Figures 29b-d) within 
the older population.   
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The mortality rates for stroke amongst the 18-64 year olds showed an overall 
downwards trend in both jurisdictions with Northern Ireland presenting slightly higher 
mortality rates than the Republic of Ireland and the rates showed a slight increase at the 
end of the study in Northern Ireland (see Figure 30a). Those mortality rates were very 
low overall in both jurisdictions. The stroke mortality rates amongst the 65-74 year olds 
declined across the study period in both jurisdictions, with Northern Ireland presenting 
higher mortality rates than the Republic of Ireland (see Figure 30b).  This study 
observed that the stroke mortality amongst the 65-74 year olds decreased by 
approximately 73% and 67% in the Republic of Ireland and Northern Ireland 
respectively.  The stroke mortality rates amongst the 75-84 year olds declined over the 
study period; with Northern Ireland presenting higher mortality rates than the Republic 
of Ireland (see Figure 30c).  The study reported that the mortality rates for stroke 
amongst the 75-84 year olds decreased by approximately 58% in both jurisdictions.  
The stroke mortality rates amongst the 85+ year olds showed an overall downwards 
trend in both jurisdictions (see Figure 30d).  The Republic of Ireland presented higher 
mortality rates in the early stages of the study while Northern Ireland presented higher 
mortality rates from the middle of the study onwards.  This study found that the cold 
period stroke mortality rates amongst the 85+ year olds decreased by approximately 
49% and 34% for Republic of Ireland and Northern Ireland respectively.  The stroke 
mortality rates were highest amongst the 85+ year olds and lowest amongst the 65-74 
year olds (see Figures 30b-d) within the older population. 
 
3.2.7 Summary of jurisdictional differences in the mortality rates 
The mortality rates showed an overall downwards trend in both jurisdictions except for 
COPD mortality which increased in Northern Ireland. The annual mortality rates and 
the summer/winter mortality rates were higher in Northern Ireland except for COPD. 
During the winter months, the mortality rates for CVD, MI, IHD and COPD were 
higher amongst males while RD, pneumonia and stroke mortality were higher amongst 
females in both jurisdictions. The mortality rates for all-cause mortality were 
comparable amongst the genders. The winter mortality rates amongst the different older 
age groups showed an overall decline in both jurisdictions and mortality rates amongst 
the 65-74 year olds were higher in Northern Ireland except for RD mortality and COPD 
mortality. The mortality rates amongst the remaining older age groups were higher in 
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the Republic of Ireland. COPD mortality was higher in all age groups in the Republic of 
Ireland. Similar patterns and trends were observed during the cold period with the 
mortality rates greater in both jurisdictions. 
 
3.3 Temperature metrics 
The temperatures in Northern Ireland were lower than those observed in the Republic of 
Ireland, with the temperatures in winter in Northern Ireland being nearly 1
o
C less than 
those in the Republic of Ireland (see Table 15).  This trend of lower temperatures in 
Northern Ireland was reflected across the seasons and the temperature metrics.  The 
mean of the maximum temperature was 10
o
C during the cold period and 8.6
o
C in the 
winter months for all of the weather stations in the Republic of Ireland.  Meanwhile the 
mean of the maximum temperature was 9.1
o
C and 7.6
o
C during the cold period and 
winter months respectively in Northern Ireland. The above results were presented in the 
co-authored publication in Appendix 2. 
 
3.4 Cold weather-mortality associations 
3.4.1 Weekly lagged associations during the cold period in the Republic of Ireland 
Table 16 presented the estimated mortality percentage change per 1
o
C decrease in 
maximum temperature in the Republic of Ireland during the cold period for all ages 18+ 
years over the study period.  All-cause mortality showed the greatest increase associated 
with cold temperatures in the preceding week to death of 1.3% (95% CI: 1.1%-1.5%) 
with the impact of cold temperature on mortality weakening by approximately 40% in 
the second week and continuing to weaken. The associations persisted up to 5 weeks 
prior to death (see Table 16).  Similar associations were reported for CVD mortality 
with an increase of 1.5% (95% CI: 1.1%-1.9%) in the week preceding death; however 
associations were observed up to the preceding 4 weeks prior to death.  IHD mortality 
showed the greatest increase of 1.6% (95% CI: 1.2%-2.1%) associated with cold 
temperature in the preceding week to death.  IHD mortality presented similar trends to 
CVD mortality and also persisted up to the preceding 4 weeks prior to death.  MI 
mortality showed comparable increases and trends to both IHD mortality and CVD 
mortality, persisting up to the preceding 4 weeks prior to death.  RD mortality  
presented the strongest increase of 2.0% (95% CI: 1.5%-2.5%) with regards to 
temperatures 2 weeks prior to death; the associations were strong in week 1 and 
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remained strong in weeks 3-5 weeks prior to death.  COPD mortality showed the 
greatest increase of 2.0% (95% CI: 1.2%-2.9%) in the preceding 4 weeks prior to death; 
with strong associations in weeks 1-3.  The associations for COPD mortality did not 
extend into week 5.  Pneumonia mortality showed the greatest increase of 2.0% (95% 
CI: 1.2%-2.8%) in the preceding weeks 2 and 3 prior to death.  The associations were  
strong in weeks 1 and 4 but they did not extend into 5 weeks prior to death.  Stroke 
mortality showed the greatest increase of 1.8% (95% CI: 1.1%-2.6%) associated with 
cold temperatures in the preceding week to death; the impact of cold temperatures on 
mortality weakened but lasted up to 3 weeks prior to death.  There were no important 
associations in weeks 2, 4 and 5. Some of the above results were presented in the co-
authored publication in Appendix 2. 
 
3.4.2 Cumulative associations during the cold period in the Republic of Ireland 
In the Republic of Ireland, the cumulative increases in mortality were calculated over 
the 5 week period for all-cause mortality and all respiratory diseases; for a 4-week 
period for CVD mortality, IHD mortality, MI mortality, COPD mortality and 
pneumonia mortality; and over the preceding 3 weeks for stroke mortality.  The 
cumulative increase for all-cause mortality was 3.7% (95% CI: 2.6%-4.8%), 3.7% (95% 
CI: 2.2%-5.3%) for CVD mortality, 3.4% (95% CI: 1.6%-5.2%) for IHD mortality and 
3.6 (95% CI: 1.5%-5.7%) for MI respectively (see Table 16). Increases for RD mortality 
were twice as large at 7.5% (95% CI: 4.8%-10.2%). COPD mortality showed 
cumulative increases of 7.1% (95% CI: 3.6%-10.5%). The cumulative increase for 
mortality from pneumonia mortality was 7.2% (95% CI: 4.0%-10.4%).  Stroke mortality 
showed a cumulative increase of 3.1% (95% CI: 1.0%-5.3%) over a 3 week period.  
 
3.4.3 Weekly lagged associations during the cold period in Northern Ireland 
In Northern Ireland, all-cause mortality showed its greatest increase of 1.4% (95% CI: 
1.1%-1.8%) with temperatures in the preceding week prior to death; with the impact of 
cold temperatures on mortality weakening but persisting up to 4 weeks prior to death 
(see Table 17).  CVD mortality showed its strongest increase of 1.1% (95% CI: 0.6%-
1.7%) in week 1 with important associations in week 3.  The associations did not extend 
beyond week 3 and there were no important associations in week 2. IHD and MI 
mortality reflected similar patterns to CVD mortality, with their strongest increases of 
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1.4% (95% CI: 0.7%-2.1%) and 1.5% (95% CI: 0.8%-2.2%) respectively in the 
preceding week to death; with strong associations remaining in week 3. RD mortality 
showed the strongest increase of 2.6% (95% CI: 1.8%-3.4%) in the preceding week to 
death; with strong associations remaining until week 3.  COPD mortality showed an 
increase of 3.7% (95% CI: 2.1%-5.3%) in the preceding week to death and remained 
strong to week 2.  The associations did not persist after week 2. Pneumonia mortality 
showed its strongest increase of 2.8% (95% CI: 1.8-3.7%) in week 3, with strong  
associations in the preceding weeks. The associations did not persist after week 3. 
Stroke mortality showed important associations up to week 4 with its strongest 
association of 1.4% (95% CI: 0.4%-2.3%) in the preceding week death. 
 
3.4.4 Cumulative associations during the cold period in Northern Ireland 
Cumulative mortality increases for Northern Ireland were calculated for associations 
with cold temperatures in the 4 weeks before death for all-cause mortality and stroke 
mortality (see Table 17). Important associations were observed up to the preceding 
week 3 for CVD mortality, IHD mortality, RD mortality and pneumonia mortality; and 
up to 2 weeks preceding to death for COPD mortality, with the cumulative increases 
only calculated over these periods. The cumulative increases for all-cause mortality, 
CVD mortality, IHD mortality, MI mortality, RD mortality, COPD, pneumonia and 
stroke were 3.1% (95% CI: 1.8%-4.4%), 2.4% (95% CI: 0.7%-4.1%), 2.5% (95% CI: 
0.3%-4.6%),  2.6% (95% CI: 0.6%-4.6%), 7.1% (95% CI: 4.8%-9.4%), 5.5% (95% CI: 
1.9%-5.8%), 6.6% (95% CI: 3.7%-9.5%) and 4.2% (95% CI: 0.4%-8.0%) respectively. 
 
3.4.5 Weekly lagged associations in the winter months in the Republic of Ireland 
Table 18 presented the estimated percentage change per 1
o
C decrease in maximum 
temperatures in the Republic of Ireland in the winter months for the ages of 18+ years, 
1984-2007.  All-cause mortality showed the greatest increase 1.8% (95% CI: 1.5%-
2.1%), in the preceding week to death (week 1), with the associations remaining strong 
but diminishing and persisting up to week 5 prior to death.  CVD mortality showed the 
greatest increase of 1.8% (95% CI: 1.3%-2.3%) in the preceding week to death; with the 
associations remaining strong although diminishing and extending up to week 4 prior to 
death.  IHD mortality followed a similar trend to CVD mortality, with its strongest 
increase of 2.1% (95% CI: 1.5%-2.7%) in the week prior to death.  MI mortality 
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reflected a similar trend to both CVD and IHD mortality with its strongest increase of 
1.9% (95% CI: 1.2%-2.7%) in the week preceding death (week 1). RD mortality 
showed its strongest increase of 3.2% (95% CI: 2.5%-3.9%) in week 2, with strong but 
diminishing associations persisting up to week 5.  The associations for both COPD and 
pneumonia mortality also persisted up to week 5, with their strongest increases of 2.9% 
(95% CI: 1.7%-4.0%) and 3.6% (95% CI: 2.6%-4.7%) in week 4 and week 2 
respectively.  Stroke mortality had its greatest increase of 2.5% (95% CI: 1.5%-3.5%) in 
the week prior to death.  The associations remained strong and extended to week 3.  The 
above results were included in the co-authored published paper (see Appendix 2). 
 
3.4.6 Cumulative associations in the winter months in the Republic of Ireland 
The cumulative increases for the Republic of Ireland were calculated over the 5-week 
period for all-cause mortality, RD mortality, COPD and pneumonia mortality; over the 
4-week period for CVD mortality, IHD mortality, and MI mortality and over the 
preceding 3 weeks for stroke mortality (see Table 18). This study reported that the 5-
week cumulative increases for all-cause mortality, RD mortality, COPD and pneumonia 
mortality were 6.4% (95% CI: 4.8%-7.9%), 12.5% (95% CI: 8.9%-16.2%), 11.7% (95% 
CI: 6.0%-17.4%) and 13.8 (95% CI: 8.4%-19.1%) respectively. CVD mortality, IHD 
mortality and MI mortality showed cumulative increases of 5.6% (95% CI: 3.5%-7.7%), 
5.3 (95% CI: 2.9%-7.8%) and 5.1% (95% CI: 2.2%-8.0%) respectively.  The cumulative 
increase for stroke mortality was 5.0% (95% CI: 2.1%-8.0%).  The above results were 
included in the co-authored published paper (see Appendix 2). 
 
3.4.7 Weekly lagged associations in the winter months in Northern Ireland 
All-cause mortality in Northern Ireland showed its strongest increase of 1.7% (95% CI: 
1.3%-2.2%) occurring in the week prior to death (see Table 19).  CVD mortality 
showed its strongest increase of 1.9 (95% CI: 1.2%-2.7%) in the week prior to death 
with the associations continuing to week 3.  IHD mortality and MI mortality reflected 
comparable trends to CVD mortality, with their strongest increases of 2.3% (95% CI: 
1.3%-3.2%) and 2.2% (95% CI: 1.2%-3.2%) respectively also occurring in the week 
preceding death.   
 
The associations for RD mortality persisted up to 4 weeks prior to death, with the  
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strongest increases of 4.3% (95% CI: 3.2%-5.3%) occurring in week 3.  COPD 
mortality showed its strongest increase of 3.9% (95% CI: 1.8%-6.0%) in week 3, with 
the associations not extending beyond week 3.  Pneumonia mortality showed its 
strongest increase of 4.1% (95% CI: 2.8%-5.4%) in week 3.  Stroke mortality showed 
the strongest increase of 2.0% (95% CI: 0.7%-3.3%) in the week preceding death and 
important associations persisted to week 3. The above results were included in the co-
authored published paper (see Appendix 2). 
 
3.4.8 Cumulative associations in the winter months in Northern Ireland 
The cumulative increases for Northern Ireland were calculated for associations with 
cold temperatures in the 4 week period prior to death for RD mortality and pneumonia 
(see Table 19).  Important associations were observed up to the preceding 3 weeks 
before death for the remaining cause-specific mortality groups and their cumulative 
increases were only calculated over those periods.  The cumulative mortality increases 
for all-cause mortality, RD mortality and pneumonia mortality were 4.5% (95% CI: 
3.2%-5.9%), 11.2% (95% CI: 7.1%-15.3%) and 10.2% (95% CI: 5.0%-15.4%) 
respectively.  The cumulative mortality increases for CVD mortality, IHD mortality, MI 
mortality, COPD and stroke mortality were 3.9% (95% CI: 1.5%-6.3%), 3.8% (95% CI: 
1.0%-6.6%), 3.7% (95% CI: 0.7%-6.7%), 10.6% (95% CI: 4.2%-17.0%), and 4.8% 
(95% CI: 0.9%-8.8%) respectively. 
 
3.4.9 Cumulative associations for age stratification and gender during the cold period 
in the Republic of Ireland 
Table 20 presented the estimated cumulative percentage change per 1
o
C decrease in the 
maximum temperatures in the Republic of Ireland during the cold period for the ages 
18+ year olds, 1984-2007.  Although there were some differences by age stratification 
and gender in the cold weather-mortality associations that were observed in the 
Republic of Ireland, this study found that those differences were not statistically 
important.  There were no estimated mortality increases in the younger population (18-
64 year olds).  This trend was reflected amongst the 65-74 year olds with the  exception 
of all-cause mortality which increased by 3.1% (95% CI: 0.8%-5.4%).  Mortality 
increases were seen in the 75+ year olds for all-cause mortality, and each cause – 
specific groups.  The greatest increase of 8.0% (95% CI: 4.4%-11.0%) was seen for RD 
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mortality and the smallest increase of 3.7% (95% CI: 0.8%-6.6%) was seen for stroke 
mortality.  The estimated cumulative increases for COPD and pneumonia mortality 
were very comparable with increases of 7.4% (95% CI: 2.3%-12.5%) and 7.4% (95% 
CI: 2.8%-12.0%) respectively.  All-cause mortality, CVD mortality, IHD mortality and 
MI mortality presented comparable estimated cumulating increases of 4.5% (95% CI: 
3.0%-5.9%), 4.4% (95% CI: 2.3%-6.4%), 4.0% (95% CI: 1.5%-6.5%), and 4.2% (95% 
CI: 1.1%-7.2%) respectively in this age group.  Estimated cumulated mortality increases 
were seen in both males and females for all-cause mortality and each cause specific 
mortality group except for stroke mortality, which was only seen in females.  The 
mortality increases were slightly higher in females than males for all-cause mortality, 
CVD mortality, IHD mortality, MI mortality, RD mortality and COPD mortality.  
However, this trend was reversed for pneumonia mortality, where mortality increases 
were higher amongst the male population. 
 
3.4.10 Cumulative associations for age stratification and gender during the cold period 
in Northern Ireland 
In Northern Ireland, it was observed that there were some differences by age and gender 
in the cold weather-mortality associations; however those differences were not 
statistically important (see Table 21).  The only estimated mortality increases were seen 
in the 18-64 year olds for all-cause mortality with an increase of 2.1% (95% CI: 0.0%-
4.3%).  Amongst the 65-74 year olds, there was an increase of 2.8% (95% CI: 1.0%-
4.6%) for all-cause mortality.  Mortality increases were seen in the 75+ year olds for all-
cause mortality and each cause specific mortality group.  The greatest increase of 5.9% 
(95% CI: 2.4%-9.3%) was seen for pneumonia mortality, closely followed by all 
respiratory mortality with an increase of 5.5% (95% CI: 3.4%-7.7%).  All-cause 
mortality presented a mortality increase of 4.1% (95% CI: 2.9%-5.2%) amongst the 75+ 
year olds.  The lowest mortality increase amongst this age group was observed for IHD 
mortality, with an increase of 3.5% (95% CI: 1.6%-5.4%).  COPD mortality, MI 
mortality, CVD mortality and stroke mortality presented mortality increases of 3.5% 
(95% CI: 0.9%-6.0%), 3.6% (95% CI: 1.3%-5.9%), 3.7% (95% CI: 2.1%-5.2%) and 
3.9% (95% CI: 0.05%-7.9%) respectively.  Mortality increases were observed for all-
cause mortality, RD mortality, COPD mortality and pneumonia mortality in both the 
male and female population; however, mortality increases were seen in the male 
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population only for CVD mortality.  There were no statistically important mortality 
increases for IHD mortality, MI mortality or stroke mortality. 
 
3.4.11 Cumulative associations for age stratification and gender in the winter months 
in the Republic of Ireland 
Table 22 presented the estimated cumulative mortality percentage change per 1
o
C  
decrease in maximum temperature in the Republic of Ireland during the winter months 
for the ages 18+ ages, 1984-2007.  There were some differences by age stratification 
and gender in the cold weather-mortality associations that were observed in the  
Republic of Ireland; however, those differences were not statistically important.  There 
were no estimated mortality increases in the 18-64 year olds.  However, mortality 
increases were seen for all-cause mortality, CVD mortality, RD mortality and COPD 
mortality amongst the 65-74 year olds, with the largest increase of 10.8% (95% CI: 
2.8%-18.8%) for RD mortality.  Mortality increases were seen in the 75+ year olds for 
all-cause mortality and each cause-specific mortality group.  The greatest mortality 
increase of 14.4% (95% CI: 8.5%-20.3%) was seen for pneumonia mortality while the 
lowest mortality increase of 5.6% (95% CI 1.7%-9.4%) was seen for stroke mortality.  
RD mortality and COPD mortality presented mortality increases of 12.9% (95% CI: 
8.6%-17.1%) and 11.8% (95% CI: 4.5%-19.1%) respectively.  These mortality 
increases were nearly double those for all-cause mortality, CVD mortality, IHD 
mortality and MI mortality, which presented increases of 7.7% (95% CI: 5.7%-9.7%), 
6.3% (95% CI: 3.5%-9.2%), 6.4% (95% CI: 3.0%-9.7%), 6.1% (95% CI: 2.0%-10.2%) 
respectively.  Mortality increases were observed for all-cause mortality and each cause-
specific mortality groups for each gender except for stroke mortality which only 
presented important associations in the female population.  This study found that the 
mortality increases were higher amongst the female population for all-cause mortality, 
IHD mortality, MI mortality, RD mortality and COPD mortality.  Mortality increases 
were higher amongst the male population for CVD mortality and pneumonia mortality. 
The above results were included in the co-authored published paper (see Appendix 2). 
 
3.4.12 Cumulative associations for age stratification and gender in the winter months 
in Northern Ireland 
There were some differences by age stratification and gender in the cold weather- 
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mortality associations that were observed in Northern Ireland; however, those 
differences were not statistically important (see Table 23).  There were no important 
increases observed amongst the 18-64 year olds for all-cause mortality and each cause-
specific mortality group, with the exception of RD mortality which presented an 
estimated mortality increase of 15.3% (95% CI: 0.5%-30.2%).  Important mortality 
increase of 4.5% (95% CI: 1.6%-7.3%), 12.8% (95% CI: 2.3%-23.2%) and 15.6% (95%  
CI: 2.6%-28.6%) were observed amongst the 65-74 year olds for all-cause mortality, 
RD mortality and COPD mortality respectively.  With the exception of stroke mortality, 
important increases were seen in all-cause mortality, CVD mortality and pneumonia 
mortality amongst the 75 + year olds.  The greatest increase of 10.4% (95% CI: 4.9%- 
15.8%) was observed for RD mortality and the lowest increase of 3.5% (95% CI: 0.1%-
6.8%) was seen in CVD mortality.  All-cause mortality and pneumonia mortality 
presented statistically important increases of 5.1 (95% CI: 3.3, 6.9) and 9.7 (95% CI: 
2.4, 17.1) respectively.  The greatest increases for RD mortality was observed in the 18-
64 year olds; for COPD, it was the 65-74 year olds, while for all-cause mortality and 
CVD mortality, it was in the 75+ year olds.  Statistically important increases were 
observed in both males and females for all-cause mortality, RD mortality and COPD 
mortality.  Mortality increases were observed for CVD mortality, IHD mortality, MI 
mortality, and stroke mortality for males; and pneumonia for females.  All-cause 
mortality showed greater mortality increases in males; while the mortality increases for 
all respiratory mortality and COPD mortality were greater amongst the females than 
males. The above results were included in the co-authored published paper (see 
Appendix 2). 
 
3.4.13 Summary of the jurisdictional differences in the cold weather-mortality 
relationship 
The cold weather-mortality associations were strongest in the week preceding death for 
all-cause mortality, CVD, MI, IHD and stroke and second week for RD mortality and 
pneumonia and the fourth week for COPD mortality in the Republic of Ireland while it 
was the first week in all mortality groups except for pneumonia (third week) in 
Northern Ireland during the cold period. The patterns were similar in the winter months 
except for COPD mortality in Northern Ireland which was strongest in the third week. 
The cold weather-mortality associations were more persistent in the Republic of Ireland, 
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extending up to 5 weeks prior to death and 4 weeks in Northern Ireland. The 
associations were strongest RD mortality in both jurisdictions with COPD mortality 
second strongest in the Republic of Ireland, and pneumonia in Northern Ireland. The 
associations were weakest for stroke mortality in the Republic of Ireland (cold period 
and winter months) and CVD mortality during the cold period and MI mortality in the 
winter months in Northern Ireland. The cold weather-mortality associations were 
stronger amongst females for all mortality groups except for RD and pneumonia 
mortality in the Republic of Ireland during the cold period and similar patterns were 
observed in the winter months except for CVD mortality which was greater amongst 
males and RD mortality which was greater amongst females. In Northern Ireland, 
stronger associations were observed in males for all-cause mortality and CVD mortality 
with no important associations observed in both genders for IHD, MI and stroke 
mortality. In the winter months, Northern Ireland observed similar patterns to the cold 
period except for IHD and MI mortality were important associations were reported 
amongst males. The Republic of Ireland presented stronger associations than Northern 
Ireland amongst the 75+ year olds for all mortality groups except for stroke mortality 
where the associations were higher in Northern Ireland during the cold period. The 
Republic of Ireland reported stronger associations for RD mortality amongst the 75+ 
year olds while in Northern Ireland it was amongst the 18-64 year olds. This pattern was 
repeated in the winter months. Northern Ireland observed stronger associations amongst 
the 18-64 year olds than the Republic of Ireland.  
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4.0 DISCUSSION 
This study examined and compared the excess winter mortality rates for all-cause and 
each cause-specific mortality group by age and gender on the island of Ireland over a 
20-year period. It also assessed the association of cold weather on all-cause and cause-
specific mortality in both jurisdictions (Republic of Ireland and Northern Ireland), and 
assessed for effect modification of the cold weather-mortality relationship by age and 
gender over a 24-year period. 
This study was unique for several reasons. It is the first study in Europe to consider the 
case-crossover approach, using daily maximum temperature as its temperature metric 
and applying a longer lag structure over a longer study period with a large population 
sample. It also assessed for effect modification by age and gender and reported on the 
associations between cold weather and COPD, pneumonia and stroke mortality as well 
as other cause-specific mortality groups. It was the first international study to compare 
two adult populations from different governmental jurisdictions within the island of 
Ireland over a long study period and using an extensive dataset. 
 
This MPhil study was part of collaboration between Brunel University and the Centre of 
Ageing Research and Development in Ireland, Dublin Institute of Technology and the 
Institute of Public Health in Ireland. The analysis and findings of the first part of this 
study on mortality rates have been published in Chapter 4 of an international 
collaborative report, ‘Fuel poverty, older people and cold weather: all all-island 
analysis’, of which the researcher was a co-author (see Appendix 1).  
 
The analysis and findings of the second part of this study, which considered the 
association of cold weather on mortality on the island of Ireland were published in a 
paper ‘The association of cold weather and all-cause and cause-specific mortality in the 
island of Ireland between 1984 and 2007’ in Environmental Health journal. The 
researcher was a co-author of the aforementioned paper (see Appendix 2). This was a 
highly accessed paper.  
 
4.1 Mortality rates 
Some of the findings from this study have been included in Chapter 4 of an international  
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report, ‘Fuel poverty, older people and cold weather: all all-island analysis’ (Goodman 
et al. 2011) and this can be found in Appendix 1. This study observed that the annual 
mortality rates for all-cause mortality, CVD mortality, MI mortality and stroke mortality 
declined across study period in both jurisdictions. Respiratory and pneumonia mortality 
rates showed an overall downward trend over the study period in both jurisdictions and 
reflected a downward trend in mortality rates seen by other studies over the last few 
decades (Layte et al. 2011; Morgan et al. 2007; Unal et al. 2004). The annual mortality 
rates from COPD mortality declined in the Republic of Ireland while it increased in 
Northern Ireland. Northern Ireland presented overall higher annual mortality rates from 
all-cause mortality, CVD mortality, MI mortality, IHD mortality and stroke mortality. 
Northern Ireland also experienced greater rates of decline in respiratory mortality and 
pneumonia mortality during the first half of this study period, these rates declining 
towards the end of the study.  
 
This study observed an overall downward trend in both the summer and winter 
mortality rates from all-cause mortality and each cause specific mortality groups except 
for COPD mortality which witnessed an increase in the rates for Northern Ireland only. 
This study reported excess winter mortality with the winter mortality rates noticeably 
higher than summer mortality rates in all-cause mortality and in each cause-specific 
mortality groups in both jurisdictions. There was some convergence of the summer and 
winter mortality rates from all-cause mortality, CVD mortality, MI mortality and 
pneumonia mortality. Northern Ireland displayed higher mortality rates in the Republic 
of Ireland in the winter months for all-cause mortality, MI mortality, IHD mortality, RD 
mortality, pneumonia mortality and stroke mortality for all ages; except for COPD 
mortality where the Republic of Ireland presented higher rates until the later stages of 
the study when the rates were higher in Northern Ireland. The male population 
presented overall higher summer and winter mortality rates for all-cause mortality, CVD 
mortality, IHD mortality, MI mortality, RD mortality and COPD mortality while 
pneumonia mortality and stroke mortality rates were higher amongst females in both 
jurisdictions.  
 
The mortality rates for all-cause mortality and each cause-specific mortality group were  
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the highest amongst the 85+year-olds and lowest amongst the 65-74 year-olds, with 
very low rates amongst the 18-64 year olds. Northern Ireland presented overall higher 
winter mortality rates for all-cause mortality in each age group. CVD mortality, MI 
mortality and IHD mortality rates were higher Northern Ireland for the 65-74 year-olds 
while this trend was reversed in the other age groups with the rates higher in the 
Republic of Ireland. COPD mortality rates were higher overall in the Republic of 
Ireland in each age group. Pneumonia mortality and stroke mortality were higher in all 
age groups in Northern Ireland. Similar trends and patterns were reflected during the 
cold period although the mortality rates were higher in both jurisdictions. 
 
The differences in mortality rates between the two jurisdictions have narrowed over 
time (Goodman et al. 2011). Some of the differences observed in Northern Ireland and 
the Republic of Ireland might be explained by systematic differences in the coding of 
deaths; however this would not explain all of the observed differences (Goodman et al. 
2011).  There may be a myriad of other factors giving rise to this, for example, diet, 
health care, public health policies and interventions and housing conditions (Goodman 
et al. 2011).  
 
The fall in mortality rates, both annual and winter, on the island of Ireland may be due 
to a number of factors. The suggestion that milder winters (Walsh 2007) may have had 
an effect on the fall in death rates is not borne out by the temperature data, which does 
not reflect the decline witnessed in mortality post 1999 (Layte et al. 2011). Coronary 
Heart Disease (CHD) mortality decreased by more than 50% between 1981 and 2000 in 
England and Wales; with approximately 40% of the UK decrease attributable to the 
combined effects of modern cardiological treatments and almost 60% reduction in 
major risk factors, particularly smoking (Unal et al. 2004). These mortality reductions 
not only reflected a substantial decline in smoking prevalence but also smaller 
reductions in mean blood pressure, total cholesterol and deprivation (Unal et al. 2004). 
This trend may have been reflected on the island of Ireland with their falling mortality 
rates. 
 
The majority of the decrease in mortality between 1985 and 2000 is attributed to  
changes in lifestyle factors but it is important to note that all the main population risk  
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factors for cardiovascular disease - smoking, physical activity, obesity, diabetes and 
population blood pressure, have all worsened in Ireland since 2000 with the exception 
of population cholesterol and so cannot explain the abrupt change in mortality trends 
(Morgan et al. 2007). Across almost all CHD medications between the period 1995 to 
2005, there was a gradual increase from the beginning of the series followed by a 
steepening increase after 1999, and a further change in the prescribing trend post- 2007 
(Layte et al. 2011). The Irish cardiovascular strategy, provide a structured approach to 
the primary and secondary prevention of cardiovascular disease in Ireland (Department 
of Health and Children 1999). The strategy included prescribing protocols for GPs, 
contributing to a steep increase in the volume of cardiovascular drugs prescribed, with 
beta-blockers increasing by 109%, ace inhibitors by 89% and statins by 206% between 
the summer of 1999 and the end of 2003 (Layte et al. 2011).  
 
4.2 Cold weather-mortality associations 
This study found that the cold weather-mortality associations persisted up to 5 weeks 
and 4 weeks preceding death in the cold period and winter months in the Republic of 
Ireland and Northern Ireland respectively. Strong associations were reported between 
the exposures to cold temperatures and estimated increased mortality on the island of 
Ireland over a period of 24 years, with some differences in the persistence and 
pronouncement of those associations between the two jurisdictions. The cold weather-
mortality associations were more persistent overall in the Republic of Ireland, with 
similar patterns observed in both jurisdictions.  
 
In the winter months, this study showed that the all-cause mortality associations were 
strongest in the week preceding death in both jurisdictions; diminishing but persisting 
up to five weeks in the Republic of Ireland and three weeks in Northern Ireland. The 
cold weather-CVD mortality associations showed similar patterns to all-cause mortality, 
with the strongest associations in the week prior to death in both jurisdictions. The 
associations diminished but extended up to 4 weeks in the Republic of Ireland and three 
weeks in Northern Ireland. The cold weather-mortality associations were more 
pronounced in the Republic of Ireland than in Northern Ireland. The Republic of Ireland 
reported cumulative estimated increases in all-cause mortality and CVD mortality of 
6.4% and 5.6% per 1°C decrease in the daily maximum temperature over five weeks 
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and four weeks respectively; in Northern Ireland the respective associations showed 
estimated increases of 4.5% and 3.9% respectively over three weeks.  
 
IHD mortality associations were strongest in the week preceding death and followed a 
similar pattern to CVD and all-cause mortality, with associations extending up to 5 
weeks in the Republic of Ireland and the four weeks in Northern Ireland. The Republic 
of Ireland observed a cumulative estimated increase of 5.3% while Northern Ireland 
reported a cumulative increase of 3.8%. MI mortality associations followed a similar 
pattern to CVD mortality and IHD mortality extending up to 4 weeks preceding death in 
the Republic of Ireland and three weeks Northern Ireland; and the cumulative 
associations were very comparable with the CVD and IHD mortality associations.  
 
RD mortality showed the strongest associations in the second week preceding death 
with the associations extending up to 5 weeks prior to death in the Republic of Ireland 
and three weeks preceding death in Northern Ireland with the associations not persisting 
beyond the third week in Northern Ireland. The cold weather-respiratory mortality 
associations were more pronounced in the Republic of Ireland; with cumulative 
associations of 12.5% and 11.2% in the Republic of Ireland and Northern Ireland 
respectively. The RD mortality associations were approximately twice those of all-cause 
mortality and more than twice those of CVD mortality in both jurisdictions.  
 
The COPD associations were strongest four weeks prior to death in the Republic of 
Ireland and three weeks preceding death in Northern Ireland, with the associations not 
persisting beyond those weeks. The study reported an estimated cumulative increase in 
COPD mortality of 11.7% in the Republic of Ireland and 10.6% in Northern Ireland and 
these associations were similar to respiratory mortality. Pneumonia mortality 
associations were strongest in the second week preceding death in the Republic of 
Ireland and third week in Northern Ireland with the associations persisting up to 5 
weeks and four weeks prior to death the Republic of Ireland and Northern Ireland 
respectively. The Republic of Ireland reported a cumulative mortality association of 
13.8% while Northern Ireland showed an increase of 10.2%. The stroke mortality 
increases were strongest in the week preceding death, extending up to 3 weeks in both 
jurisdictions. The cold weather-stroke mortality associations showed an estimated  
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increase of 5% and 4.8% in the Republic of Ireland and Northern Ireland respectively.  
 
This study observed that RD mortality was more pronounced than CVD mortality or all-
cause mortality while the all-cause mortality associations were greater than CVD 
mortality associations in both jurisdictions. Pneumonia mortality showed the most 
pronounced associations in the Republic of Ireland while in Northern Ireland it was RD 
mortality. The least pronounced associations were observed for stroke mortality in the 
Republic of Ireland and MI mortality in Northern Ireland. The cold weather-mortality 
associations were more pronounced and more prolonged in the winter months compared 
to the cold period.  In particular, the associations were more prolonged for COPD 
mortality and pneumonia mortality during the winter months in the Republic of Ireland 
and for RD mortality, COPD mortality and pneumonia mortality in Northern Ireland 
(see Tables 16-19). These findings have been highlighted in the co-authored published 
paper (see Appendix 2). 
 
The cold weather-mortality relationship was less persistent for COPD and pneumonia 
mortality during the cold period compared to the winter months in the Republic of 
Ireland, with the remaining mortality causes showing similar persistence in the two 
seasons. There were some subtle differences in Northern Ireland with the associations 
for all-cause mortality being more persistent in the cold period than the winter months, 
extending up to 4 weeks preceding death. The CVD, IHD and MI mortality associations 
in the cold period displayed comparable patterns to those in the winter months. COPD 
mortality and pneumonia mortality were less persistent in the cold period whereas 
stroke mortality was more persistent. The associations for all-cause and each cause-
specific mortality group were not as strong in the cold period as in the winter months. 
RD mortality was the strongest in the cold period in the Republic of Ireland while in the 
winter months, it was pneumonia. In Northern Ireland, pneumonia mortality was the 
second strongest during the period whereas it was COPD mortality in the winter 
months. 
 
These findings are consistent with a previous Irish study (Goodman et al. 2004) which 
examined the relationship between cold weather and mortality in Dublin over a period 
of 17 years, using Poisson regression models. They reported mortality increases for all-
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cause mortality (2.6%), cardiovascular disease (2.5%), and respiratory disease (6.7%) in 
relation to 1
o
C decrease in mean daily temperatures up to 40 days preceding death 
(Goodman et al. 2004). Similar results were observed in Scotland for all-cause 
mortality, cardiovascular disease and respiratory mortality with cold temperatures 
during the month prior to death (Carder et al. 2005; Gemmell et al. 2000). Multi-city 
studies in Europe and the US reported similar increases for all-cause and cause-specific 
mortality from cold weather during winter and the persistence of those associations, 
with similar lag periods as presented here (Analitis et al. 2008; Anderson and Bell 2009; 
Zeka et al. 2014). Cold-related mortality was most associated longer lags (average the 
current day to 25 days previous) (Anderson and Bell 2009). An Australian study  
observed that the cold associations persist for 21 days preceding death (Yu et al. 
2011a). A US study found similar prolonged associations (Braga et al. 2001). A study in 
Germany found that cold spells lead to excess mortality to relatively small degree which 
last for weeks (Laschewski and Jendritzky 2002). 
 
A Scottish study observed that the associated increase in cardiovascular deaths was 
weakest but with a significant increase in mortality that lasted for three weeks 
(Gemmell et al. 2000). In the Netherlands, it was reported that a 1.7% increase in 
cardiovascular mortality in the 30 days after each 1°C temperature decrease was 
observed (Huynen et al. 2001). In Scotland IHD mortality increased by around 1% in 
the week of and the week after a 1°C decrease in temperature with little associations 
thereafter (Gemmell et al. 2000). A British study estimated that a 1°C reduction in 
temperature on a given day would cumulatively increase the risk of MI by 2.0% over 
the current and following 28 days, the strongest effects being estimated at the 
intermediate lags of 2-7 and 8-14 days (Bhaskaran et al. 2010).  
 
Other studies have reported similar patterns and trends to those observed in this study. 
The cold effects and respiratory mortality were strongest 2 to 4 weeks after the cold 
event (Goodman et al. 2004). Winter respiratory deaths were reported to peak about 12 
days after the cold spell (Keatinge 2002). In Scotland respiratory deaths increased by 
1% 1 to 2 weeks after a decrease of 1°C in weekly mean temperature (Gemmell et al. 
2000). In eight cold climate US cities, little association of cold temperatures on deaths 
from COPD or pneumonia was reported (Braga et al. 2002). General practitioner visits 
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by the elderly for respiratory disease in London found to rise by 10.5% for each 1°C 
drop in temperature (Hajat and Haines 2002). This study reported that the strongest 
observed associations were in week two preceding death in both jurisdictions which was 
comparable with other studies (Carder et al. 2005; Donaldson and Keatinge 1997; 
Goodman et al. 2004; Huynen et al. 2001). A Scottish study observed that the 
respiratory disease mortality associations were generally larger than the associations of 
temperature on all-cause mortality and cardiovascular disease mortality (Carder et al. 
2005). They found that the strongest associations for respiratory disease mortality 
occurred at a temperature lag of 13-18 days (Carder et al. 2005).  
 
Only a small number of studies have looked at the association between cold temperature 
on mortality from COPD, pneumonia and stroke (Zeka et al. 2014). An earlier study of 
12 cold-climate US cities did not observe any increase in COPD mortality in relation to 
cold, but their reported increase for pneumonia mortality is comparable with those 
reported in this study (Braga et al. 2002; Zeka et al. 2014). Another US study reported 
elevated risk of dying of COPD associated with cold weather, in an elderly population 
(Schwartz 2005). A European study reported increases in stroke mortality associated 
with cold temperatures over 15 days before death (Analitis et al. 2008), and other 
studies in Russia and Asia reported similar findings (Atsumi et al. 2013; Hong et al. 
2012; Revich and Shaposhnikov 2008).  
 
The increased susceptibility of persons with COPD to dying on extremely cold days is 
noteworthy, although perhaps more explicable (Schwartz 2005). People with COPD 
often have cardiovascular complications, which may play a role on blood components 
(Schwartz 2005). A study in the United States found that people with COPD had 
elevated risks of dying 1.2% on cold days (Schwartz 2005). Although he reported an 
elevated risk of COPD exposure from exposure to cold temperatures, their associations 
were smaller than those observed in this study. Their study applied a short lag structure 
with a medium population study over a medium study period, which may not capture 
prolonged associations. 
 
Few studies have considered the cold association on stroke mortality using a distributed  
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medium/long lag structure (Analitis et al. 2008; Atsumi et al. 2013; Liu et al. 2011; 
Revich and Shaposhnikov 2008; Yang et al. 2012). This study’s findings showed that 
stroke mortality increases in the first 3 weeks preceding death. The cold weather-stroke 
mortality associations in this study were greater than those in some earlier studies 
(Analitis et al. 2008; Liu et al. 2011) and less than other studies (Revich and 
Shaposhnikov 2008; Yang et al. 2012). However, these differences for COPD and 
stroke mortality may be explained by the application of different lag structures over 
medium and longer term study periods in different geographic climate locations. 
 
This study found that there were weaker cold temperature associations for CVD, IHD, 
MI and stroke mortality in the second week preceding death, with those cold-weather 
mortality associations recovering the following week.  It is possible that the deaths 
observed in winter represent shifts in the timing of events that lead to deaths (mortality 
displacement), and that the effects of temperature simply serve to bring forward a death 
by a short period of time (Aylin et al. 2001). This phenomenon has been described 
previously as harvesting, which in simple terms, is likely due to the depletion in  
numbers by premature mortality of those most susceptible to cold weather (Aylin et al. 
2001; Goodman et al. 2004; Schwartz 2000, 2001).  The extended cold weather-
mortality associations observed in this study suggested that there was potentially a 
cumulative health effect of cold weather and a gradual weakening and displacement by 
death  (Schwartz 2000, 2001; Zeka et al. 2014), and were also evidenced by a small 
number of epidemiologic studies that have considered long lag structures (Analitis et al. 
2008; Anderson and Bell 2009; Barnett et al. 2012; Donaldson and Keatinge 1997; 
Gemmell et al. 2000; Goodman et al. 2004).  
 
Whilst this study examined different temperature metrics, stronger associations were 
reported for the application of maximum temperature in the models during both cold 
period and winter months in both jurisdictions.  This is consistent with recent studies 
which suggested that maximum temperature is more likely to capture days that are 
consistently cold and extreme cold days (Atsumi et al. 2013; Diaz et al. 2005).  
However, it is acknowledged that when estimating the health effects of temperature, the 
choice of the temperature measure is of less importance compared with other model  
choices, such as the length of the longest exposure lag (Barnett and Astrom 2012). 
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4.3 Effect modification and stratification by age and gender 
This study observed that the cold weather-mortality associations were generally greater 
in women than men in both jurisdictions. These findings were generally consistent with 
other studies (Barnett et al. 2005; Kysely et al. 2009; Yu et al. 2010), and however a 
study in China reported that the associations were higher males (Yang et al. 2012). 
Males were at a higher risk of cold associations than females but were not statistically 
important (Yang et al. 2012). However, they applied a different modelling design over a 
short study period using a shorter lag structure and to a medium population sample.  
 
Another study observed weak evidence for modification of the cold association by age, 
but temperature-related mortality associations were not differential by gender (O'Neill 
et al. 2003). A Scottish study found little indication that the association of temperature 
on mortality was stronger in one age-group compared with another although they 
observed that there appeared to be a difference in the distribution of the lags with 
temperature associations persisting for longer in the older age group (Carder et al. 
2005). Although their lag structure and study period was comparable, they did not 
indicate their population sample so it was not possible to determine if they used a 
comparable population sample. 
 
A British study observed evidence of effect modification by age, those aged 75-84 years 
old apparently more vulnerable to temperature effects than other age groups (Bhaskaran 
et al. 2010). Few studies have investigated the associations of temperature on risk of MI 
in the older age group; on reporting an increased cold association amongst those aged 
more than 65 years old (Morabito et al. 2006) and a further study found no difference in 
the associations when restricting their analyses only to older age groups (Danet et al. 
1999; Enquselassie et al. 1993).  
 
A study in China found statistically significant differences in effect modification 
between the oldest (85+ year olds) and the youngest (less than 65-year-olds) (Yang et 
al. 2012). Another study found stronger cold-related associations on mortality for those 
younger than 65 years old (O'Neill et al. 2003), and it was reported a qualitatively 
similar relation between weather and mortality same age-group (Curriero et al. 2002). In 
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general, reports in Europe show that the elderly are more sensitive (Ballester et al. 1997; 
Keatinge et al. 2000; Wilkinson et al. 2001; Wilkinson et al. 2004). 
 
These studies have applied different modelling approaches to different study periods 
using varying distributed lag structures with different population samples in different 
climate settings and may help to explain some of the differences in their findings. 
 
4.4 Physiological effects of cold weather exposure 
This study observed that there were strong associations with increased mortality due to 
exposure to cold temperatures, with the cold weather-mortality relationship persisting 
up to 5 weeks preceding death. These findings are physiologically plausible and it is 
conceivable that the lags for the associations of low temperatures may vary on mortality 
in length for different death categories (Carder et al. 2005). Cold weather alone causes 
striking short-term increases in mortality, mainly from increased cardiovascular, 
thrombotic and RD mortality (Donaldson and Keatinge 1997; Hampel et al. 2010). 
Overexertion in a cold environment may trigger surges in blood pressure that could lead 
to coronary plaque rupture and subsequent coronary thrombosis (Arntz et al. 2001). 
 
Deaths such as myocardial ischaemia from increased work demands on the heart muscle 
or from increased formation of thrombus can occur in hours or days (Mercer 2003; 
Neild et al. 1994). The onset of acute MI has been related to the presence of a 
vulnerable plaque, plaque disruption and fissuring and superimposed thrombosis (Fuster 
et al. 1992). Several physiologic changes have been identified which may increase the 
probability of these events (Muller et al. 1994). Elevated lipid levels (Brown et al. 
1993) and the presence of active inflammation (Berk et al. 1990) may make plaques 
more vulnerable to rupture (Sheth et al. 1999). Disruption of plaques may be 
precipitated by hemodynamic forces, especially increases in blood pressure (Gertz and 
Roberts 1990) subsequent thrombosis may be accelerated by higher levels of fibrinogen 
and other pro-coagulants (Rosito and Tofler 1996). It has been shown that serum 
cholesterol (Gordon et al. 1987), C-reactive protein (Woodhouse et al. 1994), blood 
pressure (Brennen et al 1982), fibrinogen (Stout and Crawford 1991; Woodhouse et al. 
1994), and factor VII activity (Woodhouse et al. 1994) are all higher in the winter. 
Elevation of these parameters may contribute to an increased tendency towards arterial 
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thrombosis and a higher winter incidence of acute coronary syndromes (Muller et al. 
1994). Direct exposure to cold and, probably, respiratory cross infections are 
responsible for most excess winter mortality (Donaldson and Keatinge 1997). Measures 
to reduce cold exposure therefore provide the clearest means of preventing IHD and 
probably RD mortality in winter (Donaldson and Keatinge 1997).  
 
These findings show that the cold weather-mortality relationship is strongest in the 
older population (75+ year olds), which are physiologically plausible. Previous studies 
have indicated mechanisms such as reduced skin blood flow and smaller increases in 
cardiac output, which can compromise thermoregulation (Basu 2009; Bouchama and 
Knochel 2002; McGeehin and Mirabelli 2001). Exposure to cold is greater among 
poorer individuals and the elderly have lower income levels than other age groups 
(Sheth et al. 1999) and these may affect their ability to afford to keep their homes warm 
in colder weather. Alternatively, the elderly may demonstrate exaggerated responses to 
winter weather conditions, with greater increases in blood pressure and coagulation 
parameters, or a greater likelihood of infection (Collins et al. 1985).  Blood pressure 
may vary more among elderly people between winter and summer (Ballester et al. 1997; 
Woodhouse et al. 1993) with increased blood pressure in the winter. 
 
4.5 Jurisdictional differences 
This study reported that there were comparable trends in the declining mortality rates 
and excess winter mortality, and the cold weather-mortality relationships in both 
jurisdictions albeit with some subtle differences. It is difficult to quantify the rationale 
for these small differences which were observed. However, it is suggested that the 
different public health policies and healthcare systems in the two jurisdictions may have 
an influence on the population mortality and response to cold weather (Zeka et al. 
2014). There are currently winter fuel allowances and cold weather payments, which 
target vulnerable population groups in both jurisdictions; however, these schemes differ 
substantially from each other (Department of Social Protection 2014; NI Direct 2013; 
The Marmot Review Team 2011; The United Kingdom Parliament 2013). It has been 
suggested that the fuel allowance was not sufficient in meeting home-heating costs in 
the Republic of Ireland, and this was likely due to the contribution of poor thermal 
efficiency and low household income (Healy and Clinch 2004).  
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In colder climates, it has been suggested that the maintenance of warmth in houses has a 
protective effect on winter mortality (Donaldson et al. 1998; Eng and Mercer 1998). 
One possible reason for the much lower excess winter mortality in Norway, compared 
with England and Wales may be that the heating is usually included in the rent (Laake 
and Sverre 1996); consequently, poor households should have a warm indoor 
environment (Aylin et al. 2001). The European household panel survey showed that the 
proportion of households in the UK and Ireland that reported being unable to keep their 
homes adequately warm was more than five times that in Germany (Whyley and 
Callender 1997). A British study found a link between seasonal variation deaths from 
heart attacks and strokes and quality housing in England (Wilkinson et al. 2001). 
 
The effectiveness of these cold weather and winter fuel payments in Northern Ireland 
aimed at reducing winter mortality have not been examined (Zeka et al. 2014). Rising 
fuel prices and demographic changes, combined with the economic recession have 
contributed to high levels of fuel poverty such as older people, those living alone and 
lone parent households (Goodman et al. 2011; Healy 2003; McAvoy 2007; Walker et 
al. 2013). The jurisdictional differences in housing stock, insulation and heating, also 
related to socioeconomic deprivation, influence the extent of fuel poverty (Healy 2003; 
Healy and Clinch 2004; Walker et al. 2013). In addition, differences in the 
identification of the ‘fuel poor’ and ‘those most in need’ can also impact upon the 
effectiveness and differences of the schemes in the two jurisdictions (Dubois 2012; 
Healy 2003; Liddell et al. 2012; Zeka et al. 2014). 
 
A very strong relationship has been observed between the incidence of fuel poverty, 
social class, geographic and demographic patterns of those susceptible on the island of 
Ireland (Healy and Clinch 2004; Walker et al. 2013). The number of older people, who 
are vulnerable to ill-health from cold homes, will increase as part of significantly aging 
population in both jurisdictions (Goodman et al. 2011). Currently there is a 
concentration of fuel poverty among rural older person households in Northern Ireland 
while fuel poverty is highest in most urbanised and very rural areas in the Republic of 
Ireland (Goodman et al. 2011; Healy and Clinch 2004). A greater proportion of older 
people in Northern Ireland live alone and in social housing when compared to the 
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Republic of Ireland (Goodman et al. 2011). Jurisdictional differences in the general 
population health status, provision of and access to health care, and distribution of 
health and social inequalities, potentially contribute in concurrence with these policies, 
and may explain some of the observed differences in the cold weather-mortality 
associations between the two jurisdictions (Zeka et al. 2014).  
 
It is important to recognise that climate change induced weather patterns will effect 
long-term cold weather-mortality relationship (Zeka et al. 2014). Research suggests that 
increasing global mean temperatures will do little to reduce morbidity and mortality in 
winter (Ebi and Mills 2012; Field et al. 2014; Kinney et al. 2012; Staddon et al. 2014), 
likely due to increases in temperature variability and weather extremes. These weather 
patterns have also been observed on the island of Ireland in the past few decades (Met 
Eireann 2014a; The United Kingdom Met Office 2014b), on this basis only , it may be 
possible that winter mortality will change over time (Zeka et al. 2014). However, 
whether this change will be an increase or decrease is much more complex and 
multifaceted and will depend on how rapidly the climate changes, how quickly the 
population adapt, and on infrastructural and policy interventions, and remains a  
challenge particularly in view of the aging population on the island of Ireland (Zeka et 
al. 2014). Additional analyses were carried out in this study to examine the cold 
weather-mortality relationship for different time periods in each jurisdiction in order to 
understand the long term patterns of the cold weather-mortality association (Zeka et al. 
2014). The findings suggested a slight diminishing of cold weather-mortality 
relationship in both jurisdictions over time; however, they need to be interpreted with 
caution, considering the complexity of the relationship of mortality and cold winters and 
the influence of the societal factors discussed earlier (Zeka et al. 2014). 
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5.0 CONCLUSIONS AND RECOMMENDATIONS 
 
This study found that although the population has increased in both jurisdictions on the 
island of Ireland, including the older population and life expectancy, mortality has 
declined significantly over 20 years. Northern Ireland presented higher annual mortality 
rates for all-cause mortality and each cause-specific mortality group except for COPD 
which was higher in the Republic of Ireland but the differences have narrowed 
significantly over time. These patterns in the mortality rates were reflected during the 
winter months and cold period.  
 
Despite falling mortality rates, excess winter mortality was still evident in each 
jurisdiction. The mortality rates amongst the 65-74 year olds were generally higher in 
Northern Ireland while the 75-84 year olds and 85+ year olds displayed higher mortality 
rates in the Republic of Ireland. Similar patterns were observed for male and female 
populations. The highest mortality rates were observed for all-cause mortality and CVD 
mortality whilst the lowest were reported for COPD mortality. 
 
This study suggested that there were strong associations between the exposure to cold 
temperatures and increased mortality over 24 years on the island of Ireland and between 
two different jurisdictions with the associations persisting up to 35 days and 28 days 
preceding death in the Republic of Ireland and Northern Ireland respectively. This study 
confirmed upon previous studies, which have examined the cold associations on all-
cause mortality, CVD and RD mortality (Analitis et al. 2008; Anderson and Bell 2009; 
Barnett et al. 2012; Carder et al. 2005; Gemmell et al. 2000; Goodman et al. 2004; 
Huynen et al. 2001); and extends upon the findings of a previous Irish study to the 
whole of the Irish Republic and Northern Ireland, using the most extensive dataset to 
date on the island of Ireland.  
 
This study confirmed the previous findings of prolonged associations using extended 
distributed lag structure in a temperate climate under the influence of the Gulf Stream 
jet stream. The cold weather-mortality associations were more pronounced and 
persistent in the Republic of Ireland with associations strongest for COPD, pneumonia 
and RD mortality in both jurisdictions. This study observed that the cold weather-
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mortality associations were greater in women than men in both jurisdictions. The 
extended cold weather-mortality associations suggested that there was potentially a 
cumulative health effect of cold weather and a gradual weakening and displacement by 
death (Goodman et al. 2004; Schwartz 2000, 2001; Zeka et al. 2014).  
 
The strong and persistent cold weather-mortality relationship highlights that the 
estimated increased mortality from exposure to cold temperatures in both jurisdictions is 
an important and topical public health issue. As the island of Ireland currently has the 
highest levels of excess winter mortality in Europe, with an estimated 2,800 excess 
deaths during each winter (McAvoy 2007), the key challenges are to develop and 
implement policies which tackle fuel poverty and reduce winter morbidity and mortality 
(Zeka et al. 2014). The fact that some differences in cold weather-mortality patterns are 
observed between the two jurisdictions, albeit small, suggests that policies and their 
implementation, and other societal factors potentially play a key role in determining 
population health patterns (Zeka et al. 2014).  
 
This study observed little effect on the cold weather-mortality relationship over time in 
both jurisdictions. However, the temporal separation in those preliminary analyses was 
quite crude and did not take into account other immediate and gradual changes in public 
policies and health care in the two jurisdictions (Zeka et al. 2014). Further extensive 
analyses should be undertaken to explore in depth influences of fuel poverty, 
socioeconomic, demography, health care and other important factors on the cold 
weather-mortality association. Future research should be carried out to explore the 
impact of the implementation of the winter fuel payments, cold weather payments and 
fuel allowance on the cold weather-mortality relationship to determine their potential 
effectiveness at reducing excess winter mortality.  
 
As there is a trend of increasing mean temperatures, the variability in temperature is 
likely to increase, thus potentially contributing to increased frequency of weather 
extremes (Ebi and Mills 2012; Field et al. 2014; Kinney et al. 2012; Staddon et al. 
2014). Further research should explore the impact of cold spells in addition to the 
current cold weather-mortality relationship over an extended study period to include the 
most recently available mortality and weather data and this should be modelled into the 
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future using the different predicted climate models for both jurisdictions to assess the 
impact of climate change on excess winter mortality. Future research should also 
consider the geographical variations in the current cold weather-mortality associations 
as well as the future predicted relationships. 
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7.0 FIGURES AND TABLES 
 
Figure 1. A comparison of the annual mortality rates (all ages) in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2006. 
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Figure 2. A comparison of the annual mortality rates (all ages) in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2006. 
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Figure 3. A comparison of the summer and winter mortality rates for all-cause mortality (all ages) in the Republic of Ireland (RoI) and 
Northern Ireland (NI), 1986-2007. 
 
Figure 4. A comparison of the summer and winter mortality rates for cardiovascular disease (all ages) in the Republic of Ireland (RoI) 
and Northern Ireland (NI), 1986-2007. 
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Figure 5. A comparison of the summer and winter mortality rates for ischaemic heart disease (all ages) in the Republic of Ireland (RoI) 
and Northern Ireland (NI), 1986-2007. 
 
 
 
Figure 6. A comparison of the summer and winter mortality rates for myocardial infarction (all ages) in the Republic of Ireland 
(RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 7. A comparison of the summer and winter mortality rates for all respiratory disease (all ages) in the Republic of Ireland (RoI) 
and Northern Ireland (NI), 1986-2007. 
  
Figure 8. A comparison of the summer and winter mortality rates for pneumonia (all ages) in the Republic of Ireland (RoI) and 
Northern Ireland (NI), 1986-2007. 
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Figure 9. A comparison of the summer and winter mortality rates for chronic obstructive pulmonary disease (COPD) (all ages) in the 
Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007.
 
 
Figure 10. A comparison of the summer and winter mortality rates for stroke (all ages) in the Republic of Ireland (RoI) and 
Northern Ireland (NI), 1986-2007. 
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Figure 11. A comparison of the mortality rates for all-cause mortality, cardiovascular disease, ischaemic heart disease and myocardial 
infarction in the population during the winter months (all ages) in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007.
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Figure 12. A comparison of the mortality rates for all respiratory disease, COPD, pneumonia and stroke in the population during the 
winter months (all ages) in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007.
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Figure 13. A comparison of the winter mortality rates for cardiovascular disease (CVD) amongst the 18-64 year olds, 65-74 year olds, 
75-84 year olds and 85 and over year olds in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 14. A comparison of the winter mortality rates for ischaemic heart disease (IHD) amongst the 18-64 year olds, 65-74 year olds, 
75-84 year olds and 85 and over year olds in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 15. A comparison of the winter mortality rates for myocardial infarction (MI) amongst the 18-64 year olds, 65-74 year olds, 75-
84 year olds and 85 and over year olds in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 16. A comparison of the winter mortality rates for all respiratory disease amongst the 18-64 year olds, 65-74 year olds, 75-84 
year olds and 85 and over year olds in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 17. A comparison of the winter mortality rates for chronic pulmonary obstructive disease amongst the 18-64 year olds, 65-74 
year olds, 75-84 year olds and 85 and over year olds in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 18. A comparison of the winter mortality rates for pneumonia amongst the 18-64 year olds, 65-74 year olds, 75-84 year olds and 
85 and over year olds in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 19. A comparison of the winter mortality rates for stroke amongst the 18-64 year olds, 65-74 year olds, 75-84 year olds and 
85 and over year olds in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
 
 
 
 
Goodman et al. 2011
 
Goodman et al. 2011
0
1
2
3
4
5
6
1986/87 1991/92 1996/97 2002/03 2006/07
M
o
rt
al
it
y
 r
at
es
 p
er
 1
0
0
,0
0
0
 
a) Winter mortality rates for stroke 
amongst the 18-64 year olds 
NI 18-64yrs
RoI 18-64yrs
100
150
200
250
300
350
400
1986/87 1991/92 1996/97 2002/03 2006/07
M
o
rt
al
it
y
 r
at
es
 p
er
 1
0
0
,0
0
0
 
c) Winter mortality rates for stroke  
amongst the 75-84 year olds 
NI 75-84yrs
RoI 75-84yrs
0
20
40
60
80
100
120
1986/87 1991/92 1996/97 2002/03 2006/07
M
o
rt
al
it
y
 r
at
es
 p
er
 1
0
0
,0
0
0
 
b) Winter mortality rates for stroke   
amongst the 65-74 year olds 
NI 65-74yrs
RoI 65-74yrs
400
600
800
1000
1200
1986/87 1991/92 1996/97 2002/03 2006/07
M
o
rt
al
it
y
 r
at
es
 p
er
 1
0
0
,0
0
0
 
d) Winter mortality rates for stroke  
amongst the 85+ year olds 
NI 85+yrs
RoI 85+yrs
 107 
 
Figure 20. A comparison of the mortality rates for all-cause mortality, cardiovascular disease, ischaemic heart disease and myocardial 
infarction in the male population during the cold period (all ages) in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-
2007.
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Figure 21. A comparison of the mortality rates for all respiratory disease, chronic obstructive pulmonary disease (COPD), pneumonia 
and stroke in the male population during the cold period (all ages) in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-
2007.    
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Figure 22. A comparison of the mortality rates for all-cause mortality, cardiovascular disease, ischaemic heart disease and myocardial 
infarction in the female population during the cold period (all ages) in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-
2007.
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Figure 23. A comparison of the mortality rates for all respiratory disease, chronic obstructive pulmonary disease (COPD), pneumonia 
and stroke in the female population during the cold period (all ages) in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-
2007.       
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Figure 24. A comparison of the mortality rates for cardiovascular disease amongst the 18-64 year olds, 65-74 year olds, 75-84 year olds 
and 85+ year olds during the cold period in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 25. A comparison of the mortality rates for ischaemic heart disease amongst the 18-64 year olds, 65-74 year olds, 75-84 year olds 
and 85+ year olds during the cold period in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 26. A comparison of the mortality rates for myocardial infarction amongst the 18-64 year olds, 65-74 year olds, 75-84 year olds 
and 85+ year olds during the cold period in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 27. A comparison of the mortality rates for all respiratory diseases amongst the 18-64 year olds, 65-74 year olds, 75-84 year olds 
and 85+ year olds during the cold period in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 28. A comparison of the mortality rates for chronic obstructive pulmonary disease (COPD) amongst the 18-64 year olds, 65-74 
year olds, 75-84 year olds and 85+ year olds during the cold period in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-
2007. 
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Figure 29. A comparison of the mortality rates for pneumonia amongst the 18-64 year olds, 65-74 year olds, 75-84 year olds and 85+ 
year olds during the cold period in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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Figure 30. A comparison of the mortality rates for stroke amongst the 18-64 year olds, 65-74 year olds, 75-84 year olds and 85+ year 
olds during the cold period in the Republic of Ireland (RoI) and Northern Ireland (NI), 1986-2007. 
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d) Mortality rates for stroke  
amongst the over 85 year olds 
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Table 1. A critical appraisal of epidemiological studies of the cold weather-mortality relationship 
Authors,  year Study location 
Study period 
Study 
population 
Study Design Lag 
structure 
Temperature 
Metrics 
Mortality parameters Potential 
confounders 
Comments 
Zhou et al., 2014 China 
2006-2010 
Not 
specified 
Poisson 
regression 
0-27days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Stroke 
Day of week 
Seasonality 
Secular trends 
Long lag structure 
Very short study period 
Subtropical climate 
Medium sample size 
Atsumi et al, 2013 Japan 
1993-2008 
40+years Case-crossover 0-10days Maximum 
temperature 
Cardiovascular disease 
Cardiac disease 
Stroke 
Relative humidity 
Air pollution 
Long term trend 
Seasonality 
Day of week 
Short-medium lag 
structure  
Medium study period  
Small sample size 
Guo et al, 2013a China 
2004-2008 
Not 
specified 
Poisson 
regression 
0-20days Mean 
temperature 
Ischaemic heart disease Relative humidity 
Air pollution 
 
Medium lag structure 
Short study period  
Small sample size 
Guo et al, 2013b Australia 
2000-2004 
Not 
specified 
Poisson 
regression and 
case-crossover 
0-10days Maximum 
temperature 
All-cause mortality Relative humidity 
Air pollution 
Short-medium lag 
structure  
Short study period 
Subtropical climate 
Sample size not specified 
Wu et al., 2013 China 
2006-2010 
All ages Poisson 
regression 
0-27days Mean temperature All-cause mortality Relative humidity 
Air pollution 
Long term trend 
Seasonality 
Day of week 
Public holidays 
Long lag structure  
Short study period  
Sample size not specified 
Barnett et al., 
2012 
United States 
1987-2000 
All ages Poisson 
regression 
0-21days Mean temperature Cardiovascular disease 
Respiratory disease 
Influenza 
Seasonality 
Day of week 
Long lag structure 
Medium study period 
Temperate climate 
Sample size not specified 
 
 
 119 
 
Table 1. A critical appraisal of epidemiological studies of the cold weather-mortality relationship (continued) 
Authors,  year Study location 
Study period 
Study 
population 
Study Design Lag 
structure 
Temperature 
Metrics 
Mortality parameters Potential 
confounders 
Comments 
Guo et al., 2012 Thailand 
1999-2008 
All ages Poisson 
regression 
0-21days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Cardiopulmonary 
Relative humidity 
Air pollution 
Day of week 
Long term trend 
Seasonality 
Long lag structure  
Short study period 
Subtropical climate 
Medium sample size 
 
Klot et al., 2012 United States 
1992-2000 
65+years Poisson 
regression 
0-25days Mean temperature Cardiovascular disease Relative humidity 
Long term trend 
Seasonality 
Day of week 
Medium lag structure 
Short study period 
Sample size not specified 
Miron et al., 2012 Spain 
1975-2003 
All ages Arima models 0-15days Minimum  
temperature 
All-cause mortality Not adjusted for 
air pollution 
Medium lag structure 
Long study period 
Temperate climate 
Sample size not specified 
Tian et al., 2012 China 
2000-2011 
All ages Poisson and 
case-crossover 
0-15days Mean  
temperature 
Cardiovascular disease Relative humidity 
Long term trends 
Seasonality 
Medium lag structure 
Short study period 
Small sample size 
Wichmann et al., 
2012 
Denmark 
1999-2006 
19+ years Case-crossover 0-5days Maximum 
temperature 
Myocardial infarction Air pollution 
Day of week 
Influenza 
Public holidays 
Short lag structure  
Short study period 
Temperate climate 
Small sample size 
Yang et al., 2012 China 
2003-2007 
All ages Poisson 
regression 
0-25days Mean temperature All-cause mortality 
Cardiovascular disease 
Ischaemic heart disease 
Respiratory disease 
COPD, stroke 
Air pollution Long lag structure 
Short study period 
Medium sample size 
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Table 1. A critical appraisal of epidemiological studies of the cold weather-mortality relationship (continued) 
Authors,  year Study location 
Study period 
Study 
population 
Study Design Lag 
structure 
Temperature 
Metrics 
Mortality parameters Potential 
confounders 
Comments 
Goldberg et al., 
2011 
Canada 
1984-2007 
All ages Poisson 
regression 
0-30days Maximum 
temperature 
All-cause mortality 
Cardiovascular disease 
Respiratory disease 
 
Air pollution 
Seasonality 
Long term trends 
Day of week 
Long lag structure 
Long study period 
Temperate climate 
Sample size not specified 
Guo et al., 2011 China 
2005-2007 
 
All ages Case-crossover 
combined with 
Poisson 
regression 
0-27days Maximum, 
Minimum and 
mean temperature 
All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Cardiopulmonary 
Relative humidity 
Air pollution 
Seasonality 
Long term trends 
Long lag structure 
Short study period 
Sample size not specified 
Lin et al., 2011 Taiwan 
1994-2007 
65+years Poisson 
regression 
0-30days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Air pollution 
Relative humidity 
Long lag structure 
Long study period 
Subtropical climate 
Sample size not specified 
Liu et al., 2011 China 
2003-2005 
All ages Poisson 
regression 
0-29days Mean temperature Cardiovascular disease 
Ischaemic heart disease 
Respiratory disease 
Stroke 
Relative humidity 
Air pollution 
Long term trends 
Seasonality 
Day of week 
Public holidays 
Medium lag structure 
Short study period 
Small sample size 
Rocklov et al., 
2011 
Sweden 
1990-2002 
All ages Poisson 
regression 
0-13days Maximum, 
minimum 
apparent 
temperature 
All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Air pollution  
Influenza 
Medium lag structure 
Medium study period 
Temperate climate 
Small sample size 
Wichmann et al., 
2011 
Denmark 
2002-2006 
19+ years Case-crossover 0-5days Maximum 
apparent 
temperature 
Cardiovascular disease 
Respiratory disease 
Stroke 
Air pollution 
Public holidays 
Relative humidity 
Influenza 
Short lag structure 
Short study period 
Temperate climate 
Small sample size 
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Table 1. A critical appraisal of epidemiological studies of the cold weather-mortality relationship (continued) 
Authors,  year Study location 
Study period 
Study 
population 
Study Design Lag 
structure 
Temperature 
Metrics 
Mortality parameters Potential 
confounders 
Comments 
Yu et al., 2011a Australia 
1996-2004 
15+ years Poisson 
regression 
0-30days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Relative humidity 
Air pollution 
Day of week 
Public holidays 
Influenza 
Medium lag structure 
Short study period 
Subtropical climate 
Small sample size 
Yu et al., 2011b Australia 
1996-2004 
All ages Poisson 
regression 
0-20days Maximum, 
minimum, mean 
temperature 
All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Relative humidity 
Air pollution 
Medium lag structure 
Short study period 
Subtropical climate 
Small sample size 
Gomez-Acebo et 
al., 2010 
Spain 
2004-2005 
All ages Case-crossover 0-6days Maximum, 
minimum 
temperature 
Mortality not defined Relative humidity 
Wind speed 
Day of week 
Short lag structure 
Short study period 
Temperate climate 
Sample size not specified 
Anderson and 
Bell, 2009 
United States 
1987-2000 
All ages Poisson 
regression 
0-28days Mean temperature Cardiovascular disease 
Respiratory disease 
Air pollution Long lag structure 
Long study period 
Large sample size 
Hashizume et al., 
2009 
Bangladesh  
1994-2002 
All ages Poisson 
regression 
0-13days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Long term trends 
Seasonality 
Day of week 
Medium lag structure 
Short study period 
Subtropical climate 
Small sample size 
Kysely et al., 
2009 
Czech 
Republic  
1986-2006 
25+ years 
 
Poisson 
regression 
0-20days Maximum 
temperature 
Cardiovascular disease Excluded 
influenza and 
acute respiratory 
infections 
Medium lag structure 
Medium study period 
Temperate climate 
Sample size not specified 
Analitis et al., 
2008 
Europe 
1990-2000 
All ages Poisson 
regression 
0-30days Minimum 
temperature 
All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Stroke 
Air pollution 
Air pressure 
Long term trends 
Day of week 
Calendar month 
Influenza 
Long lag structure 
Medium study period 
Temperate climate 
Large sample size 
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Table 1. A critical appraisal of epidemiological studies of the cold weather-mortality relationship (continued) 
Authors, 
year 
Study location 
Study period 
Study 
population 
Study Design Lag  
structure 
Temperature 
Metrics 
Mortality parameters Potential  
confounders 
Comments 
Carder et al., 2008 
  
Scotland 
1981-2001 
Not 
specified 
Poisson 
regression 
0-30days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
 
Seasonality 
Day of week 
Longer lag structure 
Long study period 
Temperate climate 
Sample size not specified 
McMichael et  
al., 2008 
Multi country 
Period 
unknown 
All ages Poisson 
regression 
0-13days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Cardiorespiratory 
Non-cardiorespiratory 
Air pollution 
Relative humidity 
Seasonality 
Day of week 
Medium lag structure 
Study period unknown 
Temperate, subtropical 
and tropical climate 
Sample size not specified 
Revich and 
Shaposhnikov, 
2008 
Russia 
2000-2006 
All ages Poisson 
regression 
0-28days Mean temperature All-cause mortality 
Ischaemic heart disease 
Stroke 
Chronic lower 
respiratory disease 
None Long lag structure 
Short study period 
Temperate climate 
Sample size not specified 
Hajat et al., 2007 England, 
Wales, 1993-
2003 
All ages Poisson 
regression 
0-13days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Air pollution 
Long term trends 
Seasonality 
Medium lag structure 
Long study period 
Temperate climate 
Sample size not specified 
Medina-Ramón & 
Schwartz, 2007 
United States 
1989-2000 
Not 
specified 
Case-crossover 0-1days Maximum 
temperature 
All-cause mortality 
Myocardial infarction 
Cardiac arrest 
Air pollution Short lag structure 
Medium study period 
Very large sample size 
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Table 1. A critical appraisal of epidemiological studies of the cold weather-mortality relationship (continued) 
Authors, 
year 
Study location 
Study period 
Study 
population 
Study Design Lag  
structure 
Temperature 
Metrics 
Mortality parameters Potential  
confounders 
Comments 
Medina-Ramón et 
al., 2006 
United States 
1989-2000 
All ages Case-only 0-2days Maximum 
temperature 
All-cause mortality 
Cardiovascular disease 
Ischaemic heart disease 
Myocardial infarction 
COPD, pneumonia  
Stroke 
Air pollution 
Relative humidity 
Short lag structure 
Medium study period 
Very large sample size 
Barnett et al., 
2005 
21 countries 
1980-1995 
35-64 
years 
Poisson 
regression 
1-14days Mean temperature Cardiovascular disease 
Myocardial infarction 
Long term trends 
Seasonality 
Day of week 
Medium lag structure 
Medium study period 
Subtropical and 
temperate climate 
Small sample size 
Carder et al., 2005 Scotland 
1981-2001 
All ages Poisson 
regression 
0-30days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Air pollution 
Long term trends 
Seasonality 
Day of week 
Longer lag structure 
Long study period 
Temperate climate 
Sample size not specified 
Diaz et al., 2005 Spain 
1986-1997 
65+ years Poisson 
regression and 
Arima models 
1-14days Maximum 
temperature 
All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Air pollution  
Influenza 
Seasonality 
Medium lag structure 
Medium study period 
Temperate climate 
Medium sample size 
Goodman et al., 
2004 
Republic of 
Ireland, 1980-
1996 
All ages Poisson 
regression 
1-41days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Relative humidity 
Long term trends 
Seasonality 
Day of week 
Influenza 
Longer lag structure 
Medium study period 
Temperate climate  
Small sample size 
Hong et al., 2003 Korea 
1998-2008 
All ages Case-crossover 0-4days Mean temperature Stroke Air pollution 
Relative humidity 
Air pressure 
Day of week 
Short lag structure 
Short study period 
Subtropical climate 
Very small sample size 
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Table 1. A critical appraisal of epidemiological studies of the cold weather-mortality relationship (continued) 
Authors, 
year 
Study location 
Study period 
Study 
population 
Study Design Lag  
structure 
Temperature 
Metrics 
Mortality parameters Potential  
confounders 
Comments 
O’Neil et al., 
2003 
United States 
1986-1993 
All ages Poisson 
regression 
0-3days Mean apparent 
temperature 
All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Air pollution 
Air pressure 
Long term trends 
Seasonality 
Day of week 
Short lag structure 
Short study period 
Large sample size 
 
Braga et al., 2002 United States 
1986-1993 
All ages Poisson 
regression 
0-20days Mean temperature Cardiovascular disease 
Myocardial infarction 
Respiratory mortality 
COPD, pneumonia 
Air pressure 
Long term trends 
Seasonality 
Day of week 
Medium lag structure 
Short study period 
Sample size not specified 
Hajat & Haines, 
2002 
England 
1992-1995 
65+ years Poisson 
regression 
0-24days Mean temperature Cardiovascular disease 
Respiratory disease 
Air pollution 
Long term trends 
Seasonality 
Day of week 
Public holidays 
Long lag structure 
Short study period 
Temperate climate 
Small sample size 
Laschewski & 
Jendritzsky, 2002 
Germany 
1968-1997 
All ages Poisson 
regression 
1-14days Mean perceived 
temperature 
All-cause mortality Seasonality 
Influenza 
Medium lag structure 
Long study period 
Temperate location 
Very large sample size 
Braga et al., 2001 United States 
1986-1993 
All ages Poisson 
regression 
0-21days Mean temperature All-cause mortality Relative humidity 
Air pressure 
Seasonality 
Day of week 
Long lag structure 
Short study period 
Sample size not specified 
Huynen et al., 
2001 
The 
Netherlands 
1979-1997 
All ages Poisson 
regression 
0-30days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Long term trends 
Seasonality 
Longer lag structure 
Long study period 
Temperate climate 
Sample size not specified 
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Table 1. A critical appraisal of epidemiological studies of the cold weather-mortality relationship (continued) 
Authors, 
year 
Study location 
Study period 
Study 
population 
Study Design Lag  
structure 
Temperature 
Metrics 
Mortality parameters Potential  
confounders 
Comments 
Keatinge & 
Donaldson,  2001 
England 
1976-1995 
50+ years Poisson 
regression 
0-24days Mean temperature All-cause mortality Air pollution 
Long term trends 
Seasonality 
Influenza 
Long lag structure 
Long study period 
Temperate climate 
Sample size not specified 
Rossum et al., 
2001 
1967-1970 
plus 25 year 
follow up 
40+ years Poisson 
regression 
No lags Not defined All-cause mortality 
Cardiovascular disease 
Ischaemic heart disease 
Respiratory disease 
Stroke 
Seasonality No lag structure 
Long study period 
Temperate climate 
Small sample size 
 
Gemmell et al., 
2000 
Scotland 
1981-1993 
All ages Poisson 
regression 
0-35days Mean temperature Cardiovascular disease 
Ischaemic heart disease 
Respiratory disease 
Influenza Longer lag structure 
Medium study period 
Temperate climate 
Sample size not specified 
Sheth et al., 1999 Canada 
1980-1982 
1990-1992 
All ages Linear 
regression  
No lags Not defined Myocardial infarction 
Stroke 
None No lag structure 
Short study period 
Temperate climate 
Medium sample size 
Ballester et al., 
1997 
Spain 
1991-1993 
70+years Poisson 
regression 
0-14days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory Disease 
Air pollution 
Relative humidity 
Seasonality 
Day of week 
Influenza 
Medium lag structure 
Short study period 
Temperate climate 
Sample size not specified 
Donaldson & 
Keatinge, 1997 
England 
1976-1992 
50+ years Poisson 
regression 
0-40days Mean temperature All-cause mortality 
Ischaemic heart disease 
Respiratory disease 
Stroke 
None Longer lag structure 
Medium study period 
Temperate climate 
Sample size not specified 
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Table 1. A critical appraisal of epidemiological studies of the cold weather-mortality relationship (continued) 
Authors, 
year 
Study location 
Study period 
Study 
population 
Study Design Lag  
structure 
Temperature 
Metrics 
Mortality parameters Potential  
confounders 
Comments 
The Eurowinter 
Group, 1997 
Europe 
1988-1992 
50+years Poisson 
regression 
0-12days Mean temperature All-cause mortality 
Cardiovascular disease 
Ischaemic heart disease 
Respiratory disease 
Influenza Medium lag structure 
Short study period 
Temperate climate 
Medium sample size  
Kunst et al., 1993 The 
Netherlands 
1979-1987 
Not 
specified 
Poisson 
regression 
0-30days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Air pollution 
Long term trends 
Seasonality 
Influenza 
Long lag structure 
Short study period 
Sample size not specified 
Population not specified 
Mackenbach et 
al., 1993 
The 
Netherlands 
1979-1987 
Not 
specified 
Poisson 
regression 
0-20days Mean temperature All-cause mortality 
Cardiovascular disease 
Respiratory disease 
Air pollution 
Relative humidity 
Secular  trends 
Seasonality 
Day of week 
Influenza 
Long lag structure 
Short study period 
Temperate climate 
Sample size not specified 
Population not specified 
The difference between 
daily maximum and 
minimum temperatures 
was included as a 
potential confounder 
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Table 2. Estimated mortality percentage change per 1
o
C decrease in minimum temperature in the Republic of Ireland during  
the cold period‡ for ages ≥18 years, 1984-2007.*  
Cause-specific 
mortality group 
Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Lag of Week 5 Cumulative 
   % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
 1.2 (1.0, 1.3) 0.8 (0.6, 1.0) 0.8 (0.6, 1.0) 0.6 (0.4, 0.8)) 0.3 (0.1, 0.5) 3.7 (2.8, 4.6)§ 
CVD                                   1.4 (1.0, 1.7) 0.8 (0.5, 1.2) 0.7 (0.02, 1.1) 0.6 (0.3, 0.9) 0.3 (-0.1, 0.6) 3.5 (2.3, 4.8)∂ 
    IHD
 
 
1.5 (1.1, 1.8) 0.5 (0.1, 0.9) 0.8 (0.4, 1.2) 0.5 (0.1, 0.9) 0.3 (-0.1, 0.7) 3.2 (1.8, 4.7)∂ 
    MI
 
 
1.4 (1.0, 2.0) 0.6 (0.1, 1.0) 0.7 (0.3, 1.2) 0.5 (0.1, 0.9) 0.3 (-0.1, 0.8) 3.2 (1.5, 5.0)∂ 
Respiratory Disease 
 
1.6 (1.1, 2.0) 2.1 (1.6, 2.5) 1.7 (1.3, 2.2) 1.7 (1.2, 2.1) 0.9 (0.5, 1.4) 8.0 (5.7, 10.3)§ 
    COPD 
 
1.3 (0.5, 2.0) 2.2 (1.5, 3.0) 1.7 (0.9, 2.4) 1.8 (1.0, 2.5) 0.9 (0.2, 1.7) 7.9 (4.2, 11.5) § 
    Pneumonia 
 
1.9 (1.2, 2.6) 1.8 (1.2, 2.5) 1.9 (1.2, 2.6) 1.5 (0.8, 2.1) 0.8 (0.1, 1.5) 7.9 (4.5, 11.3) § 
Stroke 
  
1.4 (0.8, 2.0) 
 
 
0.3 (-0.3, 0.9) 
 
 
0.8 (0.2, 0.9) 
 
 
0.3 (-0.2, 0.9) 
 
 
0.02 (-0.6, 0.6) 
 
 
2.5 (0.7, 4.3)† 
 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models 
included mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated  
mortality percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for  
lag15-21, week 4 for lag22-28, and week 5 for lag29-35. ‡Cold Season = October  to March. §Cumulative change calculated for lag of week 1to 5. ∂Cumulative change calculated for lag of week 1  
to 4. †Cumulative change calculated for lag of week 1-3.  
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Table 3. Estimated mortality percentage change per 1
o
C decrease in minimum temperature in Northern Ireland during the  
cold period‡ for ages ≥18 years, 1984-2007.*  
Cause-specific Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Cumulative  
mortality group % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
1.1 (0.8, 1.4) 0.9 (0.7, 1.2) 0.8 (0.5, 1.1) 0.1 (-0.1, 0.4) 2.8 (2.0, 3.6) † 
CVD                                  1.0 (0.5, 1.5) 0.7 (0.3, 1.2) 0.5 (0.0, 1.0) 0.0 (-0.5, 0.5) 2.3 (0.8, 3.7)† 
    IHD
 
0.9 (0.3, 1.5) 0.7 (0.1, 1.2) 0.6 (0.0, 1.1) 0.3 (-0.3, 0.9) 2.1 (0.5, 3.8)† 
    
 
    MI 
 
1.0 (0.4, 1.6) 0.6 (0.0, 1.2) 0.6 (0.0, 1.2) 0.4 (-0.2, 1.0) 2.2 (0.4, 4.0)† 
Respiratory Disease 1.9 (1.2, 2.5) 2.3 (1.7, 2.9) 2.0 (1.4, 2.6) 0.5 (-0.1, 1.2) 6.2 (4.3, 8.1)† 
     
     COPD 
 
   2.3 (1.0, 3.6) 2.2 (0.9, 3.5) 1.1 (-0.2, 2.4) 0.3 (-1.0, 1.7) 4.6 (2.0, 7.2)∂ 
    Pneumonia 1.5 (0.7, 2.3) 2.4 (1.7, 3.2) 2.1 (1.3, 2.9) 0.5 (-0.3, 1.3) 6.0 (3.6, 8.4)† 
Stroke 1.0 (0.2, 1.8) 0.7 (-0.1, 1.5) 1.3 (0.5, 2.1) 0.6 (-0.2, 1.4) 3.0 (0.6, 5.4 † 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction. *Models included  
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, and  
week 4 for lag22-28. ‡Cold Season = October to March. †Cumulative change calculated for lag of week 1 to 3. ∂Cumulative change calculated for lag of week 1 to 2. 
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Table 4. Estimated mortality percentage change per 1
o
C decrease in mean temperature in the Republic of Ireland during the  
cold season‡  for ages ≥18 years, 1984-2007.*  
Cause-specific Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Lag of Week 5 Cumulative 
mortality group    % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
 
All-cause Mortality           
 
1.3 (1.1, 1.5) 0.8 (0.6, 1.0) 0.9 (0.7, 1.1) 0.6 (0.4, 0.8) 0.3 (0.1, 0.5) 4.0 (2.9, 5.0)§ 
CVD                                  1.5 (1.2, 1.9) 0.9 (0.5, 1.3) 0.8 (0.02, 1.1) 0.7 (0.3, 1.0) 0.1 (-0.2, 0.5) 3.9 (2.4, 5.4)∂ 
    IHD
 
1.7 (1.2, 2.1) 0.5 (0.1, 0.9) 0.9 (0.5, 1.3) 0.5 (0.1, 0.9) 0.2 (-0.2, 0.6) 3.6 (1.9, 5.2)∂ 
    MI
 
1.4 (1.0, 1.9) 0.6 (0.1, 1.0) 0.7 (0.3, 1.2) 0.5 (0.1, 0.9) 0.3 (-0.1, 0.8) 3.7 (1.6, 5.7)∂ 
Respiratory Disease 1.7 (1.1, 2.2) 2.2 (1.7, 2.7) 1.8 (1.3, 2.3) 1.8 (1.3, 2.3) 0.8 (0.3, 1.4) 8.3 (5.7, 10.9)§ 
    COPD 1.5 (0.6, 2.3) 2.3 (1.5, 3.1) 1.7 (0.9, 2.5) 2.0 (1.2, 2.8) 0.7 (-0.1, 1.5) 7.5 (4.1, 10.8)∂ 
    Pneumonia 2.0 (1.3, 2.8) 2.0 (1.3, 2.8) 2.1 (1.3, 2.8) 1.5 (0.8, 2.3) 0.8 (0.0, 1.6) 8.5 (4.6, 12.3)§ 
Stroke 
 
1.8 (1.1, 2.5) 
 
 
0.3 (-0.4, 1.0) 
 
 
1.0 (0.3, 1.7) 
 
 
0.3 (-0.4, 1.0) 
 
 
0.1 (-0.5, 0.8) 
 
 
3.1 (1.0, 5.3)† 
 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction. *Models included  
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, week 4 
for lag22-28, and week 5 for lag29-35. ‡Cold Season = October  to March. §Cumulative change calculated for lag of week 1to 5. ∂Cumulative change calculated for lag of week 1 to 4. †Cumulative change  
calculated for lag of week 1 to 3.  
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Table 5. Estimated mortality percentage change per 1
o
C decrease in mean temperature in Northern Ireland during the cold  
period‡ for ages ≥18 years, 1984-2007.*  
Cause-specific 
mortality group 
Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Cumulative  
 % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
 
All-cause Mortality           
 
 1.3 (1.0, 1.6) 0.9 (0.6, 1.2)   0.9 (0.5, 1.2)   0.1 (-0.2, 0.4) 3.2 (1.9, 4.4) † 
CVD                                   1.1 (0.5, 1.6) 0.7 (0.1, 1.2) 0.6 (0.0, 1.2) 0.1 (-0.5, 0.6) 2.3 (0.1, 4.5)† 
    IHD
 
 
1.1 (0.5, 1.8) 0.5 (-0.1, 1.2) 0.8 (0.1, 1.4) 0.4 (-0.2, 1.1) 2.0 (-0.6, 4.5)† 
    MI
 
 
1.2 (0.5, 1.9) 0.3 (-0.3, 1.0) 0.8 (0.2, 1.5) 0.5 (-02, 1.2) 1.9 (-0.9, 4.7)† 
Respiratory Disease 
 
2.3 (1.6, 3.1) 2.3 (1.6, 3.0) 2.4 (1.7, 3.1) 0.5 (-0.2, 1.2)  7.5 (4.6, 10.5)† 
    COPD 
 
3.1 (1.6, 4.7) 2.2 (0.7, 3.6) 1.3 (-0.2, 2.8) 0.3 (-1.2, 1.8) 5.3 (2.3, 8.3)∂ 
    Pneumonia 
 
1.7 (0.7, 2.7) 2.4 (1.5, 3.4) 2.5 (1.6, 3.5) 0.6 (-0.3, 1.5) 7.3 (3.6, 11.0)† 
Stroke 
 
1.2 (0.3, 2.1) 0.7 (-0.2, 1.6) 1.4 (0.5, 2.3) 0.8 (-0.1, 1.7) 4.1 (0.4, 7.7) † 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial  infarction. *Models included  
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, and  
week 4 for lag22-28. ‡Cold Season = October to March. βCumulative change calculated for lag  of week 1 to 4. †Cumulative change calculated for lag of week 1 to 3. ∂Cumulative change calculated for 
lag of week 1 to 2. 
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Table 6. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in the Republic of Ireland during  
the cold period‡ for ages ≥18 years, 1984-2007 with DIFFT1 as an independent variable.* 
Cause-specific 
mortality group 
Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Lag of Week 5 Cumulative 
   % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
 1.3 (1.1, 1.5) 0.8 (0.5, 1.0) 0.9 (0.6, 1.1) 0.5 (0.3, 0.8) 0.2 (0.0, 0.5) 3.7 (2.6, 4.8)§ 
CVD                                    1.5 (1.1, 1.9)) 0.9 (0.4, 1.5) 0.7 (0.3, 1.1) 0.6 (0.2, 1.0) 0.02 (-0.4, 0.4) 3.7 (2.2, 5.3)∂ 
    IHD
  
1.6 (1.2, 2.1) 0.4 (0.0, 0.9) 0.8 (0.4, 1.3) 0.5 (0.1, 0.9) 0.1 (-0.3, 0.6) 3.4 (1.6, 5.2)∂ 
    MI
  
1.6 (1.0, 2.1) 0.6 (0.1, 1.1)) 0.8 (0.3, 1.4) 0.6 (0.03, 1.1)) 0.2 (-0.3, 0.8) 3.6 (4.8, 10.2)∂ 
Respiratory Disease 
 
1.5 (1.0, 2.1) 2.0 (1.4, 2.5) 1.7 (1.1, 2.2) 1.7 (1.1, 2.2)) 0.7 (0.1, 1.2) 7.5 (4.8, 10.2)§ 
    COPD 
 
1.5 (0.6, 2.4) 1.9 (1.1, 2.8) 1.7 (0.8, 2.5) 2.0 (1.2, 2.9) 0.4 (-0.5, 1.2) 7.1 (3.7, 10.5)∂ 
    Pneumonia 
 
1.8 (1.0, 2.6) 2.0 (1.2, 2.8) 2.0 (1.2, 2.8) 1.3 (0.5, 2.1) 0.7 (-0.2, 1.7) 7.2 (4.0, 10.4)∂ 
Stroke 
  
1.9 (1.1, 2.6) 
 
 
0.2 (-0.5, 0.9) 
 
 
1.0 (0.3, 1.7) 
 
 
0.1 (-0.6, 0.8) 
 
 
0.3 (-0.4, 1.0) 
 
 
3.1 (1.0, 5.2)† 
 
Abbreviations: DIFFT1 = Maximum temperature – minimum temperature (independent variable). 
CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction. *Models included  
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, week 4  
for lag22-28, and week 5 for lag29-35. ‡Cold period  = October to March. §Cumulative change calculated for lag of week 1to 5. ∂Cumulative change calculated for lag of week 1 to 4. †Cumulative change  
calculated for lag of week 1 to 3.  
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Table 7. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in the Republic of Ireland during  
the cold period‡ for ages ≥18 years, 1984-2007 with DIFFT2 as an independent variable.* 
Cause-specific 
mortality group 
Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Lag of Week 5 Cumulative 
   % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
 1.3 (1.1, 1.5) 0.8 (0.5, 1.0) 0.9 (0.6, 1.1) 0.5 (0.3, 0.8) 0.2 (0.0, 0.5) 3.7 (2.6, 4.8)§ 
CVD                                   1.5 (1.1, 1.9)) 0.9 (0.5, 1.5) 0.7 (0.3, 1.1) 0.6 (0.2, 1.0) 0.02 (-0.4, 0.4) 3.7 (2.2, 5.3)∂ 
    IHD
 
 
1.6 (1.2, 2.1) 0.4 (0.0, 0.9) 0.8 (0.4, 1.3) 0.5 (0.1, 0.9) 0.1 (-0.3, 0.6) 3.4 (1.6, 5.2)∂ 
    MI
 
 
1.6 (1.0, 2.1) 0.6 (0.1, 1.1)) 0.8 (0.3, 1.4) 0.6 (0.03, 1.1)) 0.2 (-0.3, 0.8) 3.6 (4.8, 10.2)∂ 
Respiratory Disease 
 
1.5 (1.0, 2.1) 2.0 (1.4, 2.5) 1.7 (1.1, 2.2) 1.7 (1.1, 2.2)) 0.7 (0.1, 1.2) 7.5 (4.8, 10.2)§ 
    COPD 
 
1.5 (0.6, 2.4) 1.9 (1.1, 2.8) 1.7 (0.8, 2.5) 2.0 (1.2, 2.9) 0.4 (-0.5, 1.2) 7.1 (3.6, 10.5)∂ 
    Pneumonia 
 
1.8 (1.0, 2.6) 2.0 (1.2, 2.8) 2.0 (1.2, 2.8) 1.3 (0.5, 2.1) 0.7 (-0.2, 1.7) 7.2 (4.0, 10.4)∂ 
Stroke 
  
1.9 (1.1, 2.6) 
 
 
0.2 (-0.5, 0.9) 
 
 
1.0 (0.3, 1.7) 
 
 
0.1 (-0.6, 0.8) 
 
 
0.3 (-0.4, 1.0) 
 
 
3.1 (1.0, 5.2)† 
 
Abbreviations: DIFFT2 = Maximum temperature – mean temperature (independent variable). 
CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction. *Models included  
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, week 4  
for lag22-28, and week 5 for lag29-35. ‡Cold season = October to March. §Cumulative change calculated for lag of week 1to 5. ∂Cumulative change calculated for lag of week 1 to 4. †Cumulative change  
calculated for lag of week 1 to 3.  
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Table 8. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in Northern Ireland during the  
cold period‡ for ages ≥18 years, 1984-2007 with DIFFT1 as an independent variable.* 
Cause-specific 
mortality group 
Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Cumulative  
% Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
 1.4 (1.0, 1.7) 0.8 (0.5, 1.1) 0.8 (0.5, 1.2) 0.1 (-0.3, 0.4) 3.0 (2.0, 4.0)† 
CVD                                   1.1 (0.5, 1.7) 0.5 (-0.02, 1.1) 0.7 (0.02, 1.3) 0.1 (-0.5, 0.7) 2.4 (0.6, 4.1)† 
    IHD
 
 
1.3 (0.6, 2.0) 0.3 (-0.4, 0.9) 0.9 (0.2, 1.6) 0.5 (-0.2, 1.1) 2.5 (0.5, 4.5)† 
    MI
 
 
1.4 (0.6, 2.2) 0.1 (-0.6, 0.8) 1.0 (0.2, 1.7) 0.4 (-0.3, 1.2) 2.4 (0.2, 4.6)† 
Respiratory Disease 
 
2.6 (1.8, 3.4) 2.0 (1.2, 2.7) 2.5 (1.8, 3.3) 0.5 (-0.2, 1.3) 7.6 (4.6, 10.7)† 
    COPD 
 
3.4 (1.8, 5.1) 1.9 (0.3, 3.4) 1.4 (-0.1, 3.0) 0.4 (-1.2, 2.0) 5.3 (2.1, 8.5)† 
    Pneumonia 
 
1.8 (0.7, 2.8) 2.1 (1.1, 3.0) 2.8 (1.8, 3.7) 0.7 (-0.2, 1.7) 7.3 (3.4, 11.2)† 
Stroke 
 
1.2 (0.2, 2.2) 0.7 (-0.2, 1.6) 1.2 (0.3, 2.2) 1.0 (0.0, 1.9) 4.1 (0.3, 7.9)∂ 
Abbreviations: DIFFT1 = Maximum temperature – minimum temperature (independent variable). 
CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction. *Models included mortality data for ages ≥18  
years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality percentage change per 1oC decrease in  
weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, and week 4 for lag22-28. ‡Cold season = October to  
March. ∂Cumulative change calculated for lag of week 1 to 4. †Cumulative change calculated for lag of week 1 to 3.  
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Table 9. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in Northern Ireland during the  
cold period‡ for ages ≥18 years, 1984-2007 with DIFFT2 as an independent variable.* 
Cause-specific 
mortality group 
Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Cumulative  
% Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
 1.4 (1.0, 1.7) 0.8 (0.5, 1.1) 0.8 (0.5, 1.2) 0.1 (-0.3, 0.4) 3.0 (2.0, 4.0)† 
CVD                                   1.1 (0.5, 1.7) 0.5 (-0.02, 1.1) 0.7 (0.02, 1.3) 0.1 (-0.5, 0.7) 2.4 (0.6, 4.1)† 
    IHD
 
 
1.3 (0.6, 2.0)) 0.3 (-0.4, 0.9) 0.9 (0.2, 1.6) 0.5 (-0.2, 1.1) 2.5 (0.5, 4.5)† 
    MI
 
 
1.4 (0.6, 2.2) 0.1 (-0.6, 0.8) 1.0 (0.2, 1.7) 0.4 (-0.3, 1.2) 2.4 (0.2, 4.6)† 
Respiratory Disease 
 
2.6 (1.8, 3.4)             2.0 (1.2, 2.7) 2.5 (1.8, 3.3) 0.5 (-0.2, 1.3)  7.1 (4.8, 9.4)† 
    COPD 
 
3.4 (1.8, 5.1)      1.1 (0.3, 3.4)      1.4 (-0.1, 3.0) 0.4 (-1.2, 2.0) 5.3 (2.1, 8.5)β 
    Pneumonia 
 
1.8 (0.8, 2.8) 2.1 (1.1, 3.0) 2.8 (1.8, 3.7) 0.7 (-0.2, 1.7) 6.6 (3.7, 9.5)∂ 
Stroke 
 
1.2 (0.2, 2.2)    0.7 (-0.2, 1.6)     1.2 (0.3, 2.2) 1.0 (0.01, 1.9) 4.1 (0.3, 7.9)† 
Abbreviations: DIFFT2 = Maximum temperature – mean temperature (independent variable). 
CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction. *Models included mortality data for ages ≥18  
years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality percentage change per 1oC decrease in  
weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, and week 4 for lag22-28. ‡Cold season = October to  
March. ∂Cumulative change calculated for lag of week 1 to 4. †Cumulative change calculated for lag of week 1 to 3. βCumulative change calculated for lag of week 1 to 2. 
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Table 10. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in the Republic of Ireland during  
the cold period‡ for ages ≥18 years, 1984-1991.*  
Cause-specific 
mortality group 
Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Lag of Week 5 Cumulative 
   % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
 1.1 (0.7, 1.5) 0.9 (0.5, 1.3) 0.8 (0.5, 1.1) 1.1 (0.8, 1.4) 0.8 (0.5, 1.2) 4.7 (3.0, 6.5)§ 
CVD                                   1.2 (0.6, 1.8) 1.1 (0.5, 1.7) 0.7 (0.02, 1.3) 1.1 (0.5, 1.6) 0.4 (-0.1, 1.0) 4.1 (1.8, 6.4)∂ 
    IHD
 
 
1.4 (0.7, 2.1) 0.3 (-0.4, 1.0) 0.8 (0.2, 1.5) 0.9 (0.3, 1.5) 0.6 (-0.03, 1.3) 3.5 (0.8, 6.1)∂ 
    MI
 
 
1.4 (0.6, 2.2) 0.4 (-0.3, 1.2) 1.0 (0.3, 1.7) 0.8 (0.04, 1.5) 0.6 (-0.1, 1.3) 3.6 (0.6, 6.6)∂ 
Respiratory Disease 
 
1.4 (0.4, 2.3) 1.8 (0.9, 2.7) 1.6 (0.8, 2.5) 1.6 (0.8, 2.5) 2.5 (1.6, 3.3) 8.9 (4.5, 13.3)§ 
    COPD 
 
2.0 (0.6, 3.4) 1.2 (-0.2, 2.5) 1.5 (0.2, 2.8) 1.6 (0.4, 2.9) 1.6 (0.3, 2.9) 7.9 (1.3, 15.7)§ 
    Pneumonia 
 
1.1 (0.3, 2.5) 1.7 (0.4, 3.1) 2.3 (1.0, 3.6) 1.4 (0.1, 2.7) 2.6 (1.3, 3.9) 9.12.4, 15.7)§ 
Stroke 
  
1.3 (0.2, 2.4) 
 
 
1.2 (0.1, 2.2) 
 
 
0.6 (-0.4, 1.6) 
 
 
1.6 (0.6, 2.6) 
 
 
0.1 (-1.0, 1.1) 
 
 
4.6 (0.4, 8.9)∂ 
 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction. *Models included  
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, week 4  
for lag22-28, and week 5 for lag29-35. ‡Cold season = October to March. §Cumulative change calculated for lag of week 1 to  5. ∂Cumulative change calculated for lag of week 1 to 4.  
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Table 11. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in the Republic of Ireland during  
the cold period‡ for ages ≥18 years, 1992-2007.*  
Cause-specific 
mortality group 
Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Lag of Week 5 Cumulative 
   % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
 1.4 (1.1, 1.7) 0.6 (0.3, 0.9) 0.8 (0.5, 1.1) 0.1 (-0.2, 0.4)) 0.2 (-0.1, 0.5) 2.8 (1.4, 4.2)† 
CVD                                   1.7 (1.2, 2.3) 0.7 (0.2, 1.2) 0.6 (0.02, 1.1) 0.2 (-0.3, 0.7) 0.3 (-0.2, 0.8) 3.0 (1.8, 4.1)† 
    IHD
 
 
1.8 (1.2, 2.4) 0.5 (-0.1, 1.0) 0.7 (0.1, 1.3) 0.1 (-0.5, 0.7) 0.3 (-0.3, 0.9) 3.0 (1.2, 4.8)† 
    MI
 
 
1.8 (1.1, 2.5) 0.7 (0.0, 1.4) 0.6 (-0.2, 1.3) 0.3 (-0.5, 1.0) 0.1 (-0.6, 0.8) 2.5 (1.0, 3.9)∂ 
Respiratory Disease 
 
1.7 (1.0, 2.4) 2.0 (1.3, 2.6) 1.7 (1.0, 2.4) 1.7 (1.0, 2.4) 0.4 (-0.2, 1.1) 6.6 (3.2, 10.1)§ 
    COPD 
 
1.2 (0.1, 2.3) 2.4 (1.3, 3.5) 1.9 (0.7, 3.0) 2.4 (1.2, 3.5) 0.5 (-0.6, 1.6) 7.8 (3.3, 12.4)§ 
    Pneumonia 
 
2.3 (1.3, 3.3) 2.1 (1.1, 3.1) 1.8 (0.7, 2.8) 1.2 (0.2, 2.2) 0.3 (-0.7, 1.3) 7.3 (3.3, 11.4)§ 
Stroke 
  
2.2 (1.3, 3.2) 
 
 
0.4 (-0.5, 1.4) 
 
 
1.2 (0.2, 2.1) 
 
 
-1.2 (0.3, 2.2) 
 
 
0.5 (-0.4, 1.5) 
 
 
2.9 (0.1, 5.8)† 
 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models included  
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, week 4  
for lag22-28, and week 5 for lag29-35. ‡Cold season = October to March. §Cumulative change for lag of week 1 to 4.†Cumulative change calculated for lag of week 1 to 3. ∂Cumulative change calculated  
for lag of week 1 to 2 
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Table 12. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in Northern Ireland during  
the cold period‡  for ages ≥18 years, 1984-1991.*  
Cause-specific 
mortality group 
Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Cumulative  
 % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
 1.4 (0.8, 1.9) 1.2 (0.7, 1.8) 1.2 (0.7, 1.8) 0.4 (-0.1, 0.9) 3.9 (2.2, 5.5)† 
CVD                                   1.0 (0.1, 2.0) 0.5 (-0.3, 1.4) 0.8 (0.02, 1.7) 0.6 (-0.2, 1.5) 2.4 (-0.2, 5.1)† 
    IHD
 
 
1.6 (0.6, 2.7) 0.2 (-0.8, 1.3) 1.1 (0.2, 2.1) 1.0 (0.0, 2.0) 2.5 (-0.5, 5.6)§ 
    MI
 
 
1.8 (0.7, 3.0) 0.6 (-0.5, 1.7) 1.3 (0.3, 2.3) 0.8 (-0.2, 1.9) 2.6 (-0.7, 5.8)† 
Respiratory Disease 
 
2.7 (1.4, 4.1) 2.4 (1.1, 3.6) 2.6 (1.4, 3.8) 0.8 (-0.4, 2.0) 7.7 (3.9, 18.3)† 
    COPD 
 
5.4 (2.4, 8.4) 3.2 (0.3, 6.2) 1.0 (-1.7, 3.7) 1.3 (-1.4, 4.0) 8.6 (2.7, 14.5)∂ 
    Pneumonia 
 
1.5 (-0.1, 3.2) 2.2 (0.6, 3.8) 2.8 (1.3, 4.2) 1.0 (-0.5, 2.5) 6.5 (1.8, 11.2)† 
Stroke 
 
1.2 (-0.3, 2.8)  1.5 (0.04, 3.0) 2.2 (0.8, 3.6) 0.8 (-0.6, 2.3) 5.0 (0.4, 9.5)† 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models included mortality data  
for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality percentage change per 1oC  
decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, and week 4 for lag22-28. ‡Cold season =  
October to March. §Cumulative change for lag of week 1 to 4. †Cumulative change calculated for lag of week 1 to 3. ∂Cumulative change calculated for lag of week 1 to 2. 
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Table 13. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in Northern Ireland  
during the cold period‡ for ages ≥18 years, 1992-2007.*  
Cause-specific 
mortality group 
Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Cumulative  
 % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
 1.5 (1.1, 1.9) 0.5 (0.1, 0.9) 0.6 (0.1, 0.9) 0.3 (-0.1, 0.7) 2.6 (1.3, 3.8)† 
CVD                                   1.3 (0.5, 2.0) 0.4 (-0.3, 1.2) 0.7 (0.02, 1.5) 0.4 (-0.4, 1.2) 2.4 (0.1, 4.6)† 
    IHD
 
 
1.3 (0.4, 2.1) 0.6 (-0.3, 1.4) 0.8 (-0.1, 1.7) 0.1 (-0.8, 1.0) 1.3 (0.4, 2.1)∂ 
    MI
 
 
1.3 (0.3, 2.2) 0.4 (-0.5, 1.4) 0.7 (-0.3, 1.7) 0.1 (-0.9, 1.2) 1.3 (0.3, 2.2)∂ 
Respiratory Disease 
 
2.6 (1.6, 3.5) 1.7 (0.8, 2.6) 2.5 (1.5, 3.5) 0.3 (-0.7, 1.3)  6.8 (3.9, 9.7)† 
    COPD 
 
3.1 (1.3, 5.0) 1.1 (-0.7, 2.9) 1.6 (-0.4, 3.5) 0.1 (-1.8, 2.0) 3.1 (1.3, 5.0)∂ 
    Pneumonia 
 
2.0 (0.7, 3.2) 2.0 (0.8, 3.2) 2.8 (1.5, 4.0) 0.5 (-0.8, 1.8) 6.7 (3.0, 10.4)† 
Stroke 
 
1.6 (0.4, 2.9) 0.05 (-1.1, 1.2) 0.3 (-1.0, 1.6) 0.9 (-0.3, 2.2) 1.6 (0.4, 2.9)∂ 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models  
included mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change =  
estimated mortality percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14,  
week 3 for lag15-21, and week 4 for lag22-28. ‡Cold season = October to March. †Cumulative change calculated for lag of week 1 to 3. ∂Cumulative change calculated for lag of week 1. 
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Table 14. Total number of deaths stratified by age and gender in the Republic of Ireland and Northern Ireland between 1984 and 2007. 
 
Cause of 
Death 
 
Gender 
Republic of Ireland Northern Ireland 
All Year Cold Period All Year Cold Period 
All ages 18-64 yr. 65-74 yr. 75+ yr. All ages 18-64 yr. 65-74 yr. 75+ yr. All ages 18-64 yr. 65-74 yr. 75+ yr. All ages 18-64 yr. 65-74yr. 75+ yr. 
All-cause 
Mortality 
Male 367548 82345 100866 184337 196918 39411 53776 93136 168304 40129 46253 81922 89471 19248 24425 40922 
Female 341562 52572 65219 223771 184181 24471 34704 116771 179632 26934 33587 11911 96612 12723 17801 62179 
 
 
CVD 
Male 127771 28183 37217 62371 68745 14677 20026 31487 57434 13868 17520 26046 30595 7168 9328 12939 
Female 103469 8220 18991 76258 56196 4312 10210 39949 51892 4897 10566 36429 28140 2684 5738 18798 
 
 
IHD 
Male 101936 23909 31549 46472 54697 12450 16910 23309 44975 11844 14243 18888 23990 6144 7608 9328 
Female 72103 5997 14898 51206 39066 3167 7989 26636 34911 3581 7889 23441 18932 1980 4243 12061 
 
 
MI 
Male 71695 16429 23351 31912 38526 8551 12516 16001 37543 9046 12208 16289 20063 4693 6515 8058 
Female 49351 4235 11189 33925 26868 2246 6058 17638 30452 2963 7129 20360 16602 1641 3853 10533 
 
Respiratory 
Disease 
Male 54019 5348 12151 36520 31263 2858 7169 19948 26398 3058 5634 17706 15217 1550 3264 9635 
Female 52180 3601 7966 40613 30680 2024 4736 22933 31651 2357 4123 25171 18605 1193 2418 14405 
 
 
COPD 
Male 24523 2228 6913 15371 14435 1343 4144 8360 7765 920 2357 4488 4465 568 1358 2344 
Female 16115 1422 4140 10546 9729 889 2570 5892 5627 736 1628 3263 3379 458 996 1794 
 
 
Pneumonia 
Male 21613 1556 3443 16470 12405 868 2018 9042 14113 1081 2193 10839 8163 564 1286 6010 
Female 27636 1029 2559 23933 16051 614 1458 13580 21843 819 1758 19266 12818 416 1015 11115 
 
 
Stroke 
Male 28235 3637 6932 17666 15273 1915 3719 9033 14781 1951 3552 9278 7865 1005 1866 4662 
Female 38902 2978 5834 30090 21183 1520 3139 15877           24760 1696 3468 19596 13332 866 1838 10278 
Abbreviations: COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction, total = male and female, and yr. = years. 
Zeka et al., 2014 
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Table 15. Weather descriptive for the Republic of Ireland and Northern Ireland between 1984 and 2007. 
 
       Republic of Ireland 
 
Northern Ireland 
 
Season 
 
 
Temperature* 
 
Mean ± SD 
Percentiles  
Mean ± SD 
Percentiles 
99th 90
th
 10
th
 1
st
 99th 90
th
 10
th
 1
st
 
 
 
All year 
Mean 
Minimum 
Maximum 
9.7 ± 4.4 
6.3 ± 4.4 
13.0 ± 4.8 
19.0 
15.2 
24.1 
15.4 
12.1 
19.4 
4.1 
0.6 
7.0 
0.4 
-3.5 
3.1 
9.1 ± 4.4 
5.9 ± 4.5 
12.4 ± 4.9 
18.6 
15.0 
23.5 
15.2 
11.9 
18.9 
3.4 
0.0 
6.1 
0.0 
-3.9 
2.5 
 
 
Summer
1
 
Mean 
Minimum 
Maximum
 
14.7 ± 2.3 
10.9 ± 2.6 
18.6 ± 2.8 
20.5 
16.5 
26.4 
17.8 
14.0 
22.3 
11.9 
7.6 
15.2 
9.4 
4.3 
12.6 
14.4 ± 2.4 
10.6 ± 2.7 
18.1 ± 2.8 
20.1 
16.2 
25.7 
17.5 
13.9 
21.9 
11.4 
7.1 
14.7 
8.9 
3.6 
12.0 
 
 
Winter Months
2
 
Mean 
Minimum 
Maximum
 
5.8 ± 2.9 
3.1 ± 3.3 
8.6 ± 2.8 
11.8 
10.3 
13.9 
9.5 
7.4 
12.0 
2.0 
-1.2 
4.8 
-1.1 
-4.9 
1.5 
4.9 ± 2.7 
2.2 ± 3.2 
7.6 ± 2.7 
10.7 
9.5 
13.2 
8.3 
6.4 
11.1 
1.5 
-1.8 
4.0 
-1.4 
-5.6 
1.0 
 
 
Cold Period
3
 
Mean 
Minimum 
Maximum
 
7.0 ± 3.2 
4.1 ± 3.7 
10.0 ± 3.2 
14.4 
16.0 
17.4 
11.1 
8.8 
14.0 
2.9 
-0.5 
5.7 
-0.4 
-4.4 
2.2 
6.3 ± 3.2 
3.4 ± 3.6 
9.1 ± 3.3 
14.0 
12.0 
16.7 
10.5 
8.3 
13.2 
2.3 
-1.0 
4.9 
-0.8 
-4.9 
1.7 
Abbreviations: SD = standard deviation, * in degrees Celsius (oC), 1 Summer = June to August, 2 Winter Months = December to February, and  3Cold Period = October to March. 
Zeka et al., 2014 
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Table 16. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in the Republic of Ireland during  
the cold period‡ for ages ≥18 years, 1984-2007.* 
Cause-specific Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Lag of Week 5 Cumulative 
mortality group    % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
1.3 (1.1, 1.5) 0.8 (0.5, 1.0) 0.9 (0.6, 1.1) 0.5 (0.3, 0.8) 0.2 (0.02, 0.5) 3.7 (2.6, 4.8)§ 
CVD                                  1.5 (1.1, 1.9) 0.9 (0.5, 1.3) 0.7 (0.3, 1.1) 0.6 (0.2, 1.0) 0.02 (-0.4, 0.4) 3.7 (2.2, 5.3)∂ 
    IHD
 
1.6 (1.2, 2.1) 0.4 (0.0, 0.9) 0.8 (0.4, 1.3) 0.5 (0.1, 0.9) 0.1 (-0.3, 0.6) 3.4 (1.6, 5.2)∂ 
    MI
 
1.6 (1.0, 2.1) 0.6 (0.1, 1.1) 0.8 (0.3, 1.4) 0.6 (0.03, 1.1) 0.2 (-0.3, 0.8) 3.6 (1.5, 5.7)∂ 
Respiratory Disease 1.5 (1.0, 2.1) 2.0 (1.5, 2.5) 1.7 (1.2, 2.2) 1.7 (1.1, 2.2) 0.7 (0.1, 1.2) 7.5 (4.8, 10.2)§ 
    COPD 1.5 (0.6, 2.4) 1.9 (1.1, 2.8) 1.6 (0.8, 2.5) 2.0 (1.2, 2.9) 0.4 (-0.5, 1.2) 7.1 (3.6, 10.5)∂ 
    Pneumonia 1.8 (1.0, 2.6) 2.0 (1.2, 2.8) 2.0 (1.2, 2.8) 1.3 (0.5, 2.1) 0.7 (-0.05, 1.5) 7.2 (4.0, 10.4)∂ 
Stroke 
 
1.8 (1.1, 2.6) 
 
 
0.3 (-0.4, 0.9) 
 
 
1.1 (0.4, 1.7) 
 
 
0.1 (-0.6, 0.8) 
 
 
0.3 (-0.4, 1.0) 
 
 
3.1 (1.0, 5.3)† 
 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models included  
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, week 4  
for lag22-28, and week 5 for lag29-35. ‡Cold Season = October  to March. §Cumulative change calculated for lag of week 1to 5. ∂Cumulative change calculated for lag of week 1 to 4. †Cumulative change 
calculated for lag of week 1 to 3.  
Zeka et al., 2014 
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Table 17. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in Northern Ireland during  
the cold period‡ for ages ≥18 years, 1984-2007.* 
Cause-specific Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Cumulative  
mortality group  % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
1.4 (1.1, 1.8) 0.8 (0.5, 1.1)     0.8 (0.5, 1.2)    0.4 (0.1, 0.7) 3.1 (1.8, 4.4)β 
CVD                                  1.1 (0.6, 1.7) 0.5 (-0.03, 1.1) 0.7 (0.02, 1.3) 0.1 (-0.5, 0.7) 2.4 (0.7, 4.1)† 
    IHD
 
1.4 (0.7, 2.1) 0.3 (-0.4, 0.9) 0.9 (0.2, 1.6) 0.5 (-0.2, 1.1) 2.5 (0.3, 4.6)† 
    MI
 
1.5 (0.8, 2.2) 0.3 (-0.3, 1.0) 1.0 (0.2, 1.7) 0.4 (-0.3, 1.2) 2.6 (0.6, 4.6)† 
Respiratory Disease 2.6 (1.8, 3.4) 2.0 (1.2, 2.7) 2.5 (1.8, 3.3) 0.5 (-0.2, 1.3)  7.1 (4.8, 9.4)† 
    COPD 3.7 (2.1, 5.3) 1.8 (0.3, 3.3) 1.4 (-0.2, 3.0) 0.4 (-1.2, 2.0) 5.5 (1.9, 5.8)∂ 
    Pneumonia 1.8 (0.8, 2.8) 2.1 (1.1, 3.0) 2.8 (1.8, 3.7) 0.7 (-0.2, 1.7) 6.6 (3.7, 9.5)† 
Stroke 1.4 (0.4, 2.3) 0.7 (-0.3, 1.6)     1.2 (0.3, 2.1) 1.0 (0.01, 1.9) 4.2 (0.4, 8.0)β 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models included mortality  
data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality percentage change per  
1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, and week 4 for lag22-28. ‡Cold period  
= October to March. βCumulative change calculated for lag of week 1 to 4. †Cumulative change calculated for lag of week 1 to 3. ∂Cumulative change calculated for lag of week 1 to 2. 
Zeka et al., 2014 
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Table 18. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in the Republic of Ireland during  
the winter months‡ for ages ≥18 years, 1984-2007.* 
Cause-specific Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Lag of Week 5 Cumulative 
mortality group    % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality           
 
1.8 (1.5, 2.1) 1.4 (1.0, 1.7) 1.4 (1.1, 1.7) 1.0 (0.7, 1.3) 0.8 (0.5, 1.0) 6.4 (4.8, 7.9)§ 
CVD                                  1.8 (1.3, 2.3) 1.3 (0.8, 1.8) 1.3 (0.8; 1.8) 1.2 (0.6, 1.7) 0.4 (-0.1, 0.9) 5.6 (3.5, 7.7)∂ 
    IHD
 
2.1 (1.5, 2.7) 0.8 (0.2, 1.4) 1.4 (0.8, 2.0) 1.0 (0.4, 1.6) 0.5 (-0.1, 1.1) 5.3 (2.9, 7.8)∂ 
    MI
 
1.9 (1.2, 2.7) 0.8 (0.1, 1.6) 1.4 (0.7, 2.1) 0.9 (0.2, 1.6) 0.7 (-0.03, 1.3) 5.1 (2.2, 8.0)∂ 
Respiratory Disease 2.5 (1.7, 3.2) 3.2 (2.5, 3.9) 2.6 (1.9, 3.4) 2.7 (1.9, 3.4) 1.5 (0.8, 2.2) 12.5 (8.9, 16.2)§ 
    COPD 2.3 (1.2, 3.5) 2.8 (1.6, 3.9) 2.3 (1.2, 3.5) 2.9 (1.7, 4.0) 1.4 (0.3, 2.5) 11.7 (6.0, 17.4)§ 
    Pneumonia 2.9 (1.8, 4.0) 3.6 (2.6, 4.7) 3.2 (2.2, 4.3) 2.5 (1.5, 3.6) 1.5 (0.5, 2.5) 13.8 (8.4, 19.1)§ 
Stroke 
 
2.5 (1.5, 3.5) 
 
 
1.1 (0.1, 2.1) 
 
 
1.4 (0.4, 2.4) 
 
 
0.8 (-0.2, 1.7) 
 
 
0.8 (-0.1, 1.8) 
 
 
5.0 (2.1, 8.0)† 
 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models included  
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for lag15-21, week 4  
for lag22-28, and week 5 for lag29-35. ‡Winter Months = December to February. §Cumulative change calculated for lag of week 1to 5. ∂Cumulative change calculated for lag of week 1 to 4. †Cumulative  
change calculated for lag of week 1 to 3.  
Zeka et al., 2014 
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Table 19. Estimated mortality percentage change per 1
o
C decrease in maximum temperature in Northern Ireland during  
the winter months‡ for ages ≥18 years, 1984-2007.* 
Cause-specific Lag of Week 1 Lag of Week 2 Lag of Week 3 Lag of Week 4 Cumulative  
mortality group  % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality†           
 
1.7 (1.3, 2.2) 1.2 (0.8, 1.7) 1.6 (1.1, 2.0) 0.4 (-0.01, 0.9) 4.5 (3.2, 5.9) 
CVD†                                  1.9 (1.1, 2.7) 0.5 (-0.3, 1.3) 1.5 (0.7, 2.3) 0.1 (-0.7, 0.9) 3.9 (1.5, 6.3) 
    IHD† 2.3 (1.3, 3.2) 0.1 (-0.8, 1.0) 1.5 (0.5, 2.4) -0.3 (-1.2, 0.6) 3.8 (1.0, 6.6) 
    MI† 2.2 (1.2, 3.2) -0.02 (-1.0, 1.0) 1.5 (0.5, 2.5) -0.2 (-1.2, 0.8) 3.7 (0.7, 6.7) 
Respiratory Disease∂ 2.8 (1.8, 3.9) 2.7 (1.7, 3.7) 4.3 (3.2, 5.3) 1.4 (0.4, 2.4)  11.2 (7.1, 15.3) 
    COPD† 3.7 (1.5, 5.8) 3.1 (1.0, 5.2) 3.9 (1.8, 6.0) 0.8 (-1.3, 2.9) 10.6 (4.2, 17.0) 
    Pneumonia∂ 2.1 (0.8, 3.4) 2.5 (1.2, 3.7) 4.1 (2.8, 5.4) 1.5 (0.2, 2.8) 10.2 (5.0, 15.4) 
Stroke† 2.0 (0.7, 3.3) 0.9 (-0.4, 2.2) 1.9 (0.6, 3.2) 0.9 (-0.4, 2.2) 4.8 (0.9, 8.8) 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models included mortality data  
for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality percentage change per 1oC  
decrease in weekly mean of maximum temperature. Week 1 corresponds to the mean of daily maximum temperature for lag1-7, week 2 for lag8-14, week 3 for  lag15-21, and week 4 for lag22-28. ‡Winter Months  
= December to February. ∂Cumulative change calculated for lag of week 1 to 4. †Cumulative change calculated for lag of week 1 to 3.  
Zeka et al., 2014 
 
 145 
 
Table 20. Estimated cumulative mortality percentage change per 1
0
C decrease in maximum temperature in the Republic of  
Ireland during the cold period‡ for ages ≥18 years, 1984-2007.* 
Cause-specific 
mortality group 
                                                        Male and Female All Ages 
18-64 years        65-74 years 75+ years Male Female 
% Change (95% CI)        % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
 
All-cause Mortality§           
 
 1.9 (-0.8, 4.6)         3.1 (0.8, 5.4) 4.5 (3.0, 5.9) 
 
3.6 (2.1, 5.2) 
 
3.7 (2.1, 5.3) 
CVD∂                                   3.2 (-0.8, 7.2)          2.6 (-0.5, 5.8) 4.4 (2.3, 6.4) 
 
3.5 (1.4, 5.6) 
 
4.1 (1.7, 6.4) 
IHD∂
  
3.0 (-1.4, 7.3)          2.5 (-1.1, 6.0) 4.0 (1.5, 6.5) 
 
3.1 (0.7, 5.4) 
 
3.9 (1.1, 6.7) 
MI∂
  
3.6 (-1.7, 8.8)         2.5 (-1.6, 6.6) 4.2 (1.1, 7.2) 
 
3.2 (0.4, 6.0) 
 
4.2 (0.8, 7.5) 
Respiratory Disease§ 
 
7.6 (-2.3, 17.5)           5.7 (-0.7, 12.1) 8.0 (4.4, 11.6) 
 
7.5 (3.7, 11.4) 
 
7.5 (3.6, 11.4) 
COPD§ 
 
9.8 (-2.2, 21.8)           5.5 (-1.6, 12.6) 7.4 (2.3, 12.5) 
 
6.9 (2.3, 11.5) 
 
7.4 (1.7, 13.0) 
 Pneumonia§ 
 
7.3 (-7.6, 22.1)           5.6 (-4.4, 15.7) 7.4 (2.8, 12.0) 
 
7.9 (2.9, 13.0) 
 
6.6 (2.2, 11.0) 
Stroke† 
 
-0.4 (-7.6, 6.9)          2.8 (-2.4, 8.1) 3.7 (0.8, 6.6) 
 
2.0 (-1.3, 5.4) 
 
3.9 (1.1, 6.8) 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models  
included mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated  
mortality percentage change per 1oC decrease in weekly mean of maximum temperature. ‡cold period = October to March. § Effect modification examined for cumulative change for lags of week 1to  
5; (∂) for cumulative change for lags of week 1 to 4; and (†) for cumulative change for lags of week 1 to 3.  
Zeka et al., 2014 
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Table 21. Estimated cumulative mortality percentage change per 1
0
C decrease in maximum temperature in Northern  
Ireland during the cold period‡ for ages ≥18 years, 1984-2007.* 
Cause-specific 
mortality group 
                                          Male and Female All Ages 
18-64 years 65-74 years 75+ years Male                Female 
 % Change (95% CI)    % Change (95% CI)       % Change (95% CI)   % Change (95% CI) % Change (95% CI) 
 
All-cause Mortality†          
 
 2.1 (0.0, 4.3) 2.8 (1.0, 4.6) 4.1 (2.9, 5.2) 
 
3.2 (1.3, 5.1) 
 
3.0 (1.1, 4.8) 
CVD†                                   2.4 (-0.6, 5.4) 2.3 (-0.1, 4.7)  3.7 (2.1, 5.2) 
 
2.8 (0.4, 5.2) 
 
1.9 (-0.6, 4.5) 
    IHD†
 
 
2.5 (-0.8, 5.7) 2.0 (-0.6, 4.7) 3.5 (1.6, 5.4) 
 
2.6 (-0.1, 5.4) 
 
2.5 (-0.6, 5.6) 
    MI†
 
 
3.1 (-0.9, 7.0) 1.9 (-1.2, 5.0) 3.6 (1.3, 5.9) 
 
2.6 (-0.3, 5.6) 
 
2.3 (-1.0, 5.6) 
Respiratory Disease∂ 
 
6.3 (0.3, 12.3) 3.5 (-0.4, 7.4) 5.5 (3.4, 7.7) 
 
7.2 (3.8, 10.7) 
 
7.0 (3.9, 10.2) 
    COPD† 
 
5.2 (-0.8, 11.3) 2.7 (-0.9, 6.3) 3.5 (0.9, 6.0) 
 
5.1 (0.7, 9.5) 
 
6.1 (1.0, 11.2) 
    Pneumonia∂ 
 
6.8 (-4.3, 17.9) 5.4 (-2.2, 13.0) 5.9 (2.4, 9.3) 
 
6.4 (1.7, 11.2) 
 
6.8 (2.9, 10.6) 
Stroke† 
 
1.9 (-7.7, 11.5) 3.2 (-3.8, 10.1) 3.9 (0.05, 7.9) 3.6 (-2.9, 10.0) 4.6 (-0.4, 9.6) 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models  
included mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change =  
estimated mortality percentage change per 1oC decrease in weekly mean of maximum temperature. ‡Cold period  = October to March. ∂ Effect modification examined for cumulative change  
for lags of week 1 to 4; and (†) for cumulative change for lags of week 1 to 3.  
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Table 22. Estimated cumulative mortality percentage change per 1
0
C decrease in maximum temperature in the Republic of  
Ireland during the winter months‡ for ages ≥18 years, 1984-2007.* 
Cause-specific 
mortality group 
                                                  Male and Female All Ages 
18-64 years 65-74 years 75+ years Male Female 
% Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
 
All-cause Mortality§           
 
 3.3 (-0.3, 7.0) 5.2 (2.1, 8.3) 7.7 (5.7, 9.7) 
 
6.1 (4.0, 8.2) 
 
6.6 (4.4, 8.8) 
CVD∂                                   3.9 (-1.5, 9.3) 4.8 (0.4, 9.1) 6.3 (3.5, 9.2) 
 
5.6 (2.7, 8.5) 
 
5.5 (2.4, 8.7) 
IHD∂
 
 
3.3 (-2.6, 9.3) 4.7 (-0.1, 9.5) 6.4 (3.0, 9.7) 
 
5.3 (2.1, 8.5) 
 
5.4 (1.6, 9.2) 
MI∂
 
 
4.0 (-3.1, 11.1) 4.0 (-1.5, 9.6) 6.1 (2.0, 10.2) 
 
4.9 (1.1, 8.8) 
 
5.3 (0.8, 9.9) 
Respiratory Disease§ 
 
14.4 (1.8, 27.1) 10.8 (2.8, 18.8) 12.9 (8.6, 17.1) 
 
11.6 (6.5, 16.6) 
 
13.6 (8.5, 18.7) 
COPD§ 
 
15.0 (-3.6, 33.6) 10.5 (0.04, 20.9) 11.8 (4.5, 19.1) 
 
10.2 (2.9, 17.5) 
 
14.0 (5.0, 22.0) 
 Pneumonia§ 
 
14.0 (-8.8, 36.6) 9.4 (-5.6, 24.4) 14.4 (8.5, 20.3) 
 
14.2 (6.1, 22.2) 
 
13.5 (6.3, 20.6) 
Stroke† 
 
2.9 (-7.3, 12.5) 4.2 (-2.9, 11.3) 5.6 (1.7, 9.4) 
 
3.7 (-1.0, 8.4) 
 
5.9 (2.0, 9.9) 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models included 
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. ‡Winter Months = December to February. § Effect modification examined for cumulative change for lags of week 1to 5; (∂)  
for cumulative change for lags of week 1 to 4; and (†) for cumulative change for lags of week 1 to 3.  
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Table 23. Estimated cumulative mortality percentage change per 1
0
C decrease in maximum temperature in Northern Ireland  
during the winter months‡ for ages ≥18 years, 1984-2007.* 
Cause-specific 
mortality group 
      Male and Female All Ages 
18-64 years 65-74 years 75+ years Male Female 
% Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) % Change (95% CI) 
All-cause Mortality†          
 
 2.7 (-0.7, 6.0) 4.5 (1.6, 7.3) 5.1 (3.3, 6.9) 4.8 (2.8, 6.8) 4.3 (2.4, 6.2) 
CVD†                                   4.3 (-1.7, 10.3) 4.7 (-0.1, 9.6)  3.5 (0.1, 6.8) 5.1 (1.8, 8.5) 2.6 (-0.9, 6.1) 
    IHD†
  
3.6 (-3.0, 10.3) 5.2 (-0.3, 10.6) 3.1 (-0.9, 7.2) 4.4 (0.6, 8.2) 3.1 (-1.3, 7.4) 
    MI†
 
 
4.0 (-3.5, 11.6) 4.3 (-1.6, 10.3) 3.3 (-1.2, 7.8) 
 
4.1 (0.02, 8.3) 
 
3.2 (-1.3, 7.8) 
Respiratory Disease∂ 
 
15.3 (0.5, 30.2) 12.8 (2.3, 23.2) 10.4 (4.9, 15.8) 
 
9.2 (3.0, 15.4) 
 
12.9 (7.2, 18.6) 
    COPD† 
 
11.4 (-7.0, 29.7) 15.6 (2.6, 28.6) 7.8 (-2.0, 17.6) 
 
10.4 (1.7, 19.2) 
 
10.9 (0.7, 21.1) 
    Pneumonia∂ 
 
19.2 (-6.3, 44.7) 9.5 (-7.6, 26.6) 9.7 (2.4, 17.1) 
 
7.4 (-1.1, 15.9) 
 
11.9 (5.0, 18.8) 
Stroke† 
 
6.2 (-8.0, 20.3) 3.3 (-6.8, 13.5) 5.0 (-0.3, 10.4) 6.8 (0.2, 13.4) 3.6 (-1.5, 8.7) 
Abbreviations: CI = confidence intervals, COPD = chronic obstructive pulmonary disease, CVD = cardiovascular disease, IHD = ischemic heart disease, MI = myocardial infarction.*Models included  
mortality data for ages ≥18 years, and were adjusted for Lag0 of maximum temperature, relative humidity and air pressure average over 3 day lag, and day of week. % Change = estimated mortality  
percentage change per 1oC decrease in weekly mean of maximum temperature. ‡Winter Months = December to February. ∂ Effect modification examined for cumulative change for lags of week 1 to 4;  
and (†) for cumulative change for lags of week 1 to 3.  
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